
<html lang="en"     class="pb-page"  data-request-id="daa62c88-19f8-4a40-826c-ea599df1fd35"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01127"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain" /></meta><meta name="dc.Creator" content="Mónica  García" /></meta><meta name="dc.Creator" content="Marina  Virgili" /></meta><meta name="dc.Creator" content="Mònica  Alonso" /></meta><meta name="dc.Creator" content="Carles  Alegret" /></meta><meta name="dc.Creator" content="Joan  Farran" /></meta><meta name="dc.Creator" content="Begoña  Fernández" /></meta><meta name="dc.Creator" content="Magda  Bordas" /></meta><meta name="dc.Creator" content="Rosalia  Pascual" /></meta><meta name="dc.Creator" content="Javier  Burgueño" /></meta><meta name="dc.Creator" content="Alba  Vidal-Torres" /></meta><meta name="dc.Creator" content="Antonio R.  Fernández de Henestrosa" /></meta><meta name="dc.Creator" content="Eva  Ayet" /></meta><meta name="dc.Creator" content="Manuel  Merlos" /></meta><meta name="dc.Creator" content="Jose Miguel  Vela" /></meta><meta name="dc.Creator" content="Carlos R.  Plata-Salamán" /></meta><meta name="dc.Creator" content="Carmen  Almansa" /></meta><meta name="dc.Description" content="The synthesis and pharmacological activity of a new series of 4-alkyl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as potent dual ligands for the σ1 receptor (σ1R) and the μ-opioid receptor (MOR) ..." /></meta><meta name="Description" content="The synthesis and pharmacological activity of a new series of 4-alkyl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as potent dual ligands for the σ1 receptor (σ1R) and the μ-opioid receptor (MOR) ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01127" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01127" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01127" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01127" /></link>
        
    
    

<title>Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01127" /></meta><meta property="og:title" content="Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0017.jpeg" /></meta><meta property="og:description" content="The synthesis and pharmacological activity of a new series of 4-alkyl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as potent dual ligands for the σ1 receptor (σ1R) and the μ-opioid receptor (MOR) are reported. A lead optimization program over the initial 4-aryl analogues provided 4-alkyl derivatives with the desired functionality and good selectivity and ADME profiles. Compound 14u (EST73502) showed MOR agonism and σ1R antagonism and a potent analgesic activity, comparable to the MOR agonist oxycodone in animal models of acute and chronic pain after single and repeated administration. Contrary to oxycodone, 14u produces analgesic activity with reduced opioid-induced relevant adverse events, like intestinal transit inhibition and naloxone-precipitated behavioral signs of opiate withdrawal. These results provide evidence that dual MOR agonism and σ1R antagonism may be a useful strategy for obtaining potent and safer analgesics and were the basis for the selection of 14u as a clinical candidate for the treatment of pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01127"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01127">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01127&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01127&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01127&amp;href=/doi/10.1021/acs.jmedchem.0c01127" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15508-15526</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01608" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.0c01179" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ<sub>1</sub> Receptor Antagonist Clinical Candidate for the Treatment of Pain</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Mónica García</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mónica García</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%B3nica++Garc%C3%ADa">Mónica García</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marina Virgili</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marina Virgili</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Enantia, S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Virgili">Marina Virgili</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mònica Alonso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mònica Alonso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Enantia, S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%B2nica++Alonso">Mònica Alonso</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carles Alegret</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carles Alegret</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Enantia, S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carles++Alegret">Carles Alegret</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joan Farran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joan Farran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Enantia, S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joan++Farran">Joan Farran</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Begoña Fernández</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Begoña Fernández</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bego%C3%B1a++Fern%C3%A1ndez">Begoña Fernández</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Magda Bordas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Magda Bordas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Magda++Bordas">Magda Bordas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rosalia Pascual</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rosalia Pascual</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rosalia++Pascual">Rosalia Pascual</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2535-0272" title="Orcid link">http://orcid.org/0000-0002-2535-0272</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Javier Burgueño</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Javier Burgueño</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Javier++Burgue%C3%B1o">Javier Burgueño</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alba Vidal-Torres</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alba Vidal-Torres</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alba++Vidal-Torres">Alba Vidal-Torres</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio R. Fernández de Henestrosa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio R. Fernández de Henestrosa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+R.++Fern%C3%A1ndez+de+Henestrosa">Antonio R. Fernández de Henestrosa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eva Ayet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eva Ayet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Ayet">Eva Ayet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuel Merlos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuel Merlos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuel++Merlos">Manuel Merlos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jose Miguel Vela</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jose Miguel Vela</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jose+Miguel++Vela">Jose Miguel Vela</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlos R. Plata-Salamán</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlos R. Plata-Salamán</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlos+R.++Plata-Salam%C3%A1n">Carlos R. Plata-Salamán</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Carmen Almansa</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carmen Almansa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ESTEVE Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</div><div class="loa-info-affiliations-info">WELAB, Parc Científic Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7d1e1c11101c130e1c3d0a18111c1f531f1c0f1e181112131c"><span class="__cf_email__" data-cfemail="5b383a37363a35283a1b2c3e373a3975393a29383e3734353a">[email protected]</span></a>. Telephone: 0034650697372.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Almansa">Carmen Almansa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5665-4685" title="Orcid link">http://orcid.org/0000-0001-5665-4685</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01127&amp;href=/doi/10.1021%2Facs.jmedchem.0c01127" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15508–15526</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 16, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 July 2020</li><li><span class="item_label"><b>Published</b> online</span>16 October 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01127" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01127</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15508%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DM%25C3%25B3nica%2BGarc%25C3%25ADa%252C%2BMarina%2BVirgili%252C%2BM%25C3%25B2nica%2BAlonso%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01127%26title%3DDiscovery%2Bof%2BEST73502%252C%2Ba%2BDual%2B%25CE%25BC-Opioid%2BReceptor%2BAgonist%2Band%2B%25CF%25831%2BReceptor%2BAntagonist%2BClinical%2BCandidate%2Bfor%2Bthe%2BTreatment%2Bof%2BPain%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15526%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01127"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1737</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01127" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mónica&quot;,&quot;last_name&quot;:&quot;García&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Virgili&quot;},{&quot;first_name&quot;:&quot;Mònica&quot;,&quot;last_name&quot;:&quot;Alonso&quot;},{&quot;first_name&quot;:&quot;Carles&quot;,&quot;last_name&quot;:&quot;Alegret&quot;},{&quot;first_name&quot;:&quot;Joan&quot;,&quot;last_name&quot;:&quot;Farran&quot;},{&quot;first_name&quot;:&quot;Begoña&quot;,&quot;last_name&quot;:&quot;Fernández&quot;},{&quot;first_name&quot;:&quot;Magda&quot;,&quot;last_name&quot;:&quot;Bordas&quot;},{&quot;first_name&quot;:&quot;Rosalia&quot;,&quot;last_name&quot;:&quot;Pascual&quot;},{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;Burgueño&quot;},{&quot;first_name&quot;:&quot;Alba&quot;,&quot;last_name&quot;:&quot;Vidal-Torres&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;R. Fernández de Henestrosa&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Ayet&quot;},{&quot;first_name&quot;:&quot;Manuel&quot;,&quot;last_name&quot;:&quot;Merlos&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;Miguel Vela&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;R. Plata-Salamán&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Almansa&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15508-15526&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01127&quot;},&quot;abstract&quot;:&quot;The synthesis and pharmacological activity of a new series of 4-alkyl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as potent dual ligands for the σ1 receptor (σ1R) and the μ-opioid receptor (MOR) are reported. A lead optimization program over the initial 4-aryl analogues provided 4-alkyl derivatives with the desired functionality and good selectivity and ADME profiles. Compound 14u (EST73502) showed MOR agonism and σ1R antagonism and a potent analgesic activity, comparable to the MOR agonist oxycodone in animal models of acute and chronic pain after single and repeated administration. Contrary to oxycodone, 14u produces analgesic activity with reduced opioid-induced relevant adverse events, like intestinal transit inhibition and naloxone-precipitated behavioral signs of opiate withdrawal. These results provide evidence that dual MOR agonism and σ1R antagonism may be a useful strategy for obtaining potent and safer analgesics and were the basis for the selection of 14u as a clinical candidate for the treatmen&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01127&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01127" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01127&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01127" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01127&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01127" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01127&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01127&amp;href=/doi/10.1021/acs.jmedchem.0c01127" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01127" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01127" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01127%26sid%3Dliteratum%253Aachs%26pmid%3D33064947%26genre%3Darticle%26aulast%3DGarc%25C3%25ADa%26date%3D2020%26atitle%3DDiscovery%2Bof%2BEST73502%252C%2Ba%2BDual%2B%25CE%25BC-Opioid%2BReceptor%2BAgonist%2Band%2B%25CF%25831%2BReceptor%2BAntagonist%2BClinical%2BCandidate%2Bfor%2Bthe%2BTreatment%2Bof%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15508%26epage%3D15526%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis and pharmacological activity of a new series of 4-alkyl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as potent dual ligands for the σ<sub>1</sub> receptor (σ<sub>1</sub>R) and the μ-opioid receptor (MOR) are reported. A lead optimization program over the initial 4-aryl analogues provided 4-alkyl derivatives with the desired functionality and good selectivity and ADME profiles. Compound <b>14u</b> (EST73502) showed MOR agonism and σ<sub>1</sub>R antagonism and a potent analgesic activity, comparable to the MOR agonist oxycodone in animal models of acute and chronic pain after single and repeated administration. Contrary to oxycodone, <b>14u</b> produces analgesic activity with reduced opioid-induced relevant adverse events, like intestinal transit inhibition and naloxone-precipitated behavioral signs of opiate withdrawal. These results provide evidence that dual MOR agonism and σ<sub>1</sub>R antagonism may be a useful strategy for obtaining potent and safer analgesics and were the basis for the selection of <b>14u</b> as a clinical candidate for the treatment of pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently available pain therapies are often suboptimal in terms of efficacy and side effects,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> with a high percentage of population remaining undertreated. As a new strategy to address this high unmet medical need, we recently reported the development of dual compounds targeting both the μ-opioid receptor (MOR) and the σ<sub>1</sub> receptor (σ<sub>1</sub>R).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> MOR agonists, represented here by oxycodone (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), are recognized as the most effective therapies when addressing severe pain states, but their administration is limited by their important side effects, such as constipation, respiratory depression, emesis, and physical dependence.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In addition, after long-term use MOR agonists can induce the development of analgesic tolerance that leads to substantial increases in dosing in order to maintain a clinically satisfactory pain relief. This is partially explained at the molecular level by a MOR down-regulation,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> although other phenomena may be involved. Taking into account the narrow therapeutic window of MOR agonists, this tolerance finally results in unacceptable side effects, poor patient compliance, and addiction, as revealed by the recent opioid crisis affecting the USA.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of oxycodone (<b>1</b>, MOR agonist), E-52862 (<b>2</b>, σ<sub>1</sub>R antagonist), and dual MOR and σ<sub>1</sub>R ligands <b>3</b> and <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The rationale behind the strategy of targeting in the same compound the MOR and the σ<sub>1</sub> receptor (σ<sub>1</sub>R) is linked to both the role of the σ<sub>1</sub>R in central sensitization, which could add value to types of pain where the opioids are less effective, and its potentiation of opioid analgesia. In fact, the σ<sub>1</sub>R was first described as an endogenous anti-opioid system, based on the finding that σ<sub>1</sub>R agonists counteracted MOR mediated analgesia, while σ<sub>1</sub>R antagonists potentiated it.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Later on, the involvement of the σ<sub>1</sub>R in pain was confirmed both by the development of the σ<sub>1</sub>R knockout mice (σ<sub>1</sub>R-KO),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which show no obvious phenotype and perceive normally sensory stimuli, and by the discovery of σ<sub>1</sub>R antagonists, such as S1RA (E-52862, <b>2</b>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Some of the findings observed with compound <b>2</b> support the potential therapeutic value of a dual MOR agonist/σ<sub>1</sub>R antagonist for the treatment of pain. In rodents S1RA administered in combination with morphine potentiated its analgesia but not its adverse effects,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and these findings were reproduced with other σ<sub>1</sub>R and MOR ligands and different kinds of pain models.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In the clinic, S1RA was associated with a relevant reduction of opioid-associated adverse events (nausea, vomiting, and dizziness) and a meaningful reduction for the need of concomitant antiemetic medication.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Compared to the standard clinical practice of using cocktails or multicomponent drugs, developing dual agents offers the advantages of a broader spectrum of action, better treatment compliance, lowering the risk of drug–drug interactions, simpler pharmacokinetics, and less variability among patients.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, combining two mechanisms of action in a single molecule, while keeping at the same time selectivity for other targets, is a major challenge from the medicinal chemistry point of view.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In particular, combining in the same molecule a MOR agonist and σ<sub>1</sub>R antagonist profile represented an additional particular issue, since although the assessment of functionality over the MOR receptor is well established, there is no high throughput test for establishing the functionality of σ<sub>1</sub>R ligands, often characterized only after in vivo testing.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Additionally, getting the good ADME and physicochemical properties required for in vivo activity is more complex than when addressing one single target, since often the dual activity is achieved by combining (i.e., adding) two pharmacophores and it is well-known that large, lipophilic, and flexible molecules are often associated with bad in vivo efficacy and toxicological profiles.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These problems were avoided using a pharmacophore merging approach (i.e., combining the two target pharmacophores in the same central core), which led to the development of the 4-aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives represented by the parent compound <b>3</b><a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The structure–activity relationships (SARs) around <b>3</b> showed that either changing the phenethyl group to benzyl or alkyl groups or reducing the size of any of the six-membered rings of the central scaffold to five-membered rings provided a loss of MOR affinity. In addition, the series showed poor selectivity versus the α<sub>1</sub>A adrenoreceptor (α<sub>1</sub>AR) and the human ether-a-go-go-related gene (hERG), the well-known potassium channel linked to cardiac toxicity.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This initial SAR study maintained an aryl group in position 4 and provided lead compound <b>4</b>, which showed improved hERG inhibition but still retained some α<sub>1</sub>AR affinity and had lost some MOR activity in relation to <b>3</b>. The desired ratio of in vitro affinities for the dual compounds is complex to establish, but a predominant affinity for MOR would not make evident the enhancement of the opioid analgesia provided by the σ<sub>1</sub>R antagonist component. Note that σ<sub>1</sub>R antagonists are inactive when administered alone in acute nociceptive tests<a onclick="showRef(event, 'ref9 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref16">(9,16)</a> but induce a leftward shift of the dose–response curve of opioids (including partial and weak MOR agonists) vs the curve obtained with the same opioids given alone, thus suggesting an enhancement of the opioid potency.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, such a potentiating effect was obtained with doses of opioids producing low to moderate activity when given alone and which are lower than those of σ<sub>1</sub>R ligands (for example, morphine at 2.5–5 mg/kg and σ<sub>1</sub>R antagonist <b>2</b> at 40 mg/kg) and maximal enhancement occurs when opioids are combined at low doses (around their ED<sub>25</sub> if administered alone).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, it is known that pharmacological σ<sub>1</sub>R antagonism enhances opioid antinociception but not opioid-related adverse effects.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Thus, the maximum benefit-to-risk ratio is expected for a drug combining σ<sub>1</sub>R antagonism with weak/partial MOR agonism (efficacy would result from σ<sub>1</sub>R antagonism-mediated maximization of modest opioid effect, whereas side effects would rely on such nonpotentiated baseline opioid component).</div><div class="NLM_p last">We report here the lead optimization program over <b>4</b>, which led to the identification of the dual MOR agonist and σ<sub>1</sub>R antagonist, (<i>R</i>)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (EST73502, <b>14u</b>), as a clinical candidate for the treatment of pain.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the compounds described herein<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was accomplished as described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a> and indicated in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Following a similar strategy to that described in our previous paper for R<sub>1</sub> = aryl analogues,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> a highly versatile route was devised to prepare derivatives <b>14</b>, allowing diversification in substituents R<sub>1</sub>–R<sub>3</sub> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Starting from the <i>N</i>-Boc-piperidone <b>5</b>, epoxide <b>6</b> was prepared<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> using Corey–Chaykovsky reagent<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with potassium <i>tert</i>-butoxide as the base. Next, ring opening with methanolic ammonia led to aminoalcohol <b>7</b> in good yield. Acylation with an adequate acyl halide <b>8</b> (see experimental part for the preparation of 2-bromo-4-chlorobutanoyl chloride<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>) and final intramolecular cyclization in the presence of potassium <i>tert</i>-butoxide at room temperature rendered spirocyclic compounds <b>9</b> that were N-alkylated to obtain key intermediates <b>11</b>. Alternatively, compounds <b>11</b> were also prepared by direct ring-opening of epoxide <b>6</b> with alkylamines <b>15</b> to afford amino alcohols <b>16</b>. In this case, after acylation with <b>8</b>, final cyclization with potassium <i>tert</i>-butoxide was best performed at low temperatures. Finally, Boc-deprotection followed by N-alkylation with phenethyl derivatives <b>13</b> provided the target compounds <b>14</b> in good yields.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Exploration of Substituents in R<sub>1</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> MOR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> MOR<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> MOR<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>1</sub>R<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">α<sub>1</sub>AR<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a> % inh (1 μM)</th><th class="colsep0 rowsep0" align="center">M<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12 ± 3</td><td class="colsep0 rowsep0" align="left">17 ± 9</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">>10000<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10000<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">>10000<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">17 ± 7</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7 ± 6</td><td class="colsep0 rowsep0" align="left">14 ± 2</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">6 ± 0.4</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">175 ± 85</td><td class="colsep0 rowsep0" align="left">195 ± 19</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">58 ± 10</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">2 ± 0.3</td><td class="colsep0 rowsep0" align="left">2 ± 0.1</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">10 ± 3</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">2-phenylethyl</td><td class="colsep0 rowsep0" align="left">20 ± 2</td><td class="colsep0 rowsep0" align="left">22 ± 13</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">12 ± 2</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14c</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">6 ± 1</td><td class="colsep0 rowsep0" align="left">7 ± 1</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">58 ± 15</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14d</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">33 ± 5</td><td class="colsep0 rowsep0" align="left">21 ± 2</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">30 ± 5</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14e</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">41 ± 12</td><td class="colsep0 rowsep0" align="left">65 ± 4</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">43 ± 5</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14f</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">156 ± 5</td><td class="colsep0 rowsep0" align="left">787 ± 162</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">142 ± 28</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">H<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t1fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t1fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">892 ± 196</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Binding affinity (<i>K</i><sub>i</sub>) in a MOR binding assay using [<sup>3</sup>H]-DAMGO as radioligand. Each value is the mean ± SD of at least two determinations.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">MOR functionality (EC<sub>50</sub>) measuring cyclic AMP (cAMP) on CHO-K1 cells. Each value is the mean ± SD of two determinations.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Efficacy of 100% is defined as the maximum effect induced by stimulation with DAMGO. It is provided for compounds showing EC<sub>50</sub> below 1000 nM in the functional assay.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Binding affinity (<i>K</i><sub>i</sub>) to human σ<sub>1</sub>R in transfected HEK-293 membranes using [<sup>3</sup>H](+)-pentazocine as radioligand. Each value is the mean ± SD of two determinations.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Whole-cell patch clamp hERG blockade.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Percentage inhibition of α1A receptor at 1 μM ligand concentration.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">Methods used for the synthesis of compounds according to the schemes described in the <a class="ref internalNav" href="#sec2" aria-label="Chemistry">Chemistry</a> section.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">Less than 50% inhibition at 10 μM.</p></div><div class="footnote" id="t1fn9"><sup><sup>i</sup></sup><p class="last">Enantiopure compound (<i>R</i> stereochemistry).</p></div><div class="footnote" id="t1fn10"><sup><sup>j</sup></sup><p class="last">2-Fluorophenethyl in piperidine.</p></div><div class="footnote" id="t1fn11"><sup><sup>k</sup></sup><p class="last">Less than 50% inhibition at 1 μM.</p></div></div></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOI, <sup><i>t</i></sup>BuOK, DMSO–DME, 0–5 °C, 1 h; (b) MeOH, rt, 16 h; (c) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min, or TEA, DCM, 0 °C; (d) <sup><i>t</i></sup>BuOK, THF, rt, 16 h; (e) NaH, DMF, rt; (f) TFA, DCM, rt or reflux; (g) K<sub>2</sub>CO<sub>3</sub> or DIPEA, NaI, acetonitrile, 80 °C, 16 h; (h) EtOH–water 9:1, rt, 16 h; (i) <sup><i>t</i></sup>BuOK, THF, −78 to −30 °C, 1–4 h.</p></p></figure><div class="NLM_p">Compound <b>17</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was prepared from compound <b>9-1</b> (where R<sub>2</sub> = Me, R<sub>2′</sub> = H) by direct Boc-deprotection followed by N-alkylation with 2-fluorophenethyl bromide as described above for the preparation of compounds <b>14</b> from <b>11</b>.</div><div class="NLM_p">Although <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> is of general application, some variations were used in particular cases. <i>N</i>-Phenethylpiperidone <b>18</b> is commercially available and was used to prepare compounds <b>14</b> bearing the phenethyl substituent right from the start (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). A strategy similar to that described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> afforded in good yield key intermediate <b>21</b>, which was N-alkylated to render target compounds <b>14a</b>,<b>b</b>,<b>d</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOI, NaH, DMSO, rt to 50 °C, 1 h; (b) NH<sub>3,</sub> MeOH, rt, 16 h; (c) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min; (d) <sup><i>t</i></sup>BuOK, THF, rt, 16 h; (e) NaH, DMF, rt, 16 h.</p></p></figure><div class="NLM_p">An even shorter route was used to prepare compounds <b>14g</b>, <b>14l</b>, and <b>14m</b>, by opening of the epoxide <b>19</b> with methylamine, followed by acylation and cyclization (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Dimethylated compound <b>14m</b> was best prepared using longer reaction times and higher temperatures in both steps. Chiral compound <b>14g</b> was obtained with ee 90–93% using chiral (<i>S</i>)-2-chloropropanoyl chloride <b>8-1S</b> as the acylating agent in a biphasic system (EtOAc–water) and assuming inversion of configuration in the cyclization step; final enrichment via crystallization of the hydrochloride salt was performed to reach ee >98% (as determined by chiral HPLC).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtOH–water 6:1, rt, 4 h; (b) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min (<b>14g</b>), or TEA, DCM, 0 °C, 2 h (<b>14l</b>), or NaHCO<sub>3</sub>, DCM, rt, 16 h (<b>14m</b>); (c) <sup><i>t</i></sup>BuOK, THF, −78 °C to −30 °C, 1–4 h (up to 0 °C, 3 h for <b>14m</b>).</p></p></figure><div class="NLM_p">Enantiopure compounds were more conveniently synthesized using the optimized procedure shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> and detailed for compound <b>14u</b> (described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> as representative example). Acylation of amino alcohols <b>16</b> with enantiopure acyl chlorides <b>8S</b>, followed by treatment with potassium <i>tert</i>-butoxide and assuming inversion of configuration in the cyclization, provided key intermediates <b>11</b> as the <i>R</i>-enantiomer (<b>11R</b>) with excellent yield and ee 90–94% as determined by chiral HPLC. Crystallization from a suitable solvent (i.e., for <b>11-1R</b> a mixture of isopropyl acetate and heptane) allowed for optical purity enrichment rendering compounds <b>11R</b> with ee >98%. Final Boc-deprotection followed by N-alkylation with <b>13</b> provided compounds <b>14</b> as the <i>R</i>-enantiomer with ee >97% (as determined by chiral HPLC).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min; (b) (i) <sup><i>t</i></sup>BuOK, THF, <i>T</i> < −60 °C, 1 h, (ii) crystallization from AcO<sup><i>i</i></sup>Pr–heptane; (c) TFA, DCM, rt, 3 h; (d) <b>13</b>, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, 80 °C, 16 h.</p></p></figure><div class="NLM_p">Following the same sequence described for compound <b>14u</b> but starting from the acylating reagent of opposed configuration <b>8-1R</b>, the <i>S</i>-enantiomer <b>14x</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) was obtained.</div><div class="NLM_p">A single-crystal X-ray diffraction (SCXRD) study of <b>14u</b> confirmed the <i>R</i> stereochemistry at position 2 (carbon atom labeled as C1 in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Since no suitable crystals were obtained using the free base, a limited salt screening was carried out. The hydrobromide provided crystals suitable for SCXRD analysis, from which the absolute configuration was reliably determined by anomalous dispersion effects (Flack parameter = −0.019(8)).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. View of the asymmetric unit of the crystal structure of the hydrobromide salt of <b>14u (</b>CCDC 1979266), showing the <i>R</i> configuration at position 2 (C1 atom).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, compound <b>14u</b> overlaps well with the MOR and σ<sub>1</sub>R pharmacophores used in the generation of the series in the previous work.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The ethyl group in position 4 overlaps well with the hydrophobic feature (HYD34) of the σ<sub>1</sub>R pharmacophore that was aligned with the aromatic ring feature (AR) of the MOR pharmacophore.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>14u</b> superimposed onto the MOR (left), σ<sub>1</sub>R (middle), and the merged MOR-σ<sub>1</sub>R (right) pharmacophores (the AR feature is shown unhighlighted). Pharmacophores were constructed as described in previous work.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds synthesized were evaluated in a primary σ<sub>1</sub>R binding assay using [<sup>3</sup>H]-(+)-pentazocine<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as radioligand and in a MOR binding assay using [<sup>3</sup>H]-DAMGO<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> as radioligand. The MOR functional assay was carried out by measuring cyclic AMP (cAMP) on CHO-K1 cells<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> providing EC<sub>50</sub> as well as <i>E</i><sub>max</sub> data (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Generally speaking, a full agonist profile is suggested for compounds active at the MOR with <i>E</i><sub>max</sub> above 80%. However, a cell line overexpressing the MOR with a high receptor reserve<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> is used in this assay, and thus no unequivocal determination of the functional nature (i.e., full versus partial agonism) can be established and more complex assays are needed such as partial receptor inactivation with β-funaltrexamine.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The active compounds were also evaluated at 10 μM for hERG blockade and at 1 μM in a selectivity panel constituted by the guinea pig σ<sub>2</sub> receptor (σ2R) and the following human receptors: 5-HT<sub>1A</sub> receptor, 5-HT<sub>2B</sub> receptor, α<sub>1</sub>A and α<sub>2</sub>A adrenoreceptors, dopamine transporter, δ-opioid receptor, κ-opioid receptor, histamine H<sub>1</sub> receptor, norepinephrine transporter, and serotonin transporter. This panel includes targets validated for pain and others associated with undesirable side effects in order to rule out off-target activities that could interfere with the analgesic response of the compounds. As in the 4-aryl series, selectivity was good and only some of the initial compounds were active for the α<sub>1</sub>AR, one of the issues to be improved in this lead optimization program together with hERG inhibition.</div><div class="NLM_p">The initial work over the 1-oxa-4,9-diazaspiro[5.5]undecan-3-one scaffold indicated that the structural features required to maintain dual activity were the arylethyl group in position 9 (other chain lengths impaired MOR affinity) and the carbonyl oxygen atom in position 3, while substituting position 2 with an alkyl group improved considerably MOR affinity.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> An aromatic ring in position 4 (R<sub>1</sub>) was also initially maintained, according to the superposition of the initial proposal with the MOR pharmacophore, where this ring occupied a nearby position to the phenol ring of morphine. When the current lead optimization program was initiated, we decided to explore the elongation of the distance between the aromatic ring and N<sub>4</sub>. Interestingly (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), both targets accommodated a benzyl group (<b>14a</b>), although hERG inhibition was worse in relation to <b>3</b>. Further elongation to phenethyl (<b>14b</b>) was also tolerated by both MOR and σ<sub>1</sub>R, although hERG inhibition did not improve. Many different heterocycles were introduced in both benzyl and phenethyl-type derivatives, but either one of the affinities was lost or hERG inhibition did not improve (results not shown).</div><div class="NLM_p">We decided then to explore the elimination of the aromatic ring in R<sub>1</sub>. The cyclopropyl derivative <b>14c</b> maintained affinities and provided an improved hERG result, while the simpler alkyl groups isopropyl (<b>14d</b>) and ethyl (<b>14e</b>) additionally provided a clear reduction in α1AR affinity, which for the first time was below 50% inhibition at 1 μM. The smallest alkyl derivative <b>14f</b> showed a reduced affinity for the primary targets but confirmed the trend toward α<sub>1</sub>AR affinity reduction and also provided a hERG IC<sub>50</sub> above 10 μM, our desired cutoff criteria. This improvement in hERG affinity may well be due to the relevant reduction in lipophilicity of <b>14f</b> in relation to <b>14a</b>. Finally, the unsubstituted derivative <b>17</b> was devoid of any affinity in accordance with the lack of any group covering the HYD34 or AR features of the σ<sub>1</sub>R or the MOR pharmacophores, respectively. These results indicated that an alkyl group was tolerated in position 4 and offered a chance for obtaining a dual compound with selectivity for α<sub>1</sub>A and hERG.</div><div class="NLM_p">Maintaining a methyl group in position 4, position 2 (R<sub>2</sub>) was modified (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). As in the 4-aryl series, the (<i>R</i>)-methyl <b>14g</b> was the eutomer regarding MOR affinity, while both enantiomers (<b>14g</b> and <b>14h</b>) were equipotent for the σ<sub>1</sub>R. It was confirmed that the alkyl group in R<sub>2</sub> was indeed necessary for MOR affinity, in view of the low affinity of the unsubstituted analogue <b>14i</b>. The alkyl group in R<sub>2</sub> was elongated to ethyl (<b>14j</b>) or isopropyl (<b>14k</b>), and while the dual affinity was similar to the methyl <b>14g</b>, hERG inhibition was higher. In agreement with the results obtained with the 4-aryl derivatives, further elongation of R<sub>2</sub> or introduction of polar groups, such as hydroxyl and carboxylic acid derivatives, was detrimental (results not shown). Direct attachment of a phenyl group in R<sub>2</sub> (<b>14l</b>), a substitution that had not been previously explored, also impaired MOR activity. The dimethylated compound <b>14m</b> was also poorly active at the MOR receptor, while the spirocyclopropyl <b>14n</b> was similar to <b>14g</b>. In conclusion, (<i>R</i>)-methyl, isopropyl, and spirocyclopropyl were the best possible alternatives in position 2, although the methyl group was more appealing in view of its reduced hERG inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Exploration of Substituents in R<sub>2</sub>/R<sub>2′</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">comp</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub>, R<sub>2′</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> MOR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> MOR<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> MOR<a class="ref internalNav" href="#t2fn1" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ<sub>1</sub>R<a class="ref internalNav" href="#t2fn1" aria-label="d">d</a> (<i>h,</i> nM)</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t2fn1" aria-label="e">e</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">α<sub>1</sub>AR<a class="ref internalNav" href="#t2fn1" aria-label="f">f</a> % inh (1 μM)</th><th class="colsep0 rowsep0" align="center">M<a class="ref internalNav" href="#t2fn1" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14g</b></td><td class="colsep0 rowsep0" align="left">Me, H (<i>R</i>)</td><td class="colsep0 rowsep0" align="left">91 ± 10</td><td class="colsep0 rowsep0" align="left">319 ± 104</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">277 ± 76</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t2fn1" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14h</b></td><td class="colsep0 rowsep0" align="left">Me, H (<i>S</i>)</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn2" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">1780 ± 196</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">165 ± 55</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t2fn3" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t2fn4" aria-label="k">k</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14i</b></td><td class="colsep0 rowsep0" align="left">H, H</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn2" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn2" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">282 ± 48</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t2fn3" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14j</b></td><td class="colsep0 rowsep0" align="left">Et, H (<i>R</i>)</td><td class="colsep0 rowsep0" align="left">192 ± 41</td><td class="colsep0 rowsep0" align="left">505 ± 122</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">139 ± 16</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14k</b></td><td class="colsep0 rowsep0" align="left"><sup><i>i</i></sup><i>P</i>r, H</td><td class="colsep0 rowsep0" align="left">115 ± 39</td><td class="colsep0 rowsep0" align="left">174 ± 42</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">122 ± 24</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14l</b></td><td class="colsep0 rowsep0" align="left">Ph, H</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn2" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn2" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">242 ± 13</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t2fn3" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14m</b></td><td class="colsep0 rowsep0" align="left">Me, Me</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn2" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">624 ± 35</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">50 ± 5</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t2fn3" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14n</b></td><td class="colsep0 rowsep0" align="left">spirocyclopropyl</td><td class="colsep0 rowsep0" align="left">221 ± 51</td><td class="colsep0 rowsep0" align="left">442 ± 65</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">161 ± 43</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t2fn5" aria-label="l">l</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a,b,c,d,e,f,g,h</sup></sup><p class="last">See corresponding footnotes of <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t2fn2"><sup><sup>i</sup></sup><p class="last">Less than 50% inhibition at 1 μM.</p></div><div class="footnote" id="t2fn3"><sup><sup>j</sup></sup><p class="last">Not tested.</p></div><div class="footnote" id="t2fn4"><sup><sup>k</sup></sup><p class="last">Enantiopure compound (<i>S</i> stereochemistry) was obtained by resolution of the racemate <b>14f</b> (prepared following <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) by chiral prep HPLC.</p></div><div class="footnote" id="t2fn5"><sup><sup>l</sup></sup><p class="last">Synthesis described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">Regarding the piperidinyl substituent, we knew from the 4-aryl series<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> that the phenethyl length was optimal, since benzyl or alkyl groups led to MOR affinity impairment, and that fluorine was the best substituent to maintain affinity and provide chances of keeping hERG IC<sub>50</sub> above 10 μM. A wide exploration was undertaken over a matrix of compounds composed of the best substituents in position 2 (methyl, ethyl, isopropyl, or spirocyclopropyl) and position 4 (methyl, ethyl, isopropyl, or cyclopropyl). For the sake of the length of the present paper, only detailed SAR over the 4-ethyl-2-methyl derivatives is reported (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The naked 4-ethyl derivative <b>14o</b> improved affinities for the primary targets in relation to its 4-methyl counterpart (<b>14g</b>) and maintained selectivity for the α<sub>1</sub>AR but showed suboptimal hERG inhibition. The fluoro derivatives <b>14p</b>–<b>r</b> maintained dual affinities for MOR and σ<sub>1</sub>R but did not improve hERG inhibition. The introduction of a second fluorine atom provided a loss of σ in the 2,3-difluoro (<b>14s</b>) and 2,6-difluoro (<b>14v</b>) analogues and maintained a good dual profile in the rest. However, only the 2,5-difluoroderivative <b>14u</b> showed the desired dual profile with selectivity for the α<sub>1</sub>AR and hERG inhibition with IC<sub>50</sub> above 10 μM. Other substitutions besides fluorine were also assayed, but it was again observed that polar groups were detrimental for the primary affinities, as illustrated by the low MOR affinity of compound <b>14w</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), containing a 2-pyridylethyl group, one of the few tolerated polar moieties in our previous work.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Refinement of the Phenethyl Substituents R<sub>3</sub>/R<sub>3′</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0015.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3′</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> MOR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> MOR<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a> (<i>h</i>, nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> MOR<a class="ref internalNav" href="#t3fn1" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> σ1R<a class="ref internalNav" href="#t3fn1" aria-label="d">d</a> (<i>h,</i> nM)</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t3fn1" aria-label="e">e</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">α<sub>1</sub>AR<a class="ref internalNav" href="#t3fn1" aria-label="f">f</a> % inh (1 μM)</th><th class="colsep0 rowsep0" align="center">M<a class="ref internalNav" href="#t3fn1" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14o</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">26 ± 4</td><td class="colsep0 rowsep0" align="left">49 ± 4</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">66 ± 19</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t3fn2" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14p</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">18 ± 7</td><td class="colsep0 rowsep0" align="left">24 ± 3</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">68 ± 18</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14q</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">56 ± 17</td><td class="colsep0 rowsep0" align="left">56 ± 21</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">64 ± 30</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14r</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">164 ± 29</td><td class="colsep0 rowsep0" align="left">108 ± 42</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">76 ± 12</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14s</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">22 ± 10</td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">556 ± 266</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t3fn3" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14t</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">62 ± 25</td><td class="colsep0 rowsep0" align="left">53 ± 17</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">94 ± 12</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14u</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">64 ± 5</td><td class="colsep0 rowsep0" align="left">52 ± 1</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">118 ± 7</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">>10<a class="ref internalNav" href="#t3fn3" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14v</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">21 ± 6</td><td class="colsep0 rowsep0" align="left">16 ± 1</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">609 ± 253</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t3fn4" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>4</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a,b,c,d,e,f,g</sup></sup><p class="last">See corresponding footnotes of <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t3fn2"><sup><sup>h</sup></sup><p class="last">Enantiopure compound was obtained by resolution of the racemate <b>14e</b> (prepared following <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) by chiral prep HPLC.</p></div><div class="footnote" id="t3fn3"><sup><sup>i</sup></sup><p class="last">Less than 50% inhibition at 10 μM.</p></div><div class="footnote" id="t3fn4"><sup><sup>j</sup></sup><p class="last">Not tested.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Miscellaneous Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a,b,c,d,e,f,g,h</sup></sup><p class="last">See corresponding footnotes of <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t4fn2"><sup><sup>i</sup></sup><p class="last">Not tested.</p></div><div class="footnote" id="t4fn3"><sup><sup>j</sup></sup><p class="last">Synthesis described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t4fn4"><sup><sup>k</sup></sup><p class="last">Less than 50% inhibition at 10 μM.</p></div></div><div></div></div><div class="NLM_p">Overall, compound <b>14u</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) emerged as the best derivative with the correct functionality for the primary targets. Phenytoin binding experiments<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> showed antagonist behavior for the σ<sub>1</sub>R, while β-funaltrexamine experiments<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> showed partial agonist behavior for the MOR (the detailed results will be reported elsewhere soon). Compound <b>14u</b> was devoid of hERG inhibition, had low potential for drug–drug interactions based on the low inhibition (<50% at 1 μM) of recombinant human cytochrome P450 (rhCYP) isoforms (1A2, 2C9, 2C19, 2D6, and 3A4),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and showed high in vitro metabolic stability in human liver microsomes<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>(Cl<sub>int</sub> = 2.4 (μL/min)/mg protein). Additionally, compound <b>14u</b> did not show in vitro cytotoxic potential in the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and neutral red uptake assays when tested up to 100 μM in HepG2 cells<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and lacked genotoxic potential in the SOS/umu and Ames bacterial mutation assays.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure and in vitro profile of the clinical candidate <b>14u</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>14u</b> also showed a good physicochemical profile, with moderate basicity (p<i>K</i><sub>a</sub> = 7.9) and lipophilicity (experimental log <i>P</i> = 2.7, log <i>D</i><sub>7.4</sub> = 2.0) and very high solubility in the whole physiologically meaningful pH range (thermodynamic solubility of 17.7 mg/mL at pH 7.4 and 45.1 mg/mL at pH 2). This together with its high permeability in Caco-2 cells (349 nm/s) indicates that <b>14u</b> will be classified as a BCS class I compound.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>14u</b> complied with Lipinski’s rules and was not highly basic, this being a desirable parameter as pointed out by Wager et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These authors developed the central nervous system multiparameter optimization (CNS MPO) algorithm as a holistic approach for the prediction of good ADME and safety attributes in the case of CNS-directed compounds. An MPO value of 4.4 was calculated for <b>14u</b>, which is considered to be in the desirable range. In fact <b>14u</b> crosses the BBB, showing an AUC brain/AUC plasma ratio of 2.6 (the complete pharmacokinetic study will be published in due course). This is relevant taking into account that brain exposure is required for opioids to exert antinociceptive effects in acute nociceptive tests<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and modulation of opioid analgesia by σ<sub>1</sub>R is known to occur in brainstem nuclei.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Compound <b>14u</b> failed to show any significant affinity (inhibition % at 1 μM of <50%) for another 180 molecular targets (receptors, transporters, ion channels, and enzymes),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> indicating that it selectively binds to the MOR and σ<sub>1</sub>R. Also, in agreement with the general trend of the series, the activity of <b>14u</b> for the MOR receptor is quite stereospecific, since its enantiomer (<b>14x</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) is almost devoid of affinity.</div><div class="NLM_p">In order to gain insight into the binding mechanism of compound <b>14u</b> in the MOR, its X-ray geometry was docked into the published crystal structure of the active MOR (5C1M).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The obtained complex, including the cocrystallized nanobody, was embedded into a POPC bilayer and solvated. After several equilibration steps, a 500 ns molecular dynamic simulation (MD) was run and the resulting trajectory analyzed, showing a good stability, with an average root-mean-square deviation (RMSD) of 2.4 Å and a standard deviation of 0.24 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The same was done with enantiomer <b>14x</b>, and although qualitatively the interactions of both compounds with the receptor are similar, when calculating the average interaction energy throughout the trajectories, <b>14u</b> gives a value of −110 kcal/mol whereas a value of −106 kcal/mol was obtained for <b>14x</b>. This stronger interaction of <b>14u</b> may be a reason for its more favorable binding.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Evolution of the molecular dynamics run for compounds <b>14u</b> and <b>14x</b> docked in the MOR (5C1M). (B) Docking pose of <b>14u</b> in the active MOR (5C1M). (C) 2D diagram of the main interactions of <b>14u</b> with the active MOR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The main polar protein–ligand interactions observed for <b>14u</b> are equivalent to those identified for the cocrystallized BU72: A ionic hydrogen bond interaction of the compound’s tertiary amine with Asp 147; a highly conserved amino acid in all GPCRs that bind biogenic amines; and a water-mediated interaction of the carbonyl in position 3 with His 297 with a water network that is more extended involving Tyr 148, Lys 233 (characteristic for the MOR active structure). Other observed interactions are depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C.</div><div class="NLM_p">The antinociceptive activity of compound <b>14u</b> was evaluated in the paw pressure test in CD1 male mice (<i>n</i> = 6–12 per group). After oral administration, <b>14u</b> showed a dose–response analgesic effect reaching a maximum of 64% and an ED<sub>50</sub> of 14 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). The contribution of the σ<sub>1</sub>R to its analgesic effect was evaluated by combined administration with the σ<sub>1</sub>R agonist PRE-084 (64 mg/kg, sc). In the presence of PRE-084, <b>14u</b> reached a maximal effect of 40%, showing a partial inhibition of its analgesic activity and reaching a plateau effect, in agreement with its partial MOR agonist activity. Conversely, systemic administration of the MOR antagonist naloxone (2 mg/kg, sc) fully reversed the analgesic activity of <b>14u</b>, in accordance with previous data demonstrating that blockade of the σ<sub>1</sub>R does not inhibit nociceptive pain but potentiates opioid induced analgesia.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These data show that both σ<sub>1</sub>R and MOR contribute to <b>14u</b> analgesic activity.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose–response antinociception curves in the paw pressure test of <b>14u</b> administered alone (filled points) or in the presence of the selective σ<sub>1</sub>R agonist PRE084 (empty points, A) and the MOR antagonist naloxone (empty points, B) in male CD1 mice after systemic (po) administration. Each point and vertical line represents the mean ± SEM percentage of effect (<i>n</i> = 6–12 per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The analgesic activity of <b>14u</b> was also evaluated in the partial sciatic nerve ligation (PSNL) model in CD1 male mice (<i>n</i> = 6–12 per group) in comparison to oxycodone (<b>1</b>). The neuropathic pain was evaluated by the mechanical allodynia produced, which was revealed by a decrease in the pressure required to elicit withdrawal of the ipsilateral paw after von Frey filament stimulation on days 5, 13, 18, and 22 after surgery. Compound <b>14u</b> (5 mg/kg, ip), oxycodone (<b>1</b>, 1.25 mg/kg, ip), or vehicle were repeatedly administered twice a day from day 13 to day 22 after surgery. Both, <b>14u</b> and <b>1</b> attenuated the expression of mechanical allodynia induced by PSNL, reaching a maximal effect of 56% and 51%, respectively. The effect remained unchanged throughout the treatment duration (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Effect of <b>14u</b> (blue bars) or oxycodone (<b>1</b>, gray) in comparison to vehicle (white) on PSNL-induced mechanical allodynia in male CD1 mice. Compound <b>14u</b> (5 mg/kg) and oxycodone (1.25 mg/kg) were systemically (ip) administered b.i.d. during 10 days. (B) Naloxone precipitated withdrawal response in PSNL mice repeatedly administered with <b>14u</b> (blue), oxycodone (gray), or vehicle (white) during 11 days. Naloxone (1 mg/kg, sc) was administered on day 11, 30 min after each treatment administration. The withdrawal response was evaluated immediately after naloxone injection using a global score as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Each bar and vertical line represent the mean ± SEM percentage of effect (<i>n</i> = 6–12 per group): *<i>p</i> < 0.05, **<i>p</i> < 0,01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On day 23 after surgery, the behavioral expression of withdrawal syndrome after repeated treatment was evaluated by naloxone administration (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Using a model previously described and detailed in the experimental part,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> two classes of behavioral signs were measured: (i) the number of signs and (ii) the presence or absence of each sign during 3 periods of 5 min each. A global score was calculated for each animal as the sum of all behavioral responses. No differences between <b>14u</b> and vehicle treated groups were observed after naloxone administration. However, oxycodone produced a significant expression of some behavioral signs of opiate withdrawal at the end of treatment, producing an increase in the global withdrawal score. These results demonstrate that, contrary to oxycodone, compound <b>14u</b> induced sustained analgesic effect in PSNL mice after repeated administration without expression of naloxone precipitated behavioral signs of opiate withdrawal.</div><div class="NLM_p">The effect of <b>14u</b> on intestinal transit reduction (as a surrogate of constipation) in CD1 mice was also evaluated, as an additional measure of the potential of the compound in showing a reduced opioid-induced side effect profile. The percentage of distance traveled by charcoal meal versus the total length of the small intestine was measured after drug administration in relation to the control group that received vehicle. Systemic administration of compound <b>14u</b> elicited a reduced intestinal transit inhibition in mice in comparison with oxycodone at equianalgesic doses (40 mg/kg and 20 mg/kg po, respectively, <i>n</i> = 6–12 per group, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>14u</b> (blue bars) or oxycodone (gray bars) on intestinal transit inhibition measured in the charcoal test vs the analgesic response in male CD1 mice after systemic (po) administration. Each bar and vertical line represent the mean ± SEM percentage of effect (<i>n</i> = 6–12 per group): ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, the synthesis and pharmacological activity of a new series of 4-alkyl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives <b>14</b> as potent dual ligands for σ<sub>1</sub>R and MOR are reported herein. This family was developed through a lead optimization program over the 4-aryl counterparts, which were designed by using a merging strategy of both target pharmacophores. From the beginning, the series was associated with high hERG inhibition and suboptimal selectivity for the α<sub>1</sub>AR. This second item was clearly improved on changing the aryl in position 4 by alkyl groups, but reducing hERG inhibition proved to be much more difficult. In fact, only a handful of derivatives from the hundreds prepared were above the desired threshold (IC<sub>50</sub> above 10 μM). Among them, compound <b>14u</b> selectively binds with the desired functionality to the selected targets, behaving as a partial MOR agonist and σ<sub>1</sub>R antagonist. Compound <b>14u</b> exhibited analgesic activity in animal models of acute (paw pressure) and chronic (PSNL) pain after single and repeated administration. Both σ<sub>1</sub>R and MOR contribute to its antinociceptive effect as it was shown after the combined administration with both the σ<sub>1</sub>R agonist PRE-084 and the MOR antagonist naloxone. Contrary to oxycodone, <b>14u</b> produces analgesic activity with reduced opioid induced relevant adverse events, like intestinal transit inhibition and naloxone-precipitated behavioral signs of opiate withdrawal.</div><div class="NLM_p last">Compound <b>14u</b> (EST73502, (<i>R</i>)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one) was selected as a clinical candidate for the treatment of pain in view of its potential to provide good analgesic efficacy with a substantially reduced adverse event profile in relation to the standards of care. Phase 1 clinical trials are underway and will be reported in due course.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Flash chromatography was performed on a Teledyne Isco CombiFlash RF system with disposable columns. <sup>1</sup>H spectra were recorded on a Varian Mercury 400 MHz (spectrometer fitted with a 5 mm ATB 1H/19F/X probe) with 2 H lock in deuterated solvents. Chemical shifts (δ) are in parts per million. Commercially available reagents and solvents (HPLC grade) were used without further purification for all the analytical tests. Analytical HPLC–MS for all final compounds and intermediates was performed on an Agilent HP1200-MS 6110 system. A reverse phase XBridge C18 XP column was used (4.6 mm × 30 mm, 2.5 μm), gradient 5–100% B (A = 10 mM ammonium bicarbonate, B = acetonitrile) over 8 min, injection volume 1 μL, flow 2.0 mL/min, temperature 40 °C. UV spectra were recorded at 210 nm using an Agilent HP1200 VWD detector. Mass spectra were obtained over the range <i>m</i>/<i>z</i> 50–1000 by electron spray ionization (ESI) in positive mode using Agilent MS6110 simple quadrupole. Data were integrated and reported using Agilent ChemStation software. All compounds displayed purity higher than 95% as determined by this method, with the exception of compound <b>14n</b>, whose purity was 94%. Accurate mass measurements were carried out using an Agilent 6540 UHD Accurate-Mass QTOF system and obtained by electron spray ionization (ESI) in positive mode. Chiral analytical and preparative HPLC was performed in Agilent 1100 analytical and preparative HPLC systems, respectively. The coated or immobilized polysaccharide columns were acquired from Chiral Technologies Europe; heptane and ethanol or IPA with or without DEA at variable proportions were used as mobile phases. All compounds active in biological assays were electronically filtered for structural attributes common to pan assay interference compounds (PAINS) and were found to be negative.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Determination of Physicochemical Properties</h3><div class="NLM_p last">p<i>K</i>a was calculated using ACDLABS 9.0.3 and cLogP using ChemDraw Ultra 10.0.3. Solubility was measured as thermodynamic solubility from solid compound in phosphate buffer at pH = 7.4 by HPLC. The log <i>P</i> and p<i>K</i>a were determined by using a pHmetric technique<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> in a GlpKa or a Sirius-T3 Analytical instrument.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (<i>S</i>)-2-Chloropropanoyl Chloride (<b>8-1S</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-2-chloropropanoic acid (100.00 g, 0.92 mol) in DCM (1.2 L) under a nitrogen atmosphere, DMF (2 mL) was added. Then, a solution of oxalyl chloride (83 mL, 0.97 mol) in DCM (250 mL) was added dropwise over 30 min, maintaining the internal temperature below 25 °C. After stirring for additional 2.5 h at rt, the solvent was evaporated under vacuum (bath temperature below 15 °C as the product is volatile) to give (<i>S</i>)-2-chloropropanoyl chloride (<b>8-1S</b>) as a pale yellow oil (115.90 g, 99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>,) δ 4.66 (q, <i>J</i> = 7.0 Hz, 1H), 1.82 (d, <i>J</i> = 6.8 Hz, 3H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2,5-Difluorophenethyl Methanesulfonate (<b>13-1</b>)</h3><div class="NLM_p last">A solution of 2-(2,5-difluorophenyl)ethanol (22.42 g, 0.14 mol) in DCM (224 mL) was cooled to −10 °C under a nitrogen atmosphere. TEA (20 mL, 0.14 mol) was added dropwise, maintaining the internal temperature below −5 °C. Then, methanesulfonyl chloride (11.1 mL, 0.14 mol) was added dropwise, maintaining the internal temperature below −5 °C. When the addition was completed, a white precipitate appeared. The resulting mixture was stirred for additional 2 h at rt. IPC (TLC, DCM/MeOH 9/1) was performed to monitor full conversion. Saturated aqueous NaHCO<sub>3</sub> was then added, and the resulting mixture was stirred for 1 h at rt. Then, it was extracted three times with DCM. The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness to give 2,5-difluorophenethyl methanesulfonate (<b>13-1</b>) as a yellow oil (28.03 g, 91% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.10–6.90 (m, 3H), 4.43 (t, <i>J</i> = 6.7 Hz, 2H), 3.08 (t, <i>J</i> = 6.7 Hz, 2H), 2.94 (s, 3H).</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedures for the Synthesis of 4-Alkyl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives <b>14</b>. 4-Isopropyl-2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14d</b>) (Representative Example of <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h3><div class="NLM_p">Step 1: To a suspension of trimethylsulfoxonium iodide (13.00 g, 59.07 mmol) and NaH (2.36 g, 60 wt % in mineral oil, 59.00 mmol) in dry DMSO (70 mL), a solution of 1-phenethylpiperidin-4-one (<b>18</b>, 10.00 g, 49.19 mmol) in dry DMSO (70 mL) was added dropwise. The reaction mixture was stirred at rt for 30 min, then it was heated at 50 °C for 1 h. After cooling to rt, ice was slowly added, and the reaction mixture was extracted three times with ethyl acetate. The organic phases were combined, washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum to give 6-phenethyl-1-oxa-6-azaspiro[2.5]octane (<b>19</b>) as an orange oil (8.24 g, 77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.25 (m, 2H), 7.23–7.17 (m, 3H), 2.87–2.79 (m, 2H), 2.74–2.58 (m, 8H), 1.88 (ddd, <i>J</i> = 13.2, 9.0, 4.3 Hz, 2H), 1.63–1.53 (m, 2H). HPLC–MS: purity 99%, <i>m</i>/<i>z</i> = 218.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2: A mixture of <b>19</b> (4.00 g, 18.41 mmol) and ammonia solution (79 mL, 7 M solution in MeOH, 0.55 mol) was stirred at rt overnight. The solvent was removed under vacuum to give 4-(aminomethyl)-1-phenethylpiperidin-4-ol (<b>20</b>) as a yellow oil (4.31 g, quantitative). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30–7.25 (m, 2H), 7.22–7.15 (m, 3H), 2.85–2.79 (m, 2H), 2.76 (dt, <i>J</i> = 7.0, 3.2 Hz, 2H), 2.66–2.59 (m, 4H), 2.44 (td, <i>J</i> = 10.8, 4.7 Hz, 2H), 1.66–1.54 (m, 4H). HPLC–MS: purity 90%, <i>m</i>/<i>z</i> = 235.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 3: To a solution of <b>20</b> (4.95 g, 21.12 mmol) in ethyl acetate (45 mL), a solution of K<sub>2</sub>CO<sub>3</sub> (7.33 g, 53.03 mmol) in water (35 mL) was added. After cooling to 0 °C, 2-chloropropionyl chloride (<b>8-1</b>, 2.5 mL, 25.75 mmol) was added dropwise and the reaction mixture was stirred at 0 °C for 30 min. The layers were separated, and the aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude 2-chloro-<i>N</i>-((4-hydroxy-1-phenethylpiperidin-4-yl)methyl)propanamide as an orange oil (6.00 g, 88%), which was used without further purification. To a solution of potassium <i>tert</i>-butoxide (31.3 mL, 1 M in THF, 31.30 mmol) in THF (35 mL), a solution of crude 2-chloro-<i>N</i>-((4-hydroxy-1-phenethylpiperidin-4-yl)methyl)propanamide (6.00 g, 18.47 mmol) in THF (100 mL) was added dropwise over 3 h. The reaction mixture was stirred at rt overnight. The solvent was removed under vacuum, water was added to the residue, and it was extracted with ethyl acetate. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to give 2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>21</b>) as a beige solid (2.30 g, 42%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.26 (m, 2H), 7.23–7.17 (m, 3H), 6.10 (br s, 1H, NH), 4.21 (q, <i>J</i> = 6.8 Hz, 1H), 3.37 (d, <i>J</i> = 11.9 Hz, 1H), 3.12 (dd, <i>J</i> = 11.9, 4.8 Hz, 1H), 2.85–2.78 (m, 2H), 2.74–2.67 (m, 1H), 2.67–2.60 (m, 2H), 2.59–2.48 (m, 1H), 2.35 (td, <i>J</i> = 11.2, 2.1 Hz, 1H), 2.20 (d, <i>J</i> = 14.0 Hz, 1H), 1.77–1.61 (m, 4H), 1.46 (d, <i>J</i> = 6.8 Hz, 3H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i> = 289.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Step 4: To a solution of <b>21</b> (168 mg, 0.58 mmol) in dry DMF (5 mL), NaH (47 mg, 60 wt % in mineral oil, 1.17 mmol) was added. The reaction mixture was stirred at rt for 30 min, then 2-bromopropane (0.05 mL, 0.58 mmol) was added and the resulting mixture was stirred at rt overnight. Water was added, and it was extracted with ethyl acetate. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to obtain 4-isopropyl-2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14d</b>) as a colorless oil (84 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.26 (m, 2H), 7.23–7.17 (m, 3H), 4.86 (sept, <i>J</i> = 6.8 Hz, 1H), 4.17 (q, <i>J</i> = 6.8 Hz, 1H), 3.15 (d, <i>J</i> = 12.3 Hz, 1H), 2.96 (d, <i>J</i> = 12.3 Hz, 1H), 2.87–2.79 (m, 2H), 2.75–2.60 (m, 4H), 2.60–2.43 (m, 1H), 2.36 (t, <i>J</i> = 10.1 Hz, 1H), 2.03 (d, <i>J</i> = 14.5 Hz, 1H), 1.75–1.67 (m, 2H), 1.63–1.49 (m, 1H), 1.44 (d, <i>J</i> = 6.8 Hz, 3H), 1.11 (d, <i>J</i> = 6.9 Hz, 3H), 1.07 (d, <i>J</i> = 6.7 Hz, 3H). HPLC–MS: purity 99%. HRMS [M + H]<sup>+</sup> (diff ppm) 331.2379 (0.34).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2,4-Dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14f</b>) (Representative Example of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> Using Variation from Compound <b>7</b>)</h3><div class="NLM_p">Step 1:<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> To a suspension of potassium <i>tert</i>-butoxide (73.20 g, 0.65 mol) in DMSO (550 mL), trimethylsulfoxonium iodide (160.16 g, 0.73 mol) was added portionwise in 20 min, maintaining the internal temperature between 20 and 25 °C. The reaction mixture (pale yellow solution) was stirred at rt for 90 min, then DME (150 mL) was added, and it was cooled to 0–5 °C. A solution of <i>tert</i>-butyl 4-oxopiperidine-1-carboxylate (<b>5</b>, 100.00 g, 0.50 mol) in a mixture of DMSO/DME (1/3, 200 mL) was added dropwise over 35 min, maintaining the reaction temperature below 5 °C. The reaction mixture (yellow solution) was stirred at 0–5 °C for additional 60 min. IPC (TLC, cyclohexane/ethyl acetate 7/3) was performed to monitor full conversion. Ethyl acetate (400 mL) and water (600 mL) were then added, and the reaction mixture was stirred for 20 min. The phases were separated, and the aqueous layer was extracted with ethyl acetate (2 × 400 mL). The organic phases were combined, washed with water (4 × 400 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum to give <i>tert</i>-butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate (<b>6</b>) as a white solid (97.60 g, 91% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.77–3.63 (m, 2H), 3.42 (ddd, <i>J</i> = 13.3, 9.5, 3.7 Hz, 2H), 2.68 (s, 2H), 1.79 (ddd, <i>J</i> = 13.7, 9.5, 4.4 Hz, 2H), 1.46 (s, 9H), 1.44–1.40 (m, 2H). HPLC–MS: purity 98%, <i>m</i>/<i>z</i> = 158.1 [M + H – 56]<sup>+</sup> (-<sup><i>t</i></sup>Bu, Boc fragmentation).</div><div class="NLM_p">Step 2: A mixture of <b>6</b> (16.67 g, 78.16 mmol) and ammonia solution (39 mL, 7 M solution in MeOH, 2.34 mol) was stirred at rt overnight. The solvent was removed under vacuum and the residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to give <i>tert</i>-butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate (<b>7</b>) as a yellow oil (13.39 g, 74%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) 3.86 (br s, 2H), 3.17 (t, <i>J</i> = 12.0 Hz, 2H), 2.60 (s, 2H), 1.51 (d, <i>J</i> = 12.4 Hz, 2H), 1.46 (s, 9H), 1.43–1.32 (m, 2H). HPLC–MS: purity 97%, <i>m</i>/<i>z</i> = 175.1 [M + H – 56]<sup>+</sup> (-<sup><i>t</i></sup>Bu, Boc fragmentation).</div><div class="NLM_p">Step 3: To a solution of <b>7</b> (9.50 g, 41.25 mmol) in ethyl acetate (85 mL), a solution of K<sub>2</sub>CO<sub>3</sub> (15.90 g, 115.04 mmol) in water (66 mL) was added. After cooling to 0 °C, 2-chloropropionyl chloride (<b>8-1</b>, 5.4 mL, 56.09 mmol) was added dropwise and the reaction mixture was stirred at 0 °C for further 30 min. The layers were separated, and the aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude <i>tert</i>-butyl 4-((2-chloropropanamido)methyl)-4-hydroxypiperidine-1-carboxylate as a yellow oil (12.20 g, 92%), which was used without purification. To a solution of potassium <i>tert</i>-butoxide (62.7 mL, 1 M in THF, 62.70 mmol) in a mixture of THF (164 mL) and <i>tert</i>-butanol (82 mL), warmed at 80 °C, a solution of the previous crude <i>tert</i>-butyl 4-((2-chloropropanamido)methyl)-4-hydroxypiperidine-1-carboxylate (12.20 g, 38.03 mmol) in THF (205 mL) was added dropwise over 3 h. The reaction mixture was stirred at rt overnight. The solvent was removed under vacuum, water was added to the residue, and it was extracted with ethyl acetate. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give <i>tert</i>-butyl 2-methyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate (<b>9-1</b>) as a white solid (9.29 g, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.75 (br s, 1H, NH), 4.20 (q, <i>J</i> = 6.8 Hz, 1H), 3.82 (br s, 2H), 3.38 (d, <i>J</i> = 12.0 Hz, 1H), 3.26 (t, <i>J</i> = 11.9 Hz, 1H), 3.10 (dd, <i>J</i> = 11.9, 4.8 Hz, 1H), 3.05 (t, <i>J</i> = 11.0 Hz, 1H), 2.16 (d, <i>J</i> = 15.2 Hz, 1H), 1.67–1.49 (m, 3H), 1.46 (s, 9H), 1.46 (d, <i>J</i> = 6.8 Hz, 3H). HPLC–MS: purity 94%, <i>m</i>/<i>z</i> = 229.1 [M + H – 56]<sup>+</sup> (-<sup><i>t</i></sup>Bu, Boc fragmentation).</div><div class="NLM_p">Step 4: To a solution of <b>9-1</b> (1.00 g, 3.52 mmol) in dry DMF (25 mL), NaH (0.28 g, 60 wt % in mineral oil, 7.03 mmol) was added under a nitrogen atmosphere. The mixture was stirred at rt for 30 min, then iodomethane (0.22 mL, 3.52 mmol) was added and the resulting mixture was stirred at rt overnight. Water was added, and it was extracted with ethyl acetate. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to obtain <i>tert</i>-butyl 2,4-dimethyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate (<b>11-2</b>) as a yellow oil (765 mg, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.17 (q, <i>J</i> = 6.7 Hz, 1H), 3.82 (br s, 2H), 3.42 (d, <i>J</i> = 12.2 Hz, 1H), 3.24 (t, <i>J</i> = 11.2 Hz, 1H), 3.03 (t, <i>J</i> = 11.4 Hz, 1H), 2.97 (d, <i>J</i> = 12.1 Hz, 1H), 2.97 (s, 3H), 2.15–2.06 (m, 1H), 1.63–1.50 (m, 2H), 1.46 (s, 9H), 1.44 (d, <i>J</i> = 6.8 Hz, 3H), 1.44–1.39 (m, 1H). HPLC–MS: purity 91%, <i>m</i>/<i>z</i> = 299.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 5: To a solution of <b>11-2</b> (765 mg, 2.56 mmol) in DCM (8 mL), trifluoroacetic acid (0.99 mL, 12.80 mmol) was added, and the reaction mixture was stirred at rt overnight. Then it was evaporated to dryness to give crude 2,4-dimethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one trifluoroacetate (<b>12-2</b> TFA salt) as a viscous oil (1.26 g, overweight, estimated 64 wt %; theoretical weight 0.80 g; quantitative yield was assumed) that was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (br s, 2H), 4.22 (q, <i>J</i> = 6.7 Hz, 1H), 3.53 (d, <i>J</i> = 12.7 Hz, 1H), 3.45–3.31 (m, 3H), 3.20–3.08 (m, 1H), 3.13 (d, <i>J</i> = 12.7 Hz, 1H), 3.03 (s, 3H), 2.36 (d, <i>J</i> = 15.2 Hz, 1H), 2.08–1.96 (m, 1H), 1.93–1.82 (m, 2H), 1.47 (d, <i>J</i> = 6.8 Hz, 3H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i>= 199.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Step 6: A mixture of <b>12-2</b> TFA salt (1.26 g, 64 wt %, 2.56 mmol), (2-bromoethyl)benzene (0.35 mL, 2.58 mmol), sodium iodide (0.23 g, 1.55 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (2.25 mL, 12.9 mmol) in acetonitrile (32 mL) was heated at 80 °C in a sealed tube overnight. Water was added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to obtain 2,4-dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14f</b> free base) as an oil (486 mg, 62%). To a solution of the previous free base (50 mg, 0.16 mmol) in anhydrous diethyl ether (0.5 mL), HCl (2 M solution in diethyl ether, 0.09 mL, 0.18 mmol) was added, and the mixture was stirred at rt for 2 h. The solids were filtered and dried in vacuo to give <b>14f</b> HCl salt as a white solid (32 mg, 57%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.40–7.24 (m, 5H), 4.24 (q, <i>J</i> = 6.7 Hz, 1H), 3.62–3.51 (m, 3H), 3.44–3.34 (m, 3H), 3.28–3.15 (m, 2H), 3.14–3.05 (m, 2H), 2.99 (s, 3H), 2.45 (d, <i>J</i> = 14.1 Hz, 1H), 2.02 (t, <i>J</i> = 13.9 Hz, 1H), 1.96–1.80 (m, 2H), 1.42 (d, <i>J</i> = 6.7 Hz, 3H). HPLC–MS: purity 97%. HRMS [M + H]<sup>+</sup> (diff ppm) 303.2072 (−1.6).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (<i>R</i>)-2,4-Dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14g</b>) (Representative Example of <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, Chiral Version)</h3><div class="NLM_p">Step 1: To a solution of 6-phenethyl-1-oxa-6-azaspiro[2.5]octane (<b>19</b>, 3.78 g, 17.39 mmol) in a mixture of EtOH (90 mL) and water (16 mL), methylamine solution (30 mL, 40 wt % in water, 0.35 mol) was added, and the reaction mixture was stirred at rt for 4 h. The solvent was removed under vacuum to give 4-((methylamino)methyl)-1-phenethylpiperidin-4-ol (<b>22</b>) as a pale orange solid (4.35 g, quantitative). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.26 (m, 2H), 7.23–7.17 (m, 3H), 2.88–2.76 (m, 4H), 2.69–2.60 (m, 2H), 2.53 (s, 2H), 2.49 (s, 3H), 2.53–2.44 (m, 2H), 1.70–1.57 (m, 4H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i> = 249.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2: To a solution of <b>22</b> (500 mg, 2.01 mmol) in ethyl acetate (8 mL), a solution of K<sub>2</sub>CO<sub>3</sub> (779 mg, 5.64 mmol) in water (7 mL) was added. After cooling to 0 °C, a solution of (<i>S</i>)-2-chloropropanoyl chloride (<b>8-1S</b>, 307 mg, 2.41 mmol) in EtOAc (3 mL) was added dropwise, and the reaction mixture was stirred at 0 °C for 30 min. Then, the layers were separated and the aqueous phase was extracted with ethyl acetate. The organic phases were combined, washed with saturated aqueous NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude (<i>S</i>)-2-chloro-<i>N</i>-((4-hydroxy-1-phenethylpiperidin-4-yl)methyl)-<i>N</i>-methylpropanamide (500 mg, 73%). A solution of the previous crude compound (500 mg, 1.47 mmol) in THF (15 mL) was cooled to −78 °C using a dry ice/acetone bath. Then, a solution of potassium <i>tert</i>-butoxide (1.62 mL, 1 M in THF, 1.62 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 30 min. NH<sub>4</sub>Cl saturated solution was then added, and the reaction mixture was warmed to rt and extracted with ethyl acetate. The organic phases were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum to give crude (<i>R</i>)-2,4-dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14g</b> free base) as an oil (400 mg, 90%) with ee 93% (chiral HPLC).</div><div class="NLM_p last">Step 3: To a solution of <b>14g</b> free base (1.56 g, 5.16 mmol, ee 92.4%) in diethyl ether (4 mL), a solution of HCl (2.58 mL, 2 M in diethyl ether, 5.16 mmol) was added under stirring, upon which a solid started to precipitate immediately. The resulting suspension was stirred for 1 h at rt, and then it was concentrated to dryness to obtain crude <b>14g</b> HCl salt as a white solid (1.49 g, 86% yield). The crude product was crystallized from hot acetonitrile/ethyl acetate mixture to enrich ee %: acetonitrile (30 mL) was added to crude <b>14g</b> HCl salt (1.49 g), and the mixture was heated to reflux until total solution. Ethyl acetate (119 mL) was added while hot, and the solution was allowed to cool down to rt (crystallization started at 35–38 °C) and further stirred at rt for 2.5 h. Then, the solids were collected by filtration and dried under vacuo to give <b>14g</b> HCl salt as a white solid (717 mg, 48%) with ee 98.1% (chiral HPLC). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.42–7.24 (m, 5H), 4.24 (q, <i>J</i> = 6.7 Hz, 1H), 3.61–3.52 (m, 3H), 3.42–3.33 (m, 3H), 3.27–3.15 (m, 2H), 3.14–3.08 (m, 2H), 2.98 (s, 3H), 2.45 (ddd, <i>J</i> = 15.5, 5.3, 2.7 Hz, 1H), 2.10–1.99 (m, 1H), 1.95–1.84 (m, 2H), 1.42 (d, <i>J</i> = 6.7 Hz, 3H). HPLC–MS: purity 100%. HRMS [M + H]<sup>+</sup> (diff ppm) 303.2078 (−3.65).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>S</i>)-2,4-Dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14h</b>)</h3><div class="NLM_p">Starting from racemic 2,4-dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14f</b>, 428 mg), a chiral preparative HPLC separation (column CHIRALCEL OJ; temperature ambient; flow 11 mL/min; eluent <i>n</i>-heptane/(IPA + 0.33% DEA) 95/5 v/v) was carried out to give (<i>S</i>)-2,4-dimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14h</b>) as a colorless oil (41 mg) with ee 96.1% (chiral HPLC). Its <i>R</i>-enantiomer (<b>14g</b>) was also recovered as a colorless oil (127 mg) with ee 94.5% (chiral HPLC). Absolute configuration was assigned using a sample of compound <b>14g</b> obtained as described above.</div><div class="NLM_p last">To a solution of <b>14h</b> free base (41 mg, 0.13 mmol) in anhydrous diethyl ether (1 mL), HCl (2 M solution in diethyl ether, 0.09 mL, 0.18 mmol) was added. The mixture was stirred at rt for 1 h, and then it was concentrated to dryness to give <b>14h</b> HCl salt as a white solid (35 mg, 76%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.40–7.25 (m, 5H), 4.25 (q, <i>J</i> = 6.7 Hz, 1H), 3.61–3.49 (m, 3H), 3.44–3.34 (m, 3H), 3.28–3.17 (m, 2H), 3.14–3.06 (m, 2H), 2.99 (s, 3H), 2.44 (br d, <i>J</i> = 14.2 Hz, 1H), 2.06–1.96 (m, 1H), 1.96–1.82 (m, 2H), 1.42 (d, <i>J</i> = 6.7 Hz, 3H). HPLC–MS: purity 100%. HRMS [M + H]<sup>+</sup> (diff ppm) 303.2071 (−1.17).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-Methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14i</b>) (Representative Example of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> Using Variation from Compound <b>16</b>)</h3><div class="NLM_p">Step 1: To a solution of <i>tert</i>-butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate (<b>6</b>, 41.37 g, 0.19 mol) in a mixture of EtOH–water 9:1 (850 mL), methylamine solution (456 mL, 33% solution in EtOH, 3.88 mol) was added. The reaction mixture was stirred at rt overnight. The solvent was removed under vacuum to give <i>tert</i>-butyl 4-hydroxy-4-((methylamino)methyl)piperidine-1-carboxylate (<b>16-2</b>) as a pale yellow solid (46.88 g, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.82 (br s, 2H), 3.15 (t, <i>J</i> = 11.5 Hz, 2H), 2.49 (s, 2H), 2.47 (s, 3H), 1.44 (s, 9H), 1.54–1.34 (m, 4H). HPLC–MS: purity 99%, <i>m</i>/<i>z</i> = 245.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2: To a solution of <b>16-2</b> (300 mg, 1.23 mmol) in ethyl acetate (5.4 mL), a solution of K<sub>2</sub>CO<sub>3</sub> (475 mg, 3.44 mmol) in water (4.4 mL) was added. After cooling to 0–5 °C, a solution of 2-chloroacetyl chloride (0.13 mL, 1.67 mmol) in EtOAc (0.5 mL) was added dropwise and the reaction mixture was stirred at 0–5 °C for 30 min. Then, saturated aqueous NaHCO<sub>3</sub> was added, the layers were separated, and the aqueous phase was extracted with ethyl acetate. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude <i>tert</i>-butyl 4-((2-chloro-<i>N</i>-methylacetamido)methyl)-4-hydroxypiperidine-1-carboxylate as a white solid (375 mg, 95%). A solution of the previous crude compound (375 mg, 1.17 mmol) in THF (20 mL) was cooled to −78 °C using a dry ice/acetone bath. Then, a solution of potassium <i>tert</i>-butoxide (1.52 mL, 1 M in THF, 1.52 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 30 min. NH<sub>4</sub>Cl saturated solution was then added, the reaction mixture was warmed to rt, and it was extracted with ethyl acetate. The organic phases were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum to give <i>tert</i>-butyl 4-methyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate (<b>11-3</b>) as an oil that solidified upon standing (343 mg, quantitative). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.14 (s, 2H), 3.84 (s, 2H), 3.19 (s, 2H), 3.10 (t, <i>J</i> = 12.4 Hz, 2H), 2.99 (s, 3H), 1.88 (d, <i>J</i> = 12.1 Hz, 2H), 1.56–1.47 (m, 2H), 1.46 (s, 9H). HPLC–MS: purity 91%, <i>m</i>/<i>z</i> = 285.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 3: To a solution of <b>11-3</b> (332 mg, 1.17 mmol) in DCM (16 mL), trifluoroacetic acid (0.90 mL, 11.69 mmol) was added. The reaction mixture was stirred at rt for 3 h, and then it was evaporated to dryness to give crude 4-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one trifluoroacetate (<b>12-3</b> TFA salt) as a viscous oil (686 mg, overweight, estimated 50 wt %; theoretical weight 349 mg; quantitative yield was assumed) that was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (br s, 1H), 8.61 (br s, 1H), 4.23 (s, 2H), 3.40 (d, <i>J</i> = 12.5 Hz, 2H), 3.32 (s, 2H), 3.23 (dd, <i>J</i> = 22.8, 11.4 Hz, 2H), 3.05 (s, 3H), 2.14 (d, <i>J</i> = 14.3 Hz, 2H), 1.99 (td, <i>J</i> = 14.6, 3.7 Hz, 2H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i>= 185.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Step 4: A mixture of <b>12-3</b> TFA salt (686 mg, 50 wt %, 1.17 mmol), (2-bromoethyl)benzene (260 mg, 1.40 mmol) and K<sub>2</sub>CO<sub>3</sub> (808 mg, 5.85 mmol) in acetonitrile (10 mL) were heated at 80 °C in a sealed tube overnight. Water was added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to give 4-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14i</b> free base) as a yellow oil (291 mg, 86% yield). To a solution of the previous free base (200 mg, 0.69 mmol) in a mixture of diethyl ether (4 mL) and MeOH (0.1 mL), a solution of HCl (0.38 mL, 2 M in diethyl ether, 0.76 mmol) was added under stirring, upon which a solid started to precipitate immediately. The resulting suspension was stirred for 1 h at rt. Then, the solids were collected by filtration, washed with diethyl ether, and dried under vacuum to obtain <b>14i</b> HCl salt as a white solid (155 mg, 69% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.40–7.22 (m, 5H), 4.17 (s, 2H), 3.61–3.52 (m, 2H), 3.45–3.34 (m, 4H), 3.29–3.20 (m, 2H), 3.15–3.05 (m, 2H), 3.00 (s, 3H), 2.22 (d, <i>J</i> = 13.7 Hz, 2H), 1.99 (t, <i>J</i> = 13.6 Hz, 2H). HPLC–MS: purity 100%. HRMS [M + H]<sup>+</sup> (diff ppm) 289.1921 (−3.79).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 4-Methyl-9-phenethyl-2-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14l</b>) (Representative Example of <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>)</h3><div class="NLM_p last">To a solution of 4-((methylamino)methyl)-1-phenethylpiperidin-4-ol (<b>22</b>, 572 mg, 2.30 mmol) and TEA (0.77 mL, 5.53 mmol) in DCM (27 mL), a solution of 2-chloro-2-phenylacetyl chloride (0.55 mL, 3.45 mmol) in DCM (27 mL) was added dropwise at 0 °C under a nitrogen atmosphere. The reaction mixture was stirred at 0 °C for 2 h. Saturated aqueous NaHCO<sub>3</sub> was added, and it was extracted with DCM. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude 2-chloro-<i>N</i>-((4-hydroxy-1-phenethylpiperidin-4-yl)methyl)-<i>N</i>-methyl-2-phenylacetamide as an orange oil (950 mg, overweight, quantitative yield assumed). To a solution of the previous crude compound (950 mg, 923 mg theoretical weight, 2.30 mmol) in dry THF (40 mL), cooled to −78 °C under a nitrogen atmosphere, potassium <i>tert</i>-butoxide solution (3.45 mL, 1 M in THF, 3.45 mmol) was slowly added at −78 °C, and then the reaction mixture was allowed to warm and stirred at −30 °C for 4 h. Saturated aqueous NH<sub>4</sub>Cl was then added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to give 4-methyl-9-phenethyl-2-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14l</b> free base) as an oil (349 mg, 42%). To a solution of the previous free base (150 mg, 0.41 mmol) in diethyl ether (2 mL), a solution of HCl (0.2 mL, 2 M in diethyl ether, 0.41 mmol) was added under stirring, upon which a solid started to precipitate immediately. The resulting suspension was stirred for 2 h at rt. Then, the solids were collected by filtration, washed with diethyl ether, and dried under vacuum to obtain <b>14l</b> HCl salt as a white solid (66 mg, 40% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.46–7.40 (m, 2H), 7.39–7.23 (m, 8H), 5.18 (s, 1H), 3.83 (d, <i>J</i> = 12.9 Hz, 1H), 3.68–3.61 (m, 1H), 3.59–3.53 (m, 1H), 3.42–3.22 (m, 5H), 3.14–3.07 (m, 2H), 3.03 (s, 3H), 2.59 (d, <i>J</i> = 15.7 Hz, 1H), 2.18–1.94 (m, 3H). HPLC–MS: purity 100%. HRMS [M + H]<sup>+</sup> (diff ppm) 365.2221 (0.32)</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,2,4-Trimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14m</b>) (Representative Example of <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> Bearing Disubstitution in Position <b>2</b>)</h3><div class="NLM_p last">To a solution of 4-((methylamino)methyl)-1-phenethylpiperidin-4-ol (<b>22</b>, 496 mg, 2.00 mmol) in DCM (64 mL), NaHCO<sub>3</sub> (337 mg, 4.01 mmol) was added at rt. Finally, 2-bromoisobutyryl bromide (0.30 mL, 2.41 mmol) was added dropwise under a nitrogen atmosphere, and the reaction mixture was stirred at rt overnight. 0.1 M K<sub>2</sub>CO<sub>3</sub> was added, the phases were separated, and the aqueous phase was back-extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude 2-bromo-<i>N</i>-((4-hydroxy-1-phenethylpiperidin-4-yl)methyl)-<i>N</i>,2-dimethylpropanamide as a yellow oil (749 mg, 94%). To a solution of the previous crude compound (749 mg, 1.88 mmol) in dry THF (32 mL), cooled to −78 °C under a nitrogen atmosphere, potassium <i>tert</i>-butoxide solution (3.77 mL, 1 M in THF, 3.77 mmol) was slowly added at −78 °C, and then the reaction mixture was allowed to warm to 0 °C over a period of 1 h and further stirred at 0 °C for 2 h. Saturated aqueous NH<sub>4</sub>Cl was then added, and it was extracted with ethyl acetate. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to give 2,2,4-trimethyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14m</b> free base) as an oil (275 mg, 46%). To a solution of the previous free base (275 mg, 0.87 mmol) in diethyl ether (4 mL), a solution of HCl (0.52 mL, 2 M in diethyl ether, 1.04 mmol) was added under stirring, upon which a solid started to precipitate immediately. The resulting suspension was stirred for 1 h at rt. Then, the solids were collected by filtration, washed with diethyl ether, and dried under vacuum to obtain <b>14m</b> HCl salt as a white solid (264 mg, 86% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.39–7.22 (m, 5H), 3.64–3.55 (m, 2H), 3.49 (s, 2H), 3.44–3.36 (m, 2H), 3.34–3.24 (m, 2H), 3.14–3.06 (m, 2H), 3.03 (s, 3H), 2.10–2.00 (m, 2H), 1.98–1.86 (m, 2H), 1.43 (s, 6H). HPLC–MS: purity 99%. HRMS [M + H]<sup>+</sup> (diff ppm) 317.2234 (−3.4).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 12-Methyl-8-phenethyl-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one Hydrochloride (<b>14n</b>)</h3><div class="NLM_p">Step 1: To a solution of <i>tert</i>-butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate (<b>6</b>, 10.00 g, 46.89 mmol) in a mixture of EtOH–water 9:1 (200 mL), 4-methoxybenzylamine (6.43 g, 46.90 mmol) was added. The reaction mixture was heated at 100 °C overnight in a sealed vessel. The solvent was removed under vacuum and the residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to give <i>tert</i>-butyl 4-hydroxy-4-(((4-methoxybenzyl)amino)methyl)piperidine-1-carboxylate (<b>23</b>) as a yellow oil (13.55 g, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25–7.20 (m, 2H), 6.89–6.84 (m, 2H), 3.80 (s, 3H), 3.89–3.70 (br s, 2H), 3.78 (s, 2H), 3.15 (t, <i>J</i> = 11.7 Hz, 2H), 2.55 (s, 2H), 1.54–1.47 (m, 2H), 1.45 (s, 9H), 1.43–1.35 (m, 2H). HPLC–MS: purity 98%, <i>m</i>/<i>z</i> = 351.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2: To a solution of compound <b>23</b> (9.94 g, 28.36 mmol) and TEA (9.5 mL, 68.16 mmol) in DCM (500 mL), a solution of 2-bromo-4-chlorobutanoyl chloride<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (9.35 g, 42.53 mmol) in DCM (200 mL) was added dropwise at 0 °C under a nitrogen atmosphere. The reaction mixture was stirred at 0 °C for 2 h. Saturated aqueous NaHCO<sub>3</sub> was added, and it was extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude <i>tert</i>-butyl 4-((2-bromo-4-chloro-<i>N</i>-(4-methoxybenzyl)butanamido)methyl)-4-hydroxypiperidine-1-carboxylate as an orange oil (15.10 g, quantitative). To a solution of the previous crude compound (14.80 g, 27.72 mmol) in THF (185 mL), cooled to 0 °C under a nitrogen atmosphere, potassium <i>tert</i>-butoxide solution (111 mL, 1 M in THF, 111.00 mmol) was slowly added, and the reaction mixture was stirred at 0 °C for 2 h. Saturated aqueous NH<sub>4</sub>Cl was then added, and it was extracted with ethyl acetate. The organic phases were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to give <i>tert</i>-butyl 12-(4-methoxybenzyl)-13-oxo-4-oxa-8,12-diazadispiro[2.1.5.3]tridecane-8-carboxylate (<b>24</b>) as a yellow oil (5.51 g, 48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.18 (d, <i>J</i> = 8.6 Hz, 2H), 6.87 (d, <i>J</i> = 8.7 Hz, 2H), 4.54 (s, 2H), 3.81 (s, 3H), 3.63 (br s, 2H), 3.18 (s, 2H), 3.06 (t, <i>J</i> = 11.4 Hz, 2H), 1.86 (d, <i>J</i> = 13.5 Hz, 2H), 1.43 (s, 9H), 1.48–1.34 (m, 4H), 0.98 (q, <i>J</i> = 4.5 Hz, 2H). HPLC–MS: purity 95%, <i>m</i>/<i>z</i> = 417.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 3: To a solution of <b>24</b> (1.50 g, 3.60 mmol) in DCM (36 mL), trifluoroacetic acid (2.8 mL, 36.34 mmol) was added, and the reaction mixture was stirred at rt for 4 h. The solvent was evaporated to dryness to give 12-(4-methoxybenzyl)-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one trifluoroacetate (<b>25</b> TFA salt) as a viscous yellow oil (2.30 g, 67 wt %, quantitative). The crude product was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.31 (br s, 1H), 8.94 (br s, 1H), 7.20–7.16 (m, 2H), 6.92–6.84 (m, 2H), 4.54 (s, 2H), 3.80 (s, 3H), 3.24 (s, 2H), 3.20 (d, <i>J</i> = 12.1 Hz, 2H), 3.11–2.97 (m, 2H), 2.09 (d, <i>J</i> = 14.4 Hz, 2H), 1.75 (td, <i>J</i> = 14.5, 4.3 Hz, 2H), 1.46 (q, <i>J</i> = 4.7 Hz, 2H), 0.97 (q, <i>J</i> = 4.7 Hz, 2H). HPLC–MS: purity 95%, <i>m</i>/<i>z</i> = 371.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 4: A mixture of <b>25</b> TFA salt (1.50 g, 67 wt %, 3.60 mmol), (2-bromoethyl)benzene (0.59 mL, 4.33 mmol), sodium iodide (0.32 g, 2.17 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.49 g, 18.05 mmol) in acetonitrile (36 mL) was heated at 80 °C in a sealed tube overnight. Water was added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to give 12-(4-methoxybenzyl)-8-phenethyl-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one (<b>26</b>) as an oil (1.17 g, 77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30–7.25 (m, 2H), 7.23–7.17 (m, 5H), 6.88–6.84 (m, 2H), 4.55 (s, 2H), 3.80 (s, 3H), 3.19 (s, 2H), 2.80–2.68 (m, 2H), 2.58–2.47 (m, 4H), 2.31 (td, <i>J</i> = 11.4, 2.7 Hz, 2H), 1.97–1.87 (m, 2H), 1.66–1.48 (m, 2H), 1.42 (dd, <i>J</i> = 7.9, 4.5 Hz, 2H), 0.99 (dd, <i>J</i> = 7.9, 4.5 Hz, 2H). HPLC–MS: purity 92%, <i>m</i>/<i>z</i> = 421.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 5: A mixture of <b>26</b> (0.17 g, 0.40 mmol) and CAN (0.57 g, 1.21 mmol) in a mixture of acetonitrile–water 1:1 (4 mL) was stirred at rt for 7 h. Saturated aqueous Na<sub>2</sub>CO<sub>3</sub> was added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by eluting through an acidic ion-exchange resin cartridge (SCX) to give 8-phenethyl-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one (<b>27</b>) as a pale brown oil (106 mg, 88%). The crude product was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.27 (m, 2H), 7.23–7.17 (m, 3H), 5.83 (br s, 1H, NH), 3.37 (d, <i>J</i> = 2.7 Hz, 2H), 2.84–2.77 (m, 2H), 2.71–2.57 (m, 4H), 2.39 (t, <i>J</i> = 10.2 Hz, 2H), 2.08–2.00 (m, 2H), 1.79–1.70 (m, 2H), 1.37 (dd, <i>J</i> = 8.0, 4.6 Hz, 2H), 1.02 (q, <i>J</i> = 4.6 Hz, 2H).</div><div class="NLM_p last">Step 6: To a solution of <b>27</b> (106 mg, 0.35 mmol) in dry THF (3.5 mL), NaH (16 mg, 60 wt % in mineral oil, 0.39 mmol) was added. The reaction mixture was stirred at rt for 30 min, then iodomethane (0.02 mL, 0.39 mmol) was added, and the resulting mixture was stirred at rt overnight. Saturated aqueous NaHCO<sub>3</sub> was added, and it was extracted with DCM. The organic phases were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to obtain 12-methyl-8-phenethyl-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one (<b>14n</b> free base) as a colorless oil (25 mg, 23%). To a solution of the previous free base (25 mg, 0.08 mmol) in anhydrous diethyl ether (0.5 mL), HCl (2 M solution in diethyl ether, 0.04 mL, 0.08 mmol) was added. The mixture was stirred at rt for 1 h and then it was concentrated to dryness to give <b>14n</b> HCl salt as a white solid (25 mg, 89%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.38–7.24 (m, 5H), 3.58 (d, <i>J</i> = 11.6 Hz, 2H), 3.50 (s, 2H), 3.42–3.35 (m, 2H), 3.17 (t, <i>J</i> = 12.9 Hz, 2H), 3.11–3.05 (m, 2H), 3.01 (s, 3H), 2.30 (d, <i>J</i> = 14.9 Hz, 2H), 1.97 (t, <i>J</i> = 14.3 Hz, 2H), 1.29 (q, <i>J</i> = 4.6 Hz, 2H), 1.14–1.05 (m, 2H). HPLC–MS: purity 94%. HRMS [M + H]<sup>+</sup> (diff ppm) 315.208 (−3.92).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>R</i>)-4-Ethyl-2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14o</b>)</h3><div class="NLM_p">Starting from racemic 4-ethyl-2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14e</b>, 449 mg, prepared following <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> as described for compound <b>14f</b>), a chiral preparative HPLC separation (column, CHIRALCEL OJ; temperature, ambient; flow, 16 mL/min; eluent, <i>n</i>-heptane/(IPA + 0.33% DEA) 95/5 v/v) was carried out to give (<i>R</i>)-4-ethyl-2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14o</b>) as a colorless oil (161 mg), together with its <i>S</i>-enantiomer (138 mg). Absolute configuration was assigned using a sample of compound <b>14o</b> obtained via the chiral route displayed in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> (exemplified with the preparation of compound <b>14u</b>).</div><div class="NLM_p last">To a solution of <b>14o</b> free base (161 mg, 0.51 mmol) in anhydrous diethyl ether (2 mL), HCl (2 M solution in diethyl ether, 0.33 mL, 0.66 mmol) was added. The mixture was stirred at rt for 1 h. Then, the solids were collected by filtration, washed with diethyl ether, and dried under vacuum to obtain <b>14o</b> HCl salt as a white solid (156 mg, 86%) with ee 98.5% (chiral HPLC). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.39–7.25 (m, 5H), 4.23 (q, <i>J</i> = 6.7 Hz, 1H), 3.62–3.52 (m, 3H), 3.51–3.45 (m, 1H), 3.43–3.33 (m, 4H), 3.27 (d, <i>J</i> = 12.8 Hz, 1H), 3.24–3.16 (m, 1H), 3.15–3.08 (m, 2H), 2.39 (dd, <i>J</i> = 15.4, 2.4 Hz, 1H), 2.12–2.02 (m, 1H), 1.97–1.85 (m, 2H), 1.41 (d, <i>J</i> = 6.7 Hz, 3H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H). HPLC–MS: purity 99%. HRMS [M + H]<sup>+</sup> (diff ppm) 317.2227 (−1.06).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>R</i>)-9-(2,5-Difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>14u</b>) (Representative Example of <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>)</h3><div class="NLM_p">Step 1: To a solution of <i>tert</i>-butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate (<b>6</b>, 46.10 g, 0.22 mol) in a mixture of EtOH–water 9:1 (745 mL), ethylamine solution (508 mL, 70% solution in water, 4.32 mol) was added, and the reaction mixture was stirred at rt overnight. The solvent was removed under vacuum to give <i>tert</i>-butyl 4-hydroxy-4-((ethylamino)methyl)piperidine-1-carboxylate (<b>16-1</b>) as a pale yellow oil (55.90 g, quantitative yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.84 (br s, 2H), 3.16 (t, <i>J</i> = 11.7 Hz, 2H), 2.69 (q, <i>J</i> = 7.1 Hz, 2H), 2.51 (s, 2H), 1.52–1.35 (m, 4H), 1.45 (s, 9H), 1.09 (t, <i>J</i> = 7.1 Hz, 3H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i>= 259.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2: To a solution of <b>16-1</b> (55.90 g, 0.22 mol) in ethyl acetate (500 mL), a solution of K<sub>2</sub>CO<sub>3</sub> (83.70 g, 0.60 mol) in water (608 mL) was added. After cooling to 0 °C, a solution of (<i>S</i>)-2-chloropropanoyl chloride (<b>8-1S</b>, 37.33 g, 0.29 mol) in EtOAc (336 mL) was added dropwise over 40 min, maintaining the internal temperature at <5 °C. The reaction mixture was stirred at 0–5 °C for additional 30 min. Then, the layers were separated and the aqueous phase was extracted with ethyl acetate (2 × 300 mL). The organic phases were combined, washed with cold 0.5 M HCl aqueous solution (400 mL), then saturated aqueous NaHCO<sub>3</sub> (400 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness to give crude (<i>S</i>)-<i>tert</i>-butyl 4-((2-chloro-<i>N</i>-ethylpropanamido)methyl)-4-hydroxypiperidine-1-carboxylate as a white solid (75.70 g, quantitative yield). A solution of the previous crude compound (75.42 g, 0.22 mol) in THF (1.12 L) was cooled to −70 °C using a dry ice/acetone bath. Then, a solution of potassium <i>tert</i>-butoxide (238 mL, 1 M in THF, 0.24 mol) was added dropwise over 50 min, maintaining the internal temperature below −60 °C. The reaction mixture was stirred at the same temperature for additional 30 min. NH<sub>4</sub>Cl saturated solution (600 mL) was then added, the reaction mixture was warmed to rt, and it was extracted with ethyl acetate (2 × 300 mL). The organic phases were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum to yield crude (<i>R</i>)-<i>tert</i>-butyl 4-ethyl-2-methyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate (<b>11-1R)</b> as an off-white solid (62.33 g, 92% yield) with ee 89% (chiral HPLC). The crude product was crystallized from hot isopropyl acetate/heptane to enrich ee %: isopropyl acetate (62 mL, 1 volume) was added to crude <b>11-1R</b> (62.33 g), and the mixture was heated to 100 °C until total solution. Heptane (53 mL, 0.85 volumes) was added while hot, and the solution was left to stir at rt for 30 min. Then, the mixture was cooled with an ice–water bath. After seeding, a precipitate was formed and the mixture was stirred for 1 h at 0 °C. Then the solids were collected by filtration, washed with cold isopropyl acetate/heptane mixture 1.2:1 (12 mL), and dried under vacuo to give (<i>R</i>)-<i>tert</i>-butyl 4-ethyl-2-methyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate (<b>11-1R</b>) as a white solid (41.30 g, 61% global yield) with ee 98.8% (chiral HPLC: column, Chiralpak ADH; temperature, ambient; flow, 0.5 mL/min; mobile phase, <i>n</i>-heptane/EtOH 70/30 v/v.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.15 (q, <i>J</i> = 6.8 Hz, 1H), 3.81 (br s, 2H), 3.56–3.45 (m, 1H), 3.38 (d, <i>J</i> = 12.3 Hz, 1H), 3.36–3.19 (m, 2H), 3.04 (t, <i>J</i> = 11.8 Hz, 1H), 2.97 (d, <i>J</i> = 12.2 Hz, 1H), 2.10–2.01 (m, 1H), 1.66–1.49 (m, 2H), 1.46 (s, 9H), 1.43 (d, <i>J</i> = 6.8 Hz, 3H), 1.44–1.37 (m, 1H), 1.12 (t, <i>J</i> = 7.2 Hz, 3H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i> = 313.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 3: To a solution of <b>11-1R</b> (18.20 g, 58.30 mmol) in DCM (583 mL), trifluoroacetic acid (45 mL, 0.58 mol) was added. The reaction mixture was stirred at rt for 3 h, and then it was evaporated to dryness to give crude (<i>R</i>)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one trifluoroacetate (<b>12-1R</b> TFA salt) as a viscous oil (46.63 g, overweight, estimated 41 wt %; theoretical weight 19.01 g; quantitative yield was assumed) that was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90 (br s, 2H), 4.18 (q, <i>J</i> = 6.7 Hz, 1H), 3.59–3.30 (m, 6H), 3.19–3.07 (m, 2H), 2.30 (dd, <i>J</i> = 15.4, 2.5 Hz, 1H), 2.07–1.95 (m, 1H), 1.94–1.78 (m, 2H), 1.46 (d, <i>J</i> = 6.8 Hz, 3H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H). HPLC–MS: purity 100%, <i>m</i>/<i>z</i> = 213.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Step 4: A mixture of <b>12-1R</b> TFA salt (46.63 g, 41 wt %, 58.30 mmol), 2,5-difluorophenethyl methanesulfonate (<b>13-1</b>, 22.00 g, 93.20 mmol), and K<sub>2</sub>CO<sub>3</sub> (40.30 g, 0.29 mol) in acetonitrile (228 mL) was heated in a sealed vessel at 80 °C overnight. Then, the precipitated solids were filtered off and washed with acetonitrile. The resulting solution was concentrated to dryness. The oily residue was dissolved in methyl <i>tert</i>-butyl ether (100 mL), and it was extracted with aqueous 3 M HCl solution (3 × 70 mL). The combined acidic aqueous phases were washed with methyl <i>tert</i>-butyl ether (2 × 50 mL) that was discarded, and then basified with aqueous 3 M NaOH solution until pH ∼ 13 and extracted with ethyl acetate (3 × 50 mL). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The crude product was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 10%) to give (<i>R</i>)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>14u</b> free base) as an oil (14.87 g, 72% yield). To a solution of the previous free base (14.87 g, 42.19 mmol) in a mixture of diethyl ether (300 mL) and MeOH (3.7 mL), a solution of HCl (23.2 mL, 2 M in diethyl ether, 46.40 mmol) was added under stirring, upon which a solid started to precipitate immediately. The resulting suspension was stirred for further 60 min at rt. Then, the solids were collected by filtration, washed with diethyl ether (2 × 7 mL), and dried under vacuum to obtain <b>14u</b> HCl salt as a white solid (14.58 g, 89% yield) with ee 99.0% (chiral HPLC). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.20–7.12 (m, 2H), 7.11–7.03 (m, 1H), 4.22 (q, <i>J</i> = 6.7 Hz, 1H), 3.59 (d, <i>J</i> = 12.2 Hz, 2H), 3.54 (d, <i>J</i> = 12.9 Hz, 1H), 3.52–3.45 (m, 1H), 3.44–3.33 (m, 4H), 3.28–3.20 (m, 2H), 3.19–3.12 (m, 2H), 2.40 (dd, <i>J</i> = 15.5, 2.3 Hz, 1H), 2.09–1.99 (m, 1H), 1.98–1.80 (m, 2H), 1.41 (d, <i>J</i> = 6.7 Hz, 3H), 1.14 (t, <i>J</i> = 7.2 Hz, 3H). HPLC–MS: purity 99%. HRMS [M + H]<sup>+</sup> (diff ppm) 353.2028 (1.61).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 12-Ethyl-8-(2-(pyridin-2-yl)ethyl)-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one Hydrochloride (<b>14w</b>)</h3><div class="NLM_p">Step 1: To a solution of <i>tert</i>-butyl 4-hydroxy-4-((ethylamino)methyl)piperidine-1-carboxylate (<b>16-1</b>, 11.87 g, 45.94 mmol) in ethyl acetate (119 mL), a solution of K<sub>2</sub>CO<sub>3</sub> (17.8 g, 129.00 mmol) in water (83 mL) was added. After cooling to 0–5 °C, a solution of 2-bromo-4-chlorobutanoyl chloride<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (13.70, 62.50 mmol) in EtOAc (25 mL) was added dropwise, and the reaction mixture was further stirred at 0–5 °C for 1 h. Then, saturated aqueous NaHCO<sub>3</sub> was added, the layers were separated, and the aqueous phase was extracted with ethyl acetate. The organic phases were combined, washed twice with cold 0.5 M HCl aqueous solution (70 mL), then saturated aqueous NaHCO<sub>3</sub> (70 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness to give crude <i>tert</i>-butyl 4-((2,4-dichloro-<i>N</i>-ethylbutanamido)methyl)-4-hydroxypiperidine-1-carboxylate as a cream solid (21.35 g, slight overweight, quantitative yield assumed). A solution of the previous crude compound (20.30 g theoretical weight, 45.94 mmol) in THF (767 mL) was cooled to −78 °C using a dry ice/acetone bath under a nitrogen atmosphere. Then, a solution of potassium <i>tert</i>-butoxide (69 mL, 1 M in THF, 69 mmol) was added dropwise, and the reaction mixture was stirred at −78 °C for 15 min, and then it was warmed up to −30 °C and stirred for further 2 h. NH<sub>4</sub>Cl saturated solution was then added, and the reaction mixture was warmed to rt and extracted with ethyl acetate. The organic phases were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum to give crude <i>tert-</i>butyl 2-(2-chloroethyl)-4-ethyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate as an oil (16.80 g, slight overweight, quantitative yield assumed). A solution of the previous crude compound (16.58 g theoretical weight, 45.94 mmol) in THF (120 mL) was cooled to 0–5 °C under a nitrogen atmosphere. Then, a solution of potassium <i>tert</i>-butoxide (115 mL, 1 M in THF, 115 mmol) was added dropwise, and the reaction mixture was stirred at 0–5 °C for 2 h. NH<sub>4</sub>Cl saturated solution was then added, and the reaction mixture was warmed to rt and extracted with ethyl acetate. The organic phases were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum to give <i>tert</i>-butyl 12-ethyl-13-oxo-4-oxa-8,12-diazadispiro[2.1.5.3]tridecane-8-carboxylate (<b>28</b>) as a brown oil (14.90 g, quantitative). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.79 (s, 2H), 3.45 (q, <i>J</i> = 7.2 Hz, 2H), 3.30 (s, 2H), 3.10 (t, <i>J</i> = 11.2 Hz, 2H), 2.00–1.90 (m, 2H), 1.60–1.49 (m, 2H), 1.46 (s, 9H), 1.36 (dd, <i>J</i> = 7.8, 4.5 Hz, 2H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H), 0.94 (dd, <i>J</i> = 7.8, 4.5 Hz, 2H).. HPLC–MS: purity 100%, <i>m</i>/<i>z</i> = 325.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2: To a solution of <b>28</b> (107 mg, 0.33 mmol) in DCM (5 mL), trifluoroacetic acid (0.25 mL, 3.30 mmol) was added, and the reaction mixture was heated at 40 °C for 2 h. The reaction mixture was evaporated to dryness to give crude 12-ethyl-13-oxo-4-oxa-8,12-diazadispiro[2.1.5.3]tridecane trifluoroacetate (<b>29</b> TFA salt) as a viscous oil (141 mg, overweight, estimated 79 wt %; theoretical weight 112 mg; quantitative yield was assumed), that was used in the following step without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.49 (s, 2H), 3.46 (q, <i>J</i> = 7.2 Hz, 2H), 3.33–3.27 (m, 1H), 3.20–3.07 (m, 3H), 2.23–2.15 (m, 2H), 1.93–1.83 (m, 2H), 1.29 (dd, <i>J</i> = 8.0, 4.6 Hz, 2H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H), 1.04 (dd, <i>J</i> = 8.0, 4.6 Hz, 2H). HPLC–MS: purity 97%, <i>m</i>/<i>z</i> = 225.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Step 3: A mixture of <b>29</b> TFA salt (141 mg, 79 wt %, 0.33 mmol), 2-(2-bromoethyl)pyridine hydrobromide (105 mg, 0.39 mmol), sodium iodide (29 mg, 0.19 mmol), and K<sub>2</sub>CO<sub>3</sub> (363 mg, 2.63 mmol) in acetonitrile (5 mL) was heated at 80 °C in a sealed tube overnight. Water was added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to give 12-ethyl-8-(2-(pyridin-2-yl)ethyl)-4-oxa-8,12-diazadispiro[2.1.5.3]tridecan-13-one (<b>14w</b> free base) as a yellow oil (72 mg, 66%). To a solution of the previous free base (72 mg, 0.22 mmol) in anhydrous diethyl ether (1 mL), HCl (2 M solution in diethyl ether, 0.11 mL, 0.22 mmol) was added. The mixture was stirred at rt for 1 h and then it was concentrated to dryness to give <b>14w</b> HCl salt as a white solid (74.1 mg, 92%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.65 (d, <i>J</i> = 5.3 Hz, 1H), 8.09 (t, <i>J</i> = 7.7 Hz, 1H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 7.57 (t, <i>J</i> = 6.4 Hz, 1H), 3.65–3.56 (m, 4H), 3.53 (s, 2H), 3.47 (q, <i>J</i> = 7.2 Hz, 2H), 3.42 (t, <i>J</i> = 7.6 Hz, 2H), 3.29–3.22 (m, 2H), 2.32–2.23 (m, 2H), 2.15–2.03 (m, 2H), 1.30 (dd, <i>J</i> = 7.9, 4.6 Hz, 2H), 1.17 (t, <i>J</i> = 7.2 Hz, 3H), 1.09 (dd, <i>J</i> = 7.9, 4.6 Hz, 2H). HPLC–MS: purity 98%. HRMS [M + H]<sup>+</sup> (diff ppm) 330.2174 (0.78).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 9-(2-Fluorophenethyl)-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one Hydrochloride (<b>17</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl 2-methyl-3-oxo-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate (<b>9-1</b>, 100 mg, 0.35 mmol) in DCM (1.0 mL), trifluoroacetic acid (0.27 mL, 3.52 mmol) was added, and the reaction mixture was stirred at rt for 3 h. The reaction mixture was evaporated to dryness to give crude 2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one trifluoroacetate as a viscous oil (189 mg, overweight, estimated 56 wt %; theoretical weight 105 mg; quantitative yield was assumed). A mixture of the previous trifluoroacetate salt (189 mg, 56 wt %, 0.35 mmol), 1-(2-bromoethyl)-2-fluorobenzene (86 mg, 0.42 mmol), sodium iodide (32 mg, 0.21 mmol), and K<sub>2</sub>CO<sub>3</sub> (245 mg, 1.77 mmol) in acetonitrile (3 mL) was heated at 80 °C in a sealed tube overnight. Water was added, and it was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified by flash chromatography (SiO<sub>2</sub>, DCM/MeOH up to 20%) to give 9-(2-fluorophenethyl)-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (<b>17</b> free base) as an oil (53 mg, 49%). To a solution of the previous free base (53 mg, 0.17 mmol) in anhydrous diethyl ether (0.5 mL), HCl (2 M solution in diethyl ether, 0.09 mL, 0.17 mmol) was added. The mixture was stirred at rt for 1 h and then it was evaporated to dryness to give <b>17</b> HCl salt as a white solid (45.3 mg, 76%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.39–7.28 (m, 2H), 7.20–7.08 (m, 2H), 4.24 (q, <i>J</i> = 6.8 Hz, 1H), 3.50–3.36 (m, 2H), 3.38 (d, <i>J</i> = 12.7 Hz, 1H), 3.29–3.21 (m, 3H), 3.21 (d, <i>J</i> = 12.7 Hz, 1H), 3.17–3.06 (m, 3H), 2.41 (d, <i>J</i> = 13.1 Hz, 1H), 2.01–1.93 (m, 1H), 1.92–1.80 (m, 2H), 1.42 (d, <i>J</i> = 6.8 Hz, 3H). HPLC–MS: purity 98%. HRMS [M + H]<sup>+</sup> (diff ppm) 307.1813 (−0.97).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Single-Crystal X-ray Structure Determination of <b>14u</b></h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Crystallization and Sample Preparation</h4><div class="NLM_p last">Crystals of the hydrobromide salt of <b>14u</b> were obtained by a vapor diffusion experiment of a THF solution of the compound in a heptane atmosphere. The analyzed crystal was prepared for measurement under inert conditions immersed in perfluoropolyether as a protecting oil for manipulation.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Data Collection</h4><div class="NLM_p last">Intensity measurements were carried out at the XALOC beamline at the ALBA synchrotron with 13.5 keV radiation (λ = 0.918 44 Å) using a channel-cut Si(111) monochromator and KB mirrors coated with Rh. Data collection was performed using a Bruker (currently Arinax) MD2M diffractometer and the multiaxis MK2 miniKappa goniometer by Arinax. The data were recorded using a Pilatus 2 6M area detector at 295 K. A complete data set was collected using multiple single-axis sweeps at different κ angles. Systematic absences were consistent with chiral space group <i>P</i>2<sub>1</sub> (No. 4). Programs used: data collection, in house software Collect; data processing, autoPROC<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and xia2/DIALS.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Structure Solution and Refinement</h4><div class="NLM_p last">The structure was solved by direct methods and refined on <i>F</i><sup>2</sup> by the full-matrix least-squares method using the programs SHELXS-86 and SHELXL-97.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> All the H atoms were introduced in calculated positions and refined as riding on their parent atoms with idealized geometries and with restrained isotropic displacement parameters; the H atom bonded to the N2 nitrogen atom was found in difference Fourier maps. Drawing of the structure in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> was performed with the program Mercury (Cambridge Crystallographic Data Centre, Cambridge, U.K.).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Crystal data: C<sub>19</sub>H<sub>27</sub>Br<sub>1</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>, 433.34 g/mol, monoclinic, <i>P</i>2<sub>1</sub>, <i>a</i> = 5.896(3) Å, <i>b</i> = 10.936(4) Å, <i>c</i> = 15.917(4) Å, α = 90°, β = 92.152(19)°, γ = 90°, <i>V</i> = 1025.6(7) Å<sup>3</sup>, <i>Z</i> = 2, ρ<sub>calcd</sub> = 1.403 g/cm<sup>3</sup>, 9829, measured reflections, 3360 unique reflections, <i>R</i><sub>int</sub> = 0.1077, <i>R</i><sub>1</sub> = 0.0676, wR<sub>2</sub> = 0.1777, Flack parameter<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> = −0.019(8), for 2656 reflections with <i>I</i> > 2σ(<i>I</i>), goodness-of-fit = 0.994, highest peak/deepest hole 1.13/–0.38 e/Å<sup>3</sup>.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Molecular Simulations of the MOR with Compounds <b>14u</b> and <b>14x</b></h3><div class="NLM_p last">Coordinates for the 5C1M structure were downloaded from the opm server<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> to have the system prealigned to the lipid bilayer. All nonligand and nonreceptor molecules except for the nanobody were removed, alternative conformations deleted, side-chains completed for three residues, and acetyl and methylamide capping groups were placed on Met 65 and Phe 347 of the MOR and Gln 3, Val 102, Asp 110,and Ala 127 of the nanobody. The system was typed with CHARMm, residue p<i>K</i> values were calculated, and the protein was ionized at pH 7.4.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> A binding sphere of 8 Å was defined from the position occupied by BU72 removing the ligand afterward, and the crystallized structure of compound <b>14u</b> was docked with Libdock.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The obtained complex was exported to Maestro<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> where the chirality of the previous structure was inverted to obtain as well the complex with <b>14x</b>. Each system was inserted into a SPC–POPC orthorhombic box with a 10 Å buffer between the system and the edge of the box using the Maestro’s system builder. Sodium and chloride ions were added to neutralize and to reach a final concentration of 0.15 M. Both systems were typed with the OPLS force field and equilibrated by an eight-step protocol being the final step a 20 ns NPgT molecular dynamic simulation, where restraints with a force constant of 0.1 were applied to the backbone atoms of the protein.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Finally a 500 ns production simulation in the NPgT ensemble without any restraints was run for each system and analyzed using Desmond’s Simulation Interactions Diagram and Simulation Event Analysis Panel.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Human σ<sub>1</sub> Receptor Radioligand Assay<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h3><div class="NLM_p last">The binding properties of the test compounds to human σ<sub>1</sub>R were studied in transfected HEK-293 membranes using [<sup>3</sup>H](+)-pentazocine (PerkinElmer, NET-1056) as the radioligand. The assay was carried out with 7 μg of membrane suspension, [<sup>3</sup>H]-(+)-pentazocine (5 nM, 100 μL) in either absence or presence of either buffer or 10 μM haloperidol for total and nonspecific binding, respectively. Binding buffer contained Tris-HCl (50 mM, at pH 8). Plates were incubated at 37 °C for 120 min. After the incubation period, the reaction mix was transferred to MultiScreen HTS, FC plates (Millipore) were presoaked in 100 μL of 0.1% polyethylenimine and filtered. Then, plates were washed (3 times) with ice-cold Tris-HCl (10 mM, pH 7.4). Filters were dried and counted at approximately 40% efficiency in a MicroBeta scintillation counter (PerkinElmer) using EcoScint liquid scintillation cocktail.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Human μ-Opioid Receptor Radioligand Assay<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></h3><div class="NLM_p last">Transfected CHO-K1 cell membranes (20 μg) were incubated with [<sup>3</sup>H]-DAMGO (1 nM,) in 250 μL of assay buffer containing 50 mM Tris-HCl and 5 mM MgCl<sub>2</sub> at pH 7.4. NBS (nonspecific binding) was measured by adding 10 μM naloxone. The binding of the test compound was measured at five different concentrations. Plates were incubated at 27 °C for 60 min. After the incubation period, the reaction mixture was then transferred to MultiScreen HTS, FC plates (Millipore) presoaked in 100 μL of 0.5% polyethylenimine and filtered. Then, plates were washed 3 times with ice-cold 10 mM Tris-HCl (pH 7.4). Filters were dried and counted at approximately 40% efficiency in a MicroBeta scintillation counter (PerkinElmer) using EcoScint liquid scintillation cocktail.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Human μ-Opioid Receptor Functionality<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></h3><div class="NLM_p">cAMP measurements on CHO-K1 cells stably expressing human μ-opioid receptor (PerkinElmer, ES-542-C) were performed by using homogeneous time resolved fluorescence (HTRF). 2500 cells/well were seeded the day before the experiment in Opti-Mem (10 μL) in 384-well plates. The compounds were prepared in Opti-Mem with 0.5 mM IBMX and 7.5 μM forskolin, and 10 μL was added to the cells. After 45 min at 37 °C the reaction was stopped by lysing the cells with a mixture of 10 μL of each HTRF detection reagents (Cisbio, 62AM4PEJ). Plates were incubated for an additional 1 h at room temperature and read at 665 nm/620 nm using a RubyStar Plate reader (BMG LabTech).</div><div class="NLM_p last">DAMGO was included in each assay and its maximum effect was considered as <i>E</i><sub>max</sub> = 100%.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Human α<sub>1</sub>A Adrenoreceptor Radioligand Assay<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></h3><div class="NLM_p last">Human α<sub>1</sub>A adrenoreceptor enriched membranes (10 μg) were incubated with 0.2 nM radiolabeled [<sup>3</sup>H]-prazosin in 250 μL of assay buffer containing 50 mM Hepes, 5 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, 0.2% BSA, pH 7.4. NSB (nonspecific binding) was measured by adding 1 μM prazosin in 25 μL volume. Final DMSO concentration was 0.1% (v/v). After 90 min incubation at 25 °C, binding reaction was terminated by filtering 200 μL through Multiscreen GF/C (Millipore) presoaked in 150 μL of 0.5% polyethylenimine in vacuum manifold station, followed by 3 washes with 200 μL/well of ice-cold filtration buffer containing 50 mM Hepes, 500 mM NaCl, BSA 0.1%, pH 7.4.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> hERG Assay<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></h3><div class="NLM_p last">CHO cells stably expressing hERG channels (Millipore) were cultured in F12 HAM medium supplemented with 10% FBS and 400 μg/L Geneticin. The extracellular Ringer’s solution consisted of the following (in mM): 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, 4 KCl, 145 NaCl, 10 glucose, pH 7.4, 305 mOsm. The intracellular Ringer’s solution consisted of the following (in mM): 5.37 CaCl<sub>2</sub>, 1.75 MgCl<sub>2</sub>, 31.25/10 KOH/EGTA, 10 HEPES, 210 KCl, pH 7.2, 295 mOsm. 4 mM Na<sub>2</sub>-ATP was added to intracellular Ringer’s solution shortly before use. Whole-cell currents were measured with a QPatch system (Sophion) in response to continuously executed voltage protocols as per manufacturer’s recommendations. Upon onset of the voltage protocol, cells were maintained at a holding potential (Vh) of −80 mV, then clamped briefly to −50 mV (20 ms), subsequently depolarized to 20 mV for 4800 ms, and finally repolarized to −50 mV for 5000 ms, at which potential the peak outward tail current was measured. Finally, the voltage returned to Vh for 3100 ms. Thus, voltage protocols were repeated each 15 s. For each cell, extracellular solution was applied previous to increasing concentrations of the tested compound.</div></div><div id="sec5_10_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> In Vivo Studies. Animals</h3><div class="NLM_p last">6- to 8-week-old male CD1 mice were used. All tests were performed in groups of 6–12 animals (<i>n</i> = 6–12). Animals had free access to food and water and were kept in controlled laboratory conditions with temperature at 21 ± 1 °C and a light–dark cycle of 12 h (lights on at 7:00 a.m.). Behavioral testing was conducted in a soundproof and air-regulated experimental room during the light phase and was carried out without knowledge of treatment. All animal husbandry and experimental procedures complied with European guidelines regarding the protection of animals used for experimental and other scientific purposes international standards (European Communities Council directive 2010/63) and were approved by the local ethics committee.</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Drug Administration</h3><div class="NLM_p last">For systemic administration, compound <b>14u</b>, oxycodone, PRE-084, and naloxone were dissolved in a vehicle composed of hydroxypropyl methylcellulose (HPMC) 0.5% in distilled water. The compounds were administered in a volume of 10 mL/kg.</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Paw Pressure Test</h3><div class="NLM_p">The test was performed as previously described.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Briefly, the animals were gently restrained and a constant pressure (450 g) using a cone-shaped paw-presser with a rounded tip (Analgesy-meter, Ugo-Basile) was applied to the dorsal surface of both hind paws. A chronometer was manually activated at the start of the pressure application and stopped at the onset of the struggle reaction, and the response latency was recorded in seconds. The test was performed once in each hind-paw, with a 1 min interval between each stimulation. A 50 s cutoff was established for each measurement to prevent tissue damage. The mean value of the two measurements was considered in the analyses.</div><div class="NLM_p last">Data were converted to % of antinociception. By comparison with the vehicle mean (defined as 0% of antinociception) and the cutoff (defined as 100% of antinociception), individual percentages of antinociception were determined by the formula % antinociception = [(individual test latency – mean vehicle latency)/(cut-off latency mean vehicle latency)] × 100. Data obtained were compared by using one-way ANOVA. Subsequent post-hoc Sidak’s multiple comparison test was used to compare the effects of oxycodone and compound <b>14u.</b> Statistical significance criterion was <i>p</i> < 0.05.</div></div><div id="sec5_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> PSNL Model. (1) Surgery</h3><div class="NLM_p last">The partial sciatic nerve ligation model was used to induce neuropathic pain.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Briefly, mice were anesthetized with isoflurane (induction, 5%; surgery, 3%), and the common sciatic nerve was exposed at the level of the mid-thigh of the right paw. At about 1 cm proximal to the nerve trifurcation, tight ligation was created around 33–50% of the sciatic nerve, leaving the rest of the nerve uninjured. The muscle was stitched, and the incision was closed with wound clips. The sciatic nerve injury was always produced in the right hind paw (ipsilateral paw), whereas no injury was performed on the left one (contralateral hind paw).</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2) Mechanical Allodynia Assessment</h3><div class="NLM_p last">Allodynia to mechanical stimuli was used as outcome measure of neuropathic pain and was quantified by measuring the hind paw withdrawal response to von Frey filament stimulation).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Briefly, animals were placed in a Plexiglas box (11 cm × 11 cm × 13 cm) with a wire grid bottom through which the von Frey filaments (bending force range from 0.004 to 2 g) (North Coast Medical, Inc., San Jose CA, USA) were applied by using the up–down paradigm, as previously described. Animals were habituated for 1–2 h before testing in order to allow an appropriate behavioral evaluation. Both ipsilateral and contralateral paws were tested. Clear paw withdrawal, shaking, and licking were considered as nociceptive-like responses.</div></div><div id="sec5_11_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3) Opiate Withdrawal Assessment</h3><div class="NLM_p last">Opiate withdrawal syndrome was precipitated by injecting naloxone (hydrochloride salt, 1 mg/kg, sc) and evaluating the behavioral responses over 3 consecutive periods of 5 min each (for a total time period of 15 min).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Two classes of signs were measured: the number of bouts of jumping, wet dog shakes, paw tremor, and sniffing were counted. On the other hand, teeth chattering, piloerection, salivation, body tremor, ptosis, and diarrhea were evaluated with one point being given for the presence of each sign during each period of 5 min. The number of periods showing the sign were then counted (maximum score: 3). A global score was calculated for each animal as the sum of all behavioral responses.</div></div><div id="sec5_11_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (4) Experimental Protocol</h3><div class="NLM_p last">Animals were habituated for 6–7 h to the testing environment during 3–4 days. After the last habituation period, baseline responses were established for von Frey test. One day after baseline measurements, sciatic nerve injury was induced as previously described. In order to verify the appropriate development of neuropathic pain, animals were tested on day 5 after the surgical procedure. The repeated treatment with vehicle, compound <b>14u</b>, or oxycodone started on day 13. Mice received the drug twice a day at the dose of 5 mg/kg or 1.25 mg/kg of <b>14u</b> or oxycodone respectively, during 10 consecutive days. von Frey evaluations were performed on days 13, 18, and 22 following the same experimental procedure as described before. On day 23, mice received a morning injection vehicle, oxycodone (1.25 mg/kg, ip), or compound <b>14u</b> (5 mg/kg, ip) and 30 min later, naloxone (1 mg/kg, sc). Then the opiate-induced withdrawal was evaluated during a period of 15 min. Mechanical allodynia was expressed as pressure (grams) required for the threshold of response in the von Frey filament stimulation model (mean ± SEM). Data obtained were compared in ipsilateral paws by using one-way ANOVA. Subsequent post-hoc DMS test was used to compare the effects of oxycodone and compound <b>14u</b> with vehicle in the von Frey model. Results of opiate withdrawal studies were expressed as a global score (mean ± SEM). Student <i>t</i> test was used for comparison with vehicle. Statistical significance criterion was <i>p</i> < 0.05.</div></div><div id="sec5_11_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Intestinal Transit Inhibition (Constipation)</h3><div class="NLM_p last">Intestinal transit was evaluated by identifying the leading front of an intragastrically administered marker located in the small intestine. A fresh 5% charcoal suspension in distilled water was prepared. Animals were fasted for 3–4 h and then given vehicle (HPMC 0.5%), oxycodone (20 mg/kg, po), or <b>14u</b> (40 mg/kg, ip). Then 30 min later, 0.3 mL of the charcoal suspension was administered by oral route using an intragastric probe, mice were sacrificed 30 min later under CO<sub>2</sub> atmosphere saturation, and the entire length of the small intestine was dissected free and removed from pylorus to ileocecal valve. The distance traveled by the charcoal meal and the total length of the intestine were measured in cm. The percentage of the distance traveled by the charcoal meal in relation to the total length of the intestine was calculated. The percentage of intestinal transit versus the total intestine length of each animal, and the percentage of intestinal transit inhibition versus the vehicle-treated group were calculated as % of inhibition = (((% of intestinal transit of each mouse ×100)/mean % of intestinal transit of control group) – 100) × (−1). Data obtained were compared by using one-way ANOVA. Subsequent post-hoc Sidak’s multiple comparison test was used to compare the effects of oxycodone and compound <b>14u</b>. Statistical significance criterion was <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e5227-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01127" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01127?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01127</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Analytical data for all the final compounds and intermediates, optical purity of enantiopure compounds, and experimental methods for affinity measurement in selectivity panel targets(<a href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_001.pdf">jm0c01127_si_001.pdf (1.78 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_002.csv">jm0c01127_si_002.csv (3.52 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01127" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Almansa</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5665-4685" title="Orcid link">http://orcid.org/0000-0001-5665-4685</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a0c3c1cccdc1ced3c1e0d7c5ccc1c28ec2c1d2c3c5cccfcec1"><span class="__cf_email__" data-cfemail="a5c6c4c9c8c4cbd6c4e5d2c0c9c4c78bc7c4d7c6c0c9cacbc4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mónica García</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Virgili</span> - <span class="hlFld-Affiliation affiliation">Enantia,
S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mònica Alonso</span> - <span class="hlFld-Affiliation affiliation">Enantia,
S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carles Alegret</span> - <span class="hlFld-Affiliation affiliation">Enantia,
S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joan Farran</span> - <span class="hlFld-Affiliation affiliation">Enantia,
S.L., Carrer Baldiri Reixac, 10, Parc Científic de Barcelona, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Begoña Fernández</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magda Bordas</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosalia Pascual</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2535-0272" title="Orcid link">http://orcid.org/0000-0002-2535-0272</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier Burgueño</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alba Vidal-Torres</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio R. Fernández de Henestrosa</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Ayet</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuel Merlos</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose Miguel Vela</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">WELAB, Parc Científic
Barcelona, C/Baldiri Reixac 4-8, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos R. Plata-Salamán</span> - <span class="hlFld-Affiliation affiliation">ESTEVE
Pharmaceuticals S.A., Torre Esteve, Passeig de la Zona Franca, 109, 08038 Barcelona, Spain</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">CCDC 1979266 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="http://www.ccdc.cam.ac.uk/structures" class="extLink">www.ccdc.cam.ac.uk/structures</a>.</p></div></li></ul></div><div class="ack" id="ACK-d7e5215-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Adriana Port, Raquel Enrech, Inés Álvarez, Pilar Pérez, Xavier Monroy, Marta Pujol, Enrique Hernández, Javier Farre, Raquel Fernández-Reinoso, Sandra Yeste, M<sup>a</sup> José Pretel, Georgia Gris, Carmen Segalés, Bertrand Aubel, Alicia Pardo, Ana Paz Marín, and Daniel Zamanillo for their expert contribution to analytical, in vitro, and in vivo studies, Carlos Cendón and Lydia Cárdenas for their expert contribution to the synthesis of the compounds and the resupply batches of compound <b>14u</b>, Glòria Ten for the salt screening of <b>14u</b> and the single crystal growth experiments, Joan Andreu Morató, Monica Carro, and Edmundo Ortega for their excellent technical assistance, and Carlos Pérez and Eduardo Villarroel for their contribution to compound management. This work was a part of activities in R&D Projects IDI20130943 and IDI20150915 supported by the Spanish Ministerio de Economía y Competitividad (MINECO), through the Centro para el Desarrollo Tecnológico Industrial (CDTI), cofinanced by the European Union through the European Regional Development Fund (ERDF; Fondo Europeo de Desarrollo Regional, FEDER).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">α<sub>1</sub>AR</td><td class="NLM_def"><p class="first last">α<sub>1</sub>A adrenoreceptor</p></td></tr><tr><td class="NLM_term">CAN</td><td class="NLM_def"><p class="first last">cerium ammonium nitrate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">MOR</td><td class="NLM_def"><p class="first last">μ-opioid receptor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">σ<sub>1</sub>R</td><td class="NLM_def"><p class="first last">σ<sub>1</sub> receptor</p></td></tr><tr><td class="NLM_term">σ<sub>1</sub>R-KO</td><td class="NLM_def"><p class="first last">σ<sub>1</sub> receptor knockout mice</p></td></tr><tr><td class="NLM_term">TMSOI</td><td class="NLM_def"><p class="first last">trimethylsulfoxonium iodide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, M. L.</span></span>, Ed. <span> </span><span class="NLM_article-title">Opioids and Pain Relief: A Historical Perspective</span>.  <i>Progress in Pain Research and Management</i>; <span class="NLM_publisher-name">IASP Press</span>: <span class="NLM_publisher-loc">Seattle, WA</span>, <span class="NLM_year">2003</span>; Vol  <span class="NLM_volume">25</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+L.+Meldrum&title=Progress+in+Pain+Research+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeldrum%26aufirst%3DM.%2BL.%26atitle%3DOpioids%2520and%2520Pain%2520Relief%253A%2520A%2520Historical%2520Perspective%26btitle%3DProgress%2520in%2520Pain%2520Research%2520and%2520Management%26pub%3DIASP%2520Press%26date%3D2003%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgili, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroy, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as new dual μ-opioid receptor agonists and σ<sub>1</sub> receptor antagonists for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2434</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitF2nur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2434-2454&author=M.+Garc%C3%ADaauthor=M.+Virgiliauthor=M.+Alonsoauthor=C.+Alegretauthor=B.+Fern%C3%A1ndezauthor=A.+Portauthor=R.+Pascualauthor=X.+Monroyauthor=A.+Vidal-Torresauthor=M.+T.+Serafiniauthor=J.+M.+Velaauthor=C.+Almansa&title=4-Aryl-1-oxa-4%2C9-diazaspiro%5B5.5%5Dundecane+derivatives+as+new+dual+%CE%BC-opioid+receptor+agonists+and+%CF%831+receptor+antagonists+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.9b01256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as dual μ-opioid receptor agonists and σ1 receptor antagonists for the treatment of pain</span></div><div class="casAuthors">Garcia, Monica; Virgili, Marina; Alonso, Monica; Alegret, Carles; Fernandez, Begona; Port, Adriana; Pascual, Rosalia; Monroy, Xavier; Vidal-Torres, Alba; Serafini, Maria-Teresa; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2434-2454</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-oxa-4,9-diazaspiro[5.5]undecane derivs. as potent dual ligands for the sigma-1 receptor (σ1R) and the μ-opioid receptor (MOR) are reported.  The different positions of the central scaffold, designed using a merging strategy of both targets pharmacophores, were explored using a versatile synthetic approach.  Phenethyl derivs. in position 9, substituted pyridyl moieties in position 4 and small alkyl groups in position 2 provided the best profiles.  One of the best compds., I, showed a balanced dual profile (i.e. MOR agonism and sigma antagonism) and potent analgesic activity, comparable to the MOR agonist oxycodone in the paw pressure test in mice.  Contrary to oxycodone, as expected from the addn. of σ1R antagonism, I showed local, peripheral activity in this test, which was reversed by the σ1R agonist PRE-084.  At equianalgesic doses, I showed less constipation than oxycodone, providing evidence that dual MOR agonism and σ1R antagonism may be a useful strategy for obtaining potent and safer analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN_96WgxDmIbVg90H21EOLACvtfcHk0lgroXxxZwkhAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitF2nur3M&md5=6ff458638f9069ade1ccca8adabebb9a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01256%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM.%26aulast%3DVirgili%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DAlegret%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3D4-Aryl-1-oxa-4%252C9-diazaspiro%255B5.5%255Dundecane%2520derivatives%2520as%2520new%2520dual%2520%25CE%25BC-opioid%2520receptor%2520agonists%2520and%2520%25CF%25831%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2434%26epage%3D2454%26doi%3D10.1021%2Facs.jmedchem.9b01256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span> <span> </span><span class="NLM_article-title">Opioids in neuropathic pain: Clues from animal studies</span>. <i>Eur. J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.ejpain.2004.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejpain.2004.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15737797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=113-116&author=A.+H.+Dickensonauthor=R.+Suzuki&title=Opioids+in+neuropathic+pain%3A+Clues+from+animal+studies&doi=10.1016%2Fj.ejpain.2004.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Opioids in neuropathic pain: clues from animal studies</span></div><div class="casAuthors">Dickenson, Anthony H.; Suzuki, Rie</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-116</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  For many years the clin. consensus was that opioids were ineffective in neuropathic pain.  However this view is changing and here we discuss the mechanisms of opioid analgesia in terms of the changes that can occur in preclin. models of nerve injury.  We argue that opioid mechanisms can be perturbed by neuropathy but in most cases these neg. influences can be overcome by dose-escalation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcGfiK-MHKLLVg90H21EOLACvtfcHk0lgroXxxZwkhAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWrsro%253D&md5=edcad0356537b8256e5cb6152a06126e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpain.2004.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpain.2004.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DSuzuki%26aufirst%3DR.%26atitle%3DOpioids%2520in%2520neuropathic%2520pain%253A%2520Clues%2520from%2520animal%2520studies%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2005%26volume%3D9%26spage%3D113%26epage%3D116%26doi%3D10.1016%2Fj.ejpain.2004.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrman, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritz, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10830</span>– <span class="NLM_lpage">10835</span>, <span class="refDoi"> DOI: 10.1073/pnas.1300393110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1073%2Fpnas.1300393110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23754417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10830-10835&author=N.+T.+Burfordauthor=M.+J.+Clarkauthor=T.+S.+Wehrmanauthor=S.+W.+Gerritzauthor=M.+Banksauthor=J.+O%E2%80%99Connellauthor=J.+R.+Traynorauthor=A.+Alt&title=Discovery+of+positive+allosteric+modulators+and+silent+allosteric+modulators+of+the+%CE%BC-opioid+receptor&doi=10.1073%2Fpnas.1300393110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor</span></div><div class="casAuthors">Burford, Neil T.; Clark, Mary J.; Wehrman, Tom S.; Gerritz, Samuel W.; Banks, Martyn; O'Connell, Jonathan; Traynor, John R.; Alt, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10830-10835,S10830/1-S10830/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">μ-Opioid receptors are among the most studied G protein-coupled receptors because of the therapeutic value of agonists, such as morphine, that are used to treat chronic pain.  However, these drugs have significant side effects, such as respiratory suppression, constipation, allodynia, tolerance, and dependence, as well as abuse potential.  Efforts to fine tune pain control while alleviating the side effects of drugs, both physiol. and psychol., have led to the development of a wide variety of structurally diverse agonist ligands for the μ-opioid receptor, as well as compds. that target κ- and δ-opioid receptors.  In recent years, the identification of allosteric ligands for some G protein-coupled receptors has provided breakthroughs in obtaining receptor subtype-selectivity that can reduce the overall side effect profiles of a potential drug.  However, pos. allosteric modulators (PAMs) can also have the specific advantage of only modulating the activity of the receptor when the orthosteric agonist occupies the receptor, thus maintaining spatial and temporal control of receptor signaling in vivo.  This second advantage of allosteric modulators may yield breakthroughs in opioid receptor research and could lead to drugs with improved side-effect profiles or fewer tolerance and dependence issues compared with orthosteric opioid receptor agonists.  Here, the authors describe the discovery and characterization of μ-opioid receptor PAMs and silent allosteric modulators, identified from high-throughput screening using a β-arrestin-recruitment assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdiTL5ko3pr7Vg90H21EOLACvtfcHk0lgroXxxZwkhAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7nJ&md5=5fd64e5ae56607fa2396fdd3f32caf54</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1300393110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1300393110%26sid%3Dliteratum%253Aachs%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DWehrman%26aufirst%3DT.%2BS.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DBanks%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DAlt%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520positive%2520allosteric%2520modulators%2520and%2520silent%2520allosteric%2520modulators%2520of%2520the%2520%25CE%25BC-opioid%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10830%26epage%3D10835%26doi%3D10.1073%2Fpnas.1300393110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanath, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simopoulos, T. T.</span></span> <span> </span><span class="NLM_article-title">A brief history of the opioid epidemic and strategies for pain medicine</span>. <i>Pain Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1007/s40122-018-0097-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1007%2Fs40122-018-0097-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=29691801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjmtlekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=13-21&author=M.+R.+Jonesauthor=O.+Viswanathauthor=J.+Peckauthor=A.+D.+Kayeauthor=J.+S.+Gillauthor=T.+T.+Simopoulos&title=A+brief+history+of+the+opioid+epidemic+and+strategies+for+pain+medicine&doi=10.1007%2Fs40122-018-0097-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Brief History of the Opioid Epidemic and Strategies for Pain Medicine</span></div><div class="casAuthors">Jones Mark R; Viswanath Omar; Gill Jatinder S; Simopoulos Thomas T; Peck Jacquelin; Kaye Alan D</div><div class="citationInfo"><span class="NLM_cas:title">Pain and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>
        ISSN:<span class="NLM_cas:issn">2193-8237</span>.
    </div><div class="casAbstract">The opioid epidemic has resulted from myriad causes and will not be solved by any simple solution.  Consequent to a staggering increase in opioid-related deaths in the USA, various governmental inputs and stakeholder strategies have been proposed and implemented with varying success.  This article summarizes the history of opioid use and explores the causes for the present day epidemic.  Recent trends in opioid-related data demonstrate an almost fourfold increase in overdose deaths from 1999 to 2008.  Tragically, opioids claimed over 64,000 lives just last year.  Some solutions have undergone legislation, including the limitation of numbers of opioids postsurgery, as well as growing national prevalence of enhanced recovery after surgery protocols which focus on reduced postoperative opioid consumption and shortened hospital stays.  Stricter prescribing practices and prescription monitoring programs have been instituted in the recent past.  Improvement in abuse deterrent strategies which is a major focus of the Food and Drug Administration (FDA) for all opioid preparations will likely play an important role by increasing the safety of these medications.  Future potential strategies such as additional legislative policies, public awareness, and physician education are also detailed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUyZ-LWOyWCEbxh97K6Vt6fW6udTcc2ebjdtCt_Ijb4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjmtlekuw%253D%253D&md5=386633388006687ea4c304927a1625bb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs40122-018-0097-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40122-018-0097-6%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%2BR.%26aulast%3DViswanath%26aufirst%3DO.%26aulast%3DPeck%26aufirst%3DJ.%26aulast%3DKaye%26aufirst%3DA.%2BD.%26aulast%3DGill%26aufirst%3DJ.%2BS.%26aulast%3DSimopoulos%26aufirst%3DT.%2BT.%26atitle%3DA%2520brief%2520history%2520of%2520the%2520opioid%2520epidemic%2520and%2520strategies%2520for%2520pain%2520medicine%26jtitle%3DPain%2520Ther.%26date%3D2018%26volume%3D7%26spage%3D13%26epage%3D21%26doi%3D10.1007%2Fs40122-018-0097-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Sigma antagonists potentiate opioid analgesia in rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/0304-3940(95)11504-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0304-3940%2895%2911504-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=7644123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1995&pages=137-139&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Sigma+antagonists+potentiate+opioid+analgesia+in+rats&doi=10.1016%2F0304-3940%2895%2911504-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma antagonists potentiate opioid analgesia in rats</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-9</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In mice, activation of sigma1 receptors antagonizes opioid analgesia.  Sigma antagonists potentiate opioid analgesia, implying that the anti-opioid sigma system is tonically active.  Co-administration of haloperidol with the mu opioid morphine, the kappa1 analgesic U 50488H or the kappa3 agonist naloxone benzoylhydrazone enhances the analgesic activity of all agents.  The effect results from sigma receptor blockade since (-)sulpiride, a selective D2 antagonist which does not block sigma receptors, is inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT7Y-iEDEl3bVg90H21EOLACvtfcHk0lhNByWiLKN-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D&md5=66ace8f372aca6d388626a9d9ba09728</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2895%2911504-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252895%252911504-P%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma%2520antagonists%2520potentiate%2520opioid%2520analgesia%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D190%26spage%3D137%26epage%3D139%26doi%3D10.1016%2F0304-3940%2895%2911504-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujalte, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoliu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Formalin-induced pain is reduced in sigma(1) receptor knockout mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2005.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-induced+pain+is+reduced+in+sigma%281%29+receptor+knockout+mice&doi=10.1016%2Fj.ejphar.2005.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0lhNByWiLKN-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-induced%2520pain%2520is%2520reduced%2520in%2520sigma%25281%2529%2520receptor%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74%26doi%3D10.1016%2Fj.ejphar.2005.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuberes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrocal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contijoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laggner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of σ<sub>1</sub> receptor antagonists: Identification of 4-{2-[5-methyl-1-(naphtalen-2-yl)-1<i>H</i>-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8211</span>– <span class="NLM_lpage">8224</span>, <span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+%CF%831+receptor+antagonists%3A+Identification+of+4-%7B2-%5B5-methyl-1-%28naphtalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span></div><div class="casAuthors">Diaz, Jose Luis; Cuberes, Rosa; Berrocal, Joana; Contijoch, Montserrat; Christmann, Ute; Fernandez, Ariadna; Port, Adriana; Holenz, Jorg; Buschmann, Helmut; Laggner, Christian; Serafini, Maria Teresa; Burgueno, Javier; Zamanillo, Daniel; Merlos, Manuel; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8211-8224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-arylpyrazoles as potent σ1 receptor (σ1R) antagonists are reported.  The new compds. were evaluated in vitro in human σ1R and guinea pig σ2 receptor (σ2R) binding assays.  The nature of the pyrazole substituents was crucial for activity, and a basic amine was shown to be necessary, in accordance with known receptor pharmacophores.  A wide variety of amines and spacer lengths between the amino and pyrazole groups was tolerated, but only the ethylenoxy spacer and small cyclic amines provided compds. with sufficient selectivity for σ1R vs σ2R.  The most selective compds. were further profiled, and 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862, I), which showed high activity in the mouse capsaicin model of neurogenic pain, emerged as the most interesting candidate.  In addn., compd. I exerted dose-dependent antinociceptive effects in several neuropathic pain models.  This, together with its good physicochem., safety, and ADME properties, led compd. I to be selected as clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQxd7-vnvc7Vg90H21EOLACvtfcHk0lhNByWiLKN-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI&md5=0d6a5c8008d27635117c3901ec1db3c4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520%25CF%25831%2520receptor%2520antagonists%253A%2520Identification%2520of%25204-%257B2-%255B5-methyl-1-%2528naphtalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Puente, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocasalbas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touriño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bura, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Pastor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>711</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejphar.2013.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23632394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=711&publication_year=2013&pages=63-72&author=A.+Vidal-Torresauthor=B.+de+la+Puenteauthor=M.+Rocasalbasauthor=C.+Touri%C3%B1oauthor=S.+A.+Buraauthor=B.+Fern%C3%A1ndez-Pastorauthor=L.+Romeroauthor=X.+Codonyauthor=D.+Zamanilloauthor=H.+Buschmannauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=R.+Maldonadoauthor=J.+M.+Vela&title=Sigma-1+receptor+antagonism+as+opioid+adjuvant+strategy%3A+Enhancement+of+opioid+antinociception+without+increasing+adverse+effects&doi=10.1016%2Fj.ejphar.2013.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span></div><div class="casAuthors">Vidal-Torres, Alba; de la Puente, Beatriz; Rocasalbas, Maria; Tourino, Clara; Andreea Bura, Simona; Fernandez-Pastor, Begona; Romero, Luz; Codony, Xavier; Zamanillo, Daniel; Buschmann, Helmut; Merlos, Manuel; Manuel Baeyens, Jose; Maldonado, Rafael; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">711</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While opioids are potent analgesics widely used in the management of pain, a no. of well-known adverse effects limit their use.  The sigma-1 receptor is a ligand-regulated mol. chaperone involved in pain processing, including modulation of opioid antinociception.  However, data supporting the potential use of sigma-1 receptor ligands as suitable opioid adjuvants are based on studies that use non selective ligands.  Also, safety issues derived from combination therapy are poorly addressed.  In this study we used the new selective sigma-1 receptor antagonist S1RA (E-52862) to characterize the effect of selective sigma-1 receptor blockade on opioid-induced efficacy- and safety-related outcomes in mice.  S1RA (40 mg/kg) had no effect in the tail-flick test but did enhance the antinociceptive potency of several opioids by a factor between 2 and 3.3.  The potentiating effect of S1RA on morphine antinociception did not occur in sigma-1 receptor knockout mice, which supports the selective involvement of the sigma-1 receptor.  Interestingly, S1RA co-administration restored morphine antinociception in tolerant mice and reverted the reward effects of morphine in the conditioned place preference paradigm.  In addn., enhancement of antinociception was not accompanied by potentiation of other opioid-induced effects, such as the development of morphine analgesic tolerance, phys. dependence, inhibition of gastrointestinal transit, or mydriasis.  The use of sigma-1 receptor antagonists as opioid adjuvants could represent a promising pharmacol. strategy to enhance opioid potency and, most importantly, to increase the safety margin of opioids.  S1RA is currently in phase II clin. trials for the treatment of several pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTGE08MufobVg90H21EOLACvtfcHk0lgEUv_Jm_aPPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D&md5=c2cd0eb6fe5a9232bff11fe1539f74d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DB.%26aulast%3DRocasalbas%26aufirst%3DM.%26aulast%3DTouri%25C3%25B1o%26aufirst%3DC.%26aulast%3DBura%26aufirst%3DS.%2BA.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptor%2520antagonism%2520as%2520opioid%2520adjuvant%2520strategy%253A%2520Enhancement%2520of%2520opioid%2520antinociception%2520without%2520increasing%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D711%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.ejphar.2013.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor: A new therapeutic target for pain</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>716</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.01.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+receptor%3A+A+new+therapeutic+target+for+pain&doi=10.1016%2Fj.ejphar.2013.01.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0lgEUv_Jm_aPPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520receptor%253A%2520A%2520new%2520therapeutic%2520target%2520for%2520pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2013.01.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span>E.U.
Clinical Trials Register. An exploratory, randomized, double blind,
placebo controlled, parallel groups Phase II clinical trial to evaluate
the efficacy and safety of E-52862 (400 mg) by oral route, as part
of an analgesic therapy balanced with morphine, followed by an open
label extension, in the treatment of post-operative pain due to abdominal
hysterectomy Available from <a href="http://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003302-24/results" class="extLink">www.clinicaltrialsregister.eu/ctr-search/trial/2011-003302-24/results</a> (accessed Jun 3, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=E.U.%0AClinical+Trials+Register.+An+exploratory%2C+randomized%2C+double+blind%2C%0Aplacebo+controlled%2C+parallel+groups+Phase+II+clinical+trial+to+evaluate%0Athe+efficacy+and+safety+of+E-52862+%28400+mg%29+by+oral+route%2C+as+part%0Aof+an+analgesic+therapy+balanced+with+morphine%2C+followed+by+an+open%0Alabel+extension%2C+in+the+treatment+of+post-operative+pain+due+to+abdominal%0Ahysterectomy+Available+from+www.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2011-003302-24%2Fresults+%28accessed+Jun+3%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backonja, M.</span></span> <span> </span><span class="NLM_article-title">Combination drug therapy for chronic pain: a call for more clinical studies</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2010.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.jpain.2010.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=20851058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslOns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=157-166&author=J.+Maoauthor=M.+S.+Goldauthor=M.+Backonja&title=Combination+drug+therapy+for+chronic+pain%3A+a+call+for+more+clinical+studies&doi=10.1016%2Fj.jpain.2010.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Combination Drug Therapy for Chronic Pain: A Call for More Clinical Studies</span></div><div class="casAuthors">Mao, Jianren; Gold, Michael S.; Backonja, Miroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-166</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Chronic pain is a debilitating clin. condition assocd. with a variety of disease entities including diabetic neuropathy, postherpetic neuralgia, low back pathol., fibromyalgia, and neurol. disorders.  For many general practitioners and specialists, managing chronic pain has become a daunting challenge.  As a modality of multidisciplinary chronic pain management, medications are often prescribed in combinations, an approach referred to as combination drug therapy (CDT).  However, many medications for pain therapy, including antidepressants and opioid analgesics, have significant side effects that can compd. when used in combination and impact the effectiveness of CDT.  To date, clin. practice of CDT for chronic pain has been based largely on clin. experiences.  In this article, we will focus on (1) the scientific basis and rationales for CDT, (2) current clin. data on CDT, and (3) the need for more clin. studies to establish a framework for the use of CDT.  Perspective: More preclin., clin., and translational studies are needed to improve the efficacy of combination drug therapy that is an integral part of a comprehensive approach to the management of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjDPNs-xJvEbVg90H21EOLACvtfcHk0li9uxW_xyHw9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslOns7Y%253D&md5=955711ac2946dd44adc0e8b96b6ee423</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2010.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2010.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DGold%26aufirst%3DM.%2BS.%26aulast%3DBackonja%26aufirst%3DM.%26atitle%3DCombination%2520drug%2520therapy%2520for%2520chronic%2520pain%253A%2520a%2520call%2520for%2520more%2520clinical%2520studies%26jtitle%3DJ.%2520Pain%26date%3D2011%26volume%3D12%26spage%3D157%26epage%3D166%26doi%3D10.1016%2Fj.jpain.2010.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6523</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1021/jm058225d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-43&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm&doi=10.1021%2Fjm058225d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0li9uxW_xyHw9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D43%26doi%3D10.1021%2Fjm058225d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of multitarget-directed ligands: Strategies and emerging paradigms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8881</span>– <span class="NLM_lpage">8914</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8881-8914&author=J.+Zhouauthor=X.+Jiangauthor=S.+Heauthor=H.+Jiangauthor=F.+Fengauthor=W.+Liuauthor=W.+Quauthor=H.+Sun&title=Rational+design+of+multitarget-directed+ligands%3A+Strategies+and+emerging+paradigms&doi=10.1021%2Facs.jmedchem.9b00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms</span></div><div class="casAuthors">Zhou, Junting; Jiang, Xueyang; He, Siyu; Jiang, Hongli; Feng, Feng; Liu, Wenyuan; Qu, Wei; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8881-8914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit satisfactory efficacy.  Recently, increasing evidence indicates that simultaneous modulation of multiple targets may improve both therapeutic safety and efficacy, compared with single-target drugs.  However, few multitarget drugs are on market or in clin. trials, despite the best efforts of medicinal chemists.  This article discusses the systematic establishment of target combination, lead generation, and optimization of multitarget-directed ligands (MTDLs).  Moreover, we analyze some MTDLs research cases for several complex diseases in recent years and the physicochem. properties of 117 clin. multitarget drugs, with the aim to reveal the trends and insights of the potential use of MTDLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLqk7hMZnoLVg90H21EOLACvtfcHk0li9uxW_xyHw9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D&md5=37adb9bc31802e62fd7f8d0d6e7697e3</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520multitarget-directed%2520ligands%253A%2520Strategies%2520and%2520emerging%2520paradigms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8881%26epage%3D8914%26doi%3D10.1021%2Facs.jmedchem.9b00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Selective sigma-1 receptor antagonists for the treatment of pain</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.4155%2Ffmc.14.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=25078137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1179-1199&author=C.+Almansaauthor=J.+M.+Vela&title=Selective+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.4155%2Ffmc.14.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective sigma-1 receptor antagonists for the treatment of pain</span></div><div class="casAuthors">Almansa, Carmen; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1179-1199</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The sigma-1 receptor (σ1R) is located in areas of the CNS key for pain control and belongs to a unique target class with chaperoning functions over different mol. targets involved in transmission and amplification of nociceptive messages.  Preclin. evidence supports a role for σ1R antagonists in the treatment of pain states where hypersensitivity develops as hyperalgesia and allodynia, two common symptoms encountered in neuropathic and other chronic pain conditions.  Addnl., σ1R antagonists increase opioid analgesia without increasing opioid-related unwanted effects, which point to their potential use as opioid adjuvant therapy.  This review summarizes the structure and function of the σ1R as well as the medicinal chem. and pharmacol. studies directed to the identification of σ1R antagonists for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0qGYS21i37Vg90H21EOLACvtfcHk0lgfrKgILYYwpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK&md5=3ced452012e44f478a377f0fa52995d4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.54%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DC.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1179%26epage%3D1199%26doi%3D10.4155%2Ffmc.14.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitza, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gintant, G. A.</span></span> <span> </span><span class="NLM_article-title">The [<sup>3</sup>H]-dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K<sup>+</sup>]<sub>o</sub></span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5D-dofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+Comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do&doi=10.1016%2Fj.vascn.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lgfrKgILYYwpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255D-dofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520Comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Cano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artacho-Cordón, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montilla-García, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span> <span> </span><span class="NLM_article-title">Potentiation of morphine-induced mechanical antinociception by σ<sub>1</sub> receptor inhibition: role of peripheral σ<sub>1</sub> receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.neuropharm.2013.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23524304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=348-358&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=F.+R.+Nietoauthor=R.+Gonz%C3%A1lez-Canoauthor=A.+Artacho-Cord%C3%B3nauthor=L.+Romeroauthor=A.+Montilla-Garc%C3%ADaauthor=D.+Zamanilloauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Potentiation+of+morphine-induced+mechanical+antinociception+by+%CF%831+receptor+inhibition%3A+role+of+peripheral+%CF%831+receptors&doi=10.1016%2Fj.neuropharm.2013.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Nieto, Francisco Rafael; Gonzalez-Cano, Rafael; Artacho-Cordon, Antonia; Romero, Lucia; Montilla-Garcia, Angeles; Zamanillo, Daniel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">348-358</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We studied the modulation of morphine-induced mech. antinociception and side effects by σ1 receptor inhibition.  Both wild-type (WT) and σ1 receptor knockout (σ1-KO) mice showed similar responses to paw pressure (100-600 g).  The systemic (s.c.) or local (intraplantar) administration of σ1 antagonists (BD-1063, BD-1047, NE-100 and S1RA) was devoid of antinociceptive effects in WT mice.  However, σ1-KO mice exhibited an enhanced mech. antinociception in response to systemic morphine (1-16 mg/kg).  Similarly, systemic treatment of WT mice with σ1 antagonists markedly potentiated morphine-induced antinociception, and its effects were reversed by the selective σ1 agonist PRE-084.  Although the local administration of morphine (50-200 μg) was devoid of antinociceptive effects in WT mice, it induced dose-dependent antinociception in σ1-KO mice.  This effect was limited to the injected paw.  Enhancement of peripheral morphine antinociception was replicated in WT mice locally co-administered with σ1 antagonists and the opioid.  None of the σ1 antagonists tested enhanced morphine-antinociception in σ1-KO mice, confirming a σ1-mediated action.  Morphine-induced side-effects (hyperlocomotion and inhibition of gastrointestinal transit) were unaltered in σ1-KO mice.  These results cannot be explained by a direct interaction of σ1 ligands with μ-opioid receptors or adaptive changes of μ-receptors in σ1-KO mice, given that [3H]DAMGO binding in forebrain, spinal cord, and hind-paw skin membranes was unaltered in mutant mice, and none of the σ1 drugs tested bound to μ-opioid receptors.  These results show that σ1 receptor inhibition potentiates morphine-induced mech. analgesia but not its acute side effects, and that this enhanced analgesia can be induced at peripheral level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc2KFSqih3HbVg90H21EOLACvtfcHk0lhwp-nHPvFXAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D&md5=d21562671453852a7e07c15232726ade</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3DA.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DPotentiation%2520of%2520morphine-induced%2520mechanical%2520antinociception%2520by%2520%25CF%25831%2520receptor%2520inhibition%253A%2520role%2520of%2520peripheral%2520%25CF%25831%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D348%26epage%3D358%26doi%3D10.1016%2Fj.neuropharm.2013.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Virgili, M.</span>; <span class="NLM_string-name">Alonso, M.</span>; <span class="NLM_string-name">Alegret, C.</span>; <span class="NLM_string-name">Almansa, C.</span>; <span class="NLM_string-name">García, M.</span></span> <span> </span><span class="NLM_article-title">Alkyl Derivatives of 1-Oxa-4,9-diazaspiroundecane Compounds Having Multimodal Activity Against Pain</span>. PCT Int. Appl. <span class="NLM_patent">WO2015185209A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Virgili&author=M.+Alonso&author=C.+Alegret&author=C.+Almansa&author=M.+Garc%C3%ADa&title=Alkyl+Derivatives+of+1-Oxa-4%2C9-diazaspiroundecane+Compounds+Having+Multimodal+Activity+Against+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVirgili%26aufirst%3DM.%26atitle%3DAlkyl%2520Derivatives%2520of%25201-Oxa-4%252C9-diazaspiroundecane%2520Compounds%2520Having%2520Multimodal%2520Activity%2520Against%2520Pain%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, B.</span>; <span class="NLM_string-name">Ennis, D.</span>; <span class="NLM_string-name">Eriksson, T.</span>; <span class="NLM_string-name">Gibson, S.</span>; <span class="NLM_string-name">Gu, E.</span>; <span class="NLM_string-name">Hassall, I.</span>; <span class="NLM_string-name">Hemmerling, M.</span>; <span class="NLM_string-name">Josefsson, B.</span>; <span class="NLM_string-name">Ivanova, S.</span>; <span class="NLM_string-name">Kavitake, S.</span>; <span class="NLM_string-name">Kumar, S. S.</span>; <span class="NLM_string-name">Kumar, V.</span>; <span class="NLM_string-name">Lingesha, S.</span>; <span class="NLM_string-name">Mensonides-Harsema, M.</span>; <span class="NLM_string-name">Merifield, E.</span>; <span class="NLM_string-name">Mo, J.</span>; <span class="NLM_string-name">Pavey, J.</span>; <span class="NLM_string-name">Pimm, A.</span>; <span class="NLM_string-name">Reuberson, J.</span>; <span class="NLM_string-name">Rogers, M.</span>; <span class="NLM_string-name">Schulz, H.</span>; <span class="NLM_string-name">Strandberg, P.</span>; <span class="NLM_string-name">Zhengyu, W.</span>; <span class="NLM_string-name">Cooper, M.</span></span> <span> </span><span class="NLM_article-title">Novel Tricyclic Spiropiperidine Compounds, their Synthesis and their Uses as Modulators of Chemokine Receptor Activity</span>. PCT Int. Appl. <span class="NLM_patent">WO2008010765A1</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Elkins&author=D.+Ennis&author=T.+Eriksson&author=S.+Gibson&author=E.+Gu&author=I.+Hassall&author=M.+Hemmerling&author=B.+Josefsson&author=S.+Ivanova&author=S.+Kavitake&author=S.+S.+Kumar&author=V.+Kumar&author=S.+Lingesha&author=M.+Mensonides-Harsema&author=E.+Merifield&author=J.+Mo&author=J.+Pavey&author=A.+Pimm&author=J.+Reuberson&author=M.+Rogers&author=H.+Schulz&author=P.+Strandberg&author=W.+Zhengyu&author=M.+Cooper&title=Novel+Tricyclic+Spiropiperidine+Compounds%2C+their+Synthesis+and+their+Uses+as+Modulators+of+Chemokine+Receptor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DElkins%26aufirst%3DB.%26atitle%3DNovel%2520Tricyclic%2520Spiropiperidine%2520Compounds%252C%2520their%2520Synthesis%2520and%2520their%2520Uses%2520as%2520Modulators%2520of%2520Chemokine%2520Receptor%2520Activity%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaykovsky, M.</span></span> <span> </span><span class="NLM_article-title">Dimethyloxosulfonium methylide ((CH<sub>3</sub>)<sub>2</sub>SOCH<sub>2</sub>) and dimethylsulfonium methylide ((CH<sub>3</sub>)<sub>2</sub>SCH<sub>2</sub>). Formation and application to organic synthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1353</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1021/ja01084a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01084a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaF2MXntlGrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1965&pages=1353-1364&author=E.+J.+Coreyauthor=M.+Chaykovsky&title=Dimethyloxosulfonium+methylide+%28%28CH3%292SOCH2%29+and+dimethylsulfonium+methylide+%28%28CH3%292SCH2%29.+Formation+and+application+to+organic+synthesis&doi=10.1021%2Fja01084a034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dimethyloxosulfonium methylide and dimethylsulfonium methylide. Formation and application to organic synthesis</span></div><div class="casAuthors">Corey, E. J.; Chaykovsky, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1353-64</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The generation of dimethyloxosulfonium methylide (Me2SOCH2) and dimethylsulfonium methylide (Me2SCH2) as reactive intermediates is described.  Both ylides are nucleophiles and both function to transfer methylene to certain electrophilic unsatd. linkages, including C:O, C:N, C:S, and in certain cases, C:C.  The less reactive oxosulfonium ylide interacts with the carbonyl function of aromatic and nonconjugated aldehydes and ketones to form oxiranes and with α,β-unsatd. ketones which are Michael receptors to form cyclopropyl ketones.  The sulfonium ylide reacts with the same substrates to give oxiranes exclusively even with the α,β-unsatd. carbonyl systems.  These reactions are quite general and, therefore, of considerable practical value.  The stereochemistry of carbonyl addn. to cyclohexanones varies depending on the ylide; the oxosulfonium ylide reacts by equatorial addn. (i.e., of methylene) and the sulfonium ylide shows a preference for axial addn.  A no. of other reactions of these ylides are described including "over-all methylene insertion," and a differential comparison of their chem. properties is made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0xfN-tNfFLVg90H21EOLACvtfcHk0lhwp-nHPvFXAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXntlGrtw%253D%253D&md5=ae22573e36db50409c7832e5950df7f1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja01084a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01084a034%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DChaykovsky%26aufirst%3DM.%26atitle%3DDimethyloxosulfonium%2520methylide%2520%2528%2528CH3%25292SOCH2%2529%2520and%2520dimethylsulfonium%2520methylide%2520%2528%2528CH3%25292SCH2%2529.%2520Formation%2520and%2520application%2520to%2520organic%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1965%26volume%3D87%26spage%3D1353%26epage%3D1364%26doi%3D10.1021%2Fja01084a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abrecht, S.</span></span> <span> </span><span class="NLM_article-title">Method for the Preparation of Alpha-bromo-lactam Derivatives</span>. U.S. Patent <span class="NLM_patent">US6,114,541</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=S.+Abrecht&title=Method+for+the+Preparation+of+Alpha-bromo-lactam+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbrecht%26aufirst%3DS.%26atitle%3DMethod%2520for%2520the%2520Preparation%2520of%2520Alpha-bromo-lactam%2520Derivatives%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleissner, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Rice, F. Y.</span></span> <span> </span><span class="NLM_article-title">Characterization of the binding of [<sup>3</sup>H](+)pentazocine to recognition sites in guinea pig brain</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(92)90153-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+binding+of+%5B3H%5D%28%2B%29pentazocine+to+recognition+sites+in+guinea+pig+brain&doi=10.1016%2F0922-4106%2892%2990153-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0lgCf1r_fELmlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255D%2528%252B%2529pentazocine%2520to%2520recognition%2520sites%2520in%2520guinea%2520pig%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378%26doi%3D10.1016%2F0922-4106%2892%2990153-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroy, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, J.</span></span> <span> </span><span class="NLM_article-title">A complementary scale of biased agonism for agonists with differing maximal responses</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">15389</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-15258-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1038%2Fs41598-017-15258-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=29133887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADC%252BC1M3gvVegsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=15389&author=J.+Burgue%C3%B1oauthor=M.+Pujolauthor=X.+Monroyauthor=D.+Rocheauthor=M.+J.+Varelaauthor=M.+Merlosauthor=J.+Giraldo&title=A+complementary+scale+of+biased+agonism+for+agonists+with+differing+maximal+responses&doi=10.1038%2Fs41598-017-15258-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses</span></div><div class="casAuthors">Burgueno Javier; Pujol Marta; Monroy Xavier; Merlos Manuel; Roche David; Giraldo Jesus; Roche David; Giraldo Jesus; Roche David; Varela Maria Jose</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15389</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compelling data in the literature from the recent years leave no doubt about the pluridimensional nature of G protein-coupled receptor function and the fact that some ligands can couple with different efficacies to the multiple pathways that a receptor can signal through, a phenomenon most commonly known as functional selectivity or biased agonism.  Nowadays, transduction coefficients (log(τ/KA)), based on the Black and Leff operational model of agonism, are widely used to calculate bias.  Nevertheless, combining both affinity and efficacy in a single parameter can result in compounds showing a defined calculated bias of one pathway over other though displaying varying experimental bias preferences.  In this paper, we present a novel scale (log(τ)), that attempts to give extra substance to different compound profiles in order to better classify compounds and quantify their bias.  The efficacy-driven log(τ) scale is not proposed as an alternative to the affinity&efficacy-driven log(τ/KA) scale but as a complement in those situations where partial agonism is present.  Both theoretical and practical approaches using μ-opioid receptor agonists are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8ACsymX9-Ay-bLEOO4dYpfW6udTcc2eZhUgB7omMo1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3gvVegsg%253D%253D&md5=8c43e0cc2e5e1fe47fa40c2c3d50b7f6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-15258-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-15258-z%26sid%3Dliteratum%253Aachs%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DPujol%26aufirst%3DM.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DRoche%26aufirst%3DD.%26aulast%3DVarela%26aufirst%3DM.%2BJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DGiraldo%26aufirst%3DJ.%26atitle%3DA%2520complementary%2520scale%2520of%2520biased%2520agonism%2520for%2520agonists%2520with%2520differing%2520maximal%2520responses%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D15389%26doi%3D10.1038%2Fs41598-017-15258-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, E.</span></span> <span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15635593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma+1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain</span></div><div class="casAuthors">Cobos, Enrique J.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">192-195</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors evaluated the effects of phenytoin (DPH) on the affinity for sigma-1 (σ1) receptors of agonist or antagonist σ1 ligands in guinea pig brain.  Heterologous competition expts. showed that DPH (250 μM and 1 mM) concn.-dependently increased the affinity of the σ1 agonists dextromethorphan, (+)-SKF-10,047, (+)-3-PPP, and PRE-084.  However, neither DPH 250 μM nor 1 mM increased (in fact, they slightly decreased) the affinity of the σ1 receptor antagonists haloperidol, BD 1063, NE-100, progesterone, and BD 1047.  These findings suggest that allosteric modulation by DPH of the affinity of σ1 receptor ligands depends on the agonist or antagonist characteristics of the ligand.  Therefore, detg. in vitro the differential modulation by DPH of σ1 ligand affinity appears to constitute a procedure that can predict the pharmacol. profile of different σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoossDgzqW_ibVg90H21EOLACvtfcHk0lgCf1r_fELmlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D&md5=2243891ce029ec03b1910ce6bd4e49c8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma%25201%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Stresser, D. M.</span></span> <span> </span><span class="NLM_article-title">High-throughput Screening of Human Cytochrome P450 inhibitors Using Fluorometric Substrates. Methodology for 25 Enzyme/Substrate Pairs</span>. In  <i>Optimization in Drug Discovery. In Vitro Methods</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span>, <span class="NLM_string-name">Caldwell, G. W.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">230</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1385%2F1-59259-800-5%3A215" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=215-230&author=D.+M.+Stresserauthor=Z.+Yan&author=G.+W.+Caldwell&title=Optimization+in+Drug+Discovery.+In+Vitro+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1385%2F1-59259-800-5%3A215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F1-59259-800-5%253A215%26sid%3Dliteratum%253Aachs%26aulast%3DStresser%26aufirst%3DD.%2BM.%26atitle%3DHigh-throughput%2520Screening%2520of%2520Human%2520Cytochrome%2520P450%2520inhibitors%2520Using%2520Fluorometric%2520Substrates.%2520Methodology%2520for%252025%2520Enzyme%252FSubstrate%2520Pairs%26btitle%3DOptimization%2520in%2520Drug%2520Discovery.%2520In%2520Vitro%2520Methods%26aulast%3DYan%26aufirst%3DZ.%26pub%3DHumana%2520Press%26date%3D2004%26spage%3D215%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span>; <span class="NLM_string-name">Caldwell, G. W.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Cytochrome P450 inhibition in Human Liver Microsomes</span>. In  <i>Optimization in Drug Discovery. In Vitro Methods</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span>, <span class="NLM_string-name">Caldwell, G. W.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">244</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1385%2F1-59259-800-5%3A231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=231-244&author=Z.+Yan&author=G.+W.+Caldwellauthor=Z.+Yan&author=G.+W.+Caldwell&title=Optimization+in+Drug+Discovery.+In+Vitro+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1385%2F1-59259-800-5%3A231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F1-59259-800-5%253A231%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DEvaluation%2520of%2520Cytochrome%2520P450%2520inhibition%2520in%2520Human%2520Liver%2520Microsomes%26btitle%3DOptimization%2520in%2520Drug%2520Discovery.%2520In%2520Vitro%2520Methods%26aulast%3DYan%26aufirst%3DZ.%26pub%3DHumana%2520Press%26date%3D2004%26spage%3D231%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span> <i>Drug Interaction Studies—Study Design, Data Analysis, Implications
for Dosing and Labeling</i>; <span class="NLM_publisher-name">Center for Drug
Evaluation and Research (CDER), Food and Drug Administration</span>, September 2006 and February 2012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Drug+Interaction+Studies%E2%80%94Study+Design%2C+Data+Analysis%2C+Implications%0Afor+Dosing+and+Labeling%3B+Center+for+Drug%0AEvaluation+and+Research+%28CDER%29%2C+Food+and+Drug+Administration%2C+September+2006+and+February+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDrug%2520Interaction%2520Studies%25E2%2580%2594Study%2520Design%252C%2520Data%2520Analysis%252C%2520Implications%250Afor%2520Dosing%2520and%2520Labeling%26pub%3DCenter%2520for%2520Drug%250AEvaluation%2520and%2520Research%2520%2528CDER%2529%252C%2520Food%2520and%2520Drug%2520Administration" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastall, P.</span></span> <span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0li-DZHxvA6lkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0li-DZHxvA6lkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Putnam, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bombick, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doolittle, D.J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/S0887-2333(02)00050-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2FS0887-2333%2802%2900050-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=12206827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Khsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=599-607&author=K.+P.+Putnamauthor=D.+W.+Bombickauthor=D.J.+Doolittle&title=Evaluation+of+eight+in+vitro+assays+for+assessing+the+cytotoxicity+of+cigarette+smoke+condensate&doi=10.1016%2FS0887-2333%2802%2900050-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate</span></div><div class="casAuthors">Putnam, K. P.; Bombick, D. W.; Doolittle, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology in Vitro</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">599-607</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The accurate assessment of cytotoxicity is important for evaluating the potential of a test agent to induce pathologies that result from cell killing and to det. appropriate doses for other endpoints, such as genetic toxicol. studies.  The objective of this work was to det. the most sensitive assays for assessing cytotoxicity in Chinese hamster ovary (CHO) cells following short-term (1 h) and long-term (24 h) exposure to cigarette smoke condensate (CSC).  Eight in vitro cytotoxicity assays with different endpoints were used to evaluate the cytotoxicity of Kentucky ref. 1R4F (K1R4F) CSC in CHO cells.  The assays used for this study were neutral red uptake, LDH release, kenacid blue binding, MTT formation, XTT formation, acid phosphatase activity, sulforhodamine B binding and resazurin binding.  Four of the more widely used cytotoxicity assays (neutral red, MTT, kenacid blue and LDH) were also evaluated at 3-, 6-, 12- and 18-h time points.  At the 1-h exposure time, LDH was the most sensitive with toxicity obsd. beginning at 100 μg/mL.  None of the other assays demonstrated a concn.-dependent increase in toxicity after 1-h exposures even at the max. concn. of 150 μg/mL of CSC.  Following 24 h of exposure, neutral red and kenacid blue were the most sensitive.  The results of the study indicate the assay that measured membrane integrity was the most sensitive for short exposure times, whereas the neutral red and kenacid blue assays that measured total cell no. were more sensitive for longer exposure times.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraDGdWNI78VLVg90H21EOLACvtfcHk0lhZz-a5Oo82gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Khsrc%253D&md5=c9f7eededcbdc95816f16111d76e2178</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0887-2333%2802%2900050-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0887-2333%252802%252900050-4%26sid%3Dliteratum%253Aachs%26aulast%3DPutnam%26aufirst%3DK.%2BP.%26aulast%3DBombick%26aufirst%3DD.%2BW.%26aulast%3DDoolittle%26aufirst%3DD.J.%26atitle%3DEvaluation%2520of%2520eight%2520in%2520vitro%2520assays%2520for%2520assessing%2520the%2520cytotoxicity%2520of%2520cigarette%2520smoke%2520condensate%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2002%26volume%3D16%26spage%3D599%26epage%3D607%26doi%3D10.1016%2FS0887-2333%2802%2900050-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0lhZz-a5Oo82gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reifferscheid, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heil, J.</span></span> <span> </span><span class="NLM_article-title">Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data</span>. <i>Mutat. Res., Genet. Toxicol. Test.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/S0165-1218(96)90021-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2FS0165-1218%2896%2990021-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=8792833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK28XltVOqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=1996&pages=129-145&author=G.+Reifferscheidauthor=J.+Heil&title=Validation+of+the+SOS%2Fumu+test+using+test+results+of+486+chemicals+and+comparison+with+the+Ames+test+and+carcinogenicity+data&doi=10.1016%2FS0165-1218%2896%2990021-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data</span></div><div class="casAuthors">Reifferscheid, Georg; Heil, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">3,4</span>),
    <span class="NLM_cas:pages">129-145</span>CODEN:
                <span class="NLM_cas:coden">MGTOEB</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study gives a comprehensive update of all umu genotoxicity assay results published so far.  The available data of 486 chems. investigated with the umu test are compared with the Ames test (274 compds.) as well as rodent carcinogenicity data (179 compds.).  On the whole, there is good agreement between the umu test and the Ames test results, with a concordance of about 90%.  The umu test was able to detect 86% of the Ames mutagens, while the Ames test (using at least 5 strains) detected 97% of the umu pos. compds.  The elimination of TA102 from the set of Ames tester strains reduced the percentage of detectable umu genotoxins from 97 to 86%.  The agreement between carcinogenesis and umu response was 65%, which is comparable to earlier studies concerning rodent carcinogenesis and Salmonella mutagenesis.  The present compilation of umu results provides a database that can be used for the comparison of the SOS-inducing activity of chems. and their mutagenicity, resp., carcinogenicity.  The results presented here clearly demonstrate that a chem. which induces the expression of the umu operon can be regarded a rodent carcinogen with a high degree of certainty (93%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSq51aXTvfbbVg90H21EOLACvtfcHk0lhZz-a5Oo82gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVOqsr8%253D&md5=f867f98abb745d6cfab49ffa39fad10d</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2FS0165-1218%2896%2990021-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-1218%252896%252990021-X%26sid%3Dliteratum%253Aachs%26aulast%3DReifferscheid%26aufirst%3DG.%26aulast%3DHeil%26aufirst%3DJ.%26atitle%3DValidation%2520of%2520the%2520SOS%252Fumu%2520test%2520using%2520test%2520results%2520of%2520486%2520chemicals%2520and%2520comparison%2520with%2520the%2520Ames%2520test%2520and%2520carcinogenicity%2520data%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Test.%26date%3D1996%26volume%3D369%26spage%3D129%26epage%3D145%26doi%3D10.1016%2FS0165-1218%2896%2990021-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amidon, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernäs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crison, J. R.</span></span> <span> </span><span class="NLM_article-title">A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1023/A:1016212804288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1023%2FA%3A1016212804288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=7617530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK2MXksVGqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1995&pages=413-420&author=G.+L.+Amidonauthor=H.+Lennern%C3%A4sauthor=V.+P.+Shahauthor=J.+R.+Crison&title=A+theoretical+basis+for+a+biopharmaceutic+drug+classification%3A+the+correlation+of+in+vitro+drug+product+dissolution+and+in+vivo+bioavailability&doi=10.1023%2FA%3A1016212804288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability</span></div><div class="casAuthors">Amidon, Gordon L.; Lennernaes, Hans; Shah, Vinod P.; Crison, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-20</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A biopharmaceutics drug classification scheme for correlating in vitro drug product dissoln. and in vivo bioavailability is proposed based on recognizing that drug dissoln. and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption.  This anal. uses a transport model and human permeability results for estg. in vivo drug absorption to illustrate the primary importance of soly. and permeability on drug absorption.  The fundamental parameters which define oral drug absorption in humans resulting from this anal. are discussed and used as a basis for this classification scheme.  These biopharmaceutic drug classes are defined as: High soly.-high permeability drugs; Low soly.-high permeability drugs; High soly.-low permeability drugs; and Low soly.-low permeability drugs.  Based on this classification scheme, suggestions are made for setting stds. for in vitro drug dissoln. testing methodol. which will correlate with the in vivo process.  This methodol. must be based on the physiol. and phys. chem. properties controlling drug absorption.  This anal.points out conditions under which no in vitro-in vivo correlation may be expected, e.g., rapidly dissolving low permeability drugs.  For very rapidly dissolving high soly. drugs, e.g., 85% dissoln. in <15 min, a simple one point dissoln. test, is all that may be needed to insure bioavailability.  For slowly dissolving drugs a dissoln. profile is required with multiple time points in systems which would include low pH, physiol. pH, and surfactants and the in vitro conditions should mimic the in vivo processes.  This classification scheme provides a basis for establishing in vitro-in vivo correlations and for estg. the absorption of drugs based on the fundamental dissoln. and permeability properties of physiol. importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJdUzHIRA0ZrVg90H21EOLACvtfcHk0lhZz-a5Oo82gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVGqur8%253D&md5=3f472093c5341be6b36e87ddfeb7223f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1023%2FA%3A1016212804288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1016212804288%26sid%3Dliteratum%253Aachs%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26aulast%3DShah%26aufirst%3DV.%2BP.%26aulast%3DCrison%26aufirst%3DJ.%2BR.%26atitle%3DA%2520theoretical%2520basis%2520for%2520a%2520biopharmaceutic%2520drug%2520classification%253A%2520the%2520correlation%2520of%2520in%2520vitro%2520drug%2520product%2520dissolution%2520and%2520in%2520vivo%2520bioavailability%26jtitle%3DPharm.%2520Res.%26date%3D1995%26volume%3D12%26spage%3D413%26epage%3D420%26doi%3D10.1023%2FA%3A1016212804288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond Rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lio_ZC1whBEgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lê, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappell, H.</span></span> <span> </span><span class="NLM_article-title">Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1007/BF02244172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1007%2FBF02244172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1652143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1991&pages=164-166&author=M.+J.+K.+Walkerauthor=A.+D.+L%C3%AAauthor=C.+X.+Poulosauthor=H.+Cappell&title=Role+of+central+versus+peripheral+opioid+receptors+in+analgesia+induced+by+repeated+administration+of+opioid+antagonists&doi=10.1007%2FBF02244172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists</span></div><div class="casAuthors">Walker, M. J. Katharine; Le, A. D.; Poulos, Constantine X.; Cappell, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-6</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Although analgesia induced by blockade of opioid receptors has been well established, it is still unknown whether its development is mediated by the blockade of centrally located opioid receptors.  Therefore, rats were treated with either systemically or intracerebroventricularly (ICV) applied naloxone or quaternary naltrexone (QN), an opioid antagonist that does not easily penetrate the blood-brain barrier.  Following antagonist administration, each animal was tested for paw lick latency on a 51° hot plate.  Hot plate testing and drug injections were carried out for 4 consecutive days.  Rats treated with ICV microinjections of QN or naloxone displayed paw lick latencies that were longer than those obsd. in control animals.  In contrast, rats treated with s.c. injections of QN did not show any increase in paw lick latency, whereas rats treated with s.c. injections of naloxone displayed paw lick latencies that were longer than those of control rats.  These results are consistent with the hypothesis that the blockade of central opioid receptors underlies the development of an analgesic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9PYJ90eTTUrVg90H21EOLACvtfcHk0lio_ZC1whBEgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWqs74%253D&md5=0a709922b479e4c4f7b699f9c97429a1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02244172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02244172%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DM.%2BJ.%2BK.%26aulast%3DL%25C3%25AA%26aufirst%3DA.%2BD.%26aulast%3DPoulos%26aufirst%3DC.%2BX.%26aulast%3DCappell%26aufirst%3DH.%26atitle%3DRole%2520of%2520central%2520versus%2520peripheral%2520opioid%2520receptors%2520in%2520analgesia%2520induced%2520by%2520repeated%2520administration%2520of%2520opioid%2520antagonists%26jtitle%3DPsychopharmacology%26date%3D1991%26volume%3D104%26spage%3D164%26epage%3D166%26doi%3D10.1007%2FBF02244172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">1278</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.121137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1124%2Fjpet.107.121137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=17545312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslKrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=1278-1285&author=J.+Meiauthor=G.+W.+Pasternak&title=Modulation+of+brainstem+opiate+analgesia+in+the+rat+by+sigma+1+receptors%3A+a+microinjection+study&doi=10.1124%2Fjpet.107.121137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of brainstem opiate analgesia in the rat by σ1 receptors: a microinjection study</span></div><div class="casAuthors">Mei, Jianfeng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1278-1285</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">σ1 Receptors have been implicated in the modulation of opioid analgesia.  In the current study, we examd. the role of σ1 systems in the periaqueductal gray (PAG), the rostroventral medulla (RVM), and the locus coeruleus (LC) of the rat, regions previously shown to be sensitive to morphine.  Morphine was a potent analgesic in all three regions.  Coadministration of the σ1 agonist (+)-pentazocine diminished the analgesic actions of morphine in all three regions, although the PAG was far less sensitive than the other two regions.  Blockade of the σ1 receptors with haloperidol in the RVM markedly enhanced the analgesic actions of coadministered morphine, implying a tonic activity of the σ1 system in this region.  This effect was mimicked by down-regulation of RVM σ1 receptors using an antisense approach.  However, no tonic σ1 activity was obsd. in either the LC or the PAG.  The RVM also was important in modulating analgesia elicited from morphine microinjected into the PAG.  The analgesic actions of morphine given into the PAG could be attenuated by (+)-pentazocine placed into the RVM, whereas haloperidol in the RVM enhanced PAG morphine analgesia.  These studies illustrate the pharmacol. importance of σ1 receptors in the brainstem modulation of opioid analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb56qFzGuBK7Vg90H21EOLACvtfcHk0lio_ZC1whBEgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslKrtLw%253D&md5=8e082fd6a528e53d21527454c61d3c47</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121137%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DModulation%2520of%2520brainstem%2520opiate%2520analgesia%2520in%2520the%2520rat%2520by%2520sigma%25201%2520receptors%253A%2520a%2520microinjection%2520study%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D1278%26epage%3D1285%26doi%3D10.1124%2Fjpet.107.121137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadal, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arroyos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Arconada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segalés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laloya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escriche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-García, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plata-Salamán, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">2289</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01942.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+Giraldoauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+R.+Plata-Salam%C3%A1nauthor=J.+M.+Vela&title=Pharmacological+properties+of+S1RA%2C+a+new+sigma-1+receptor+antagonist+that+inhibits+neuropathic+pain+and+activity-induced+spinal+sensitization&doi=10.1111%2Fj.1476-5381.2012.01942.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0ljknOo7GwwWfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DPharmacological%2520properties%2520of%2520S1RA%252C%2520a%2520new%2520sigma-1%2520receptor%2520antagonist%2520that%2520inhibits%2520neuropathic%2520pain%2520and%2520activity-induced%2520spinal%2520sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D306%26doi%3D10.1111%2Fj.1476-5381.2012.01942.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinberg, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into mu-opioid receptor activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nature14886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1038%2Fnature14886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=26245379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=315-321&author=W.+Huangauthor=A.+Manglikauthor=A.+J.+Venkatakrishnanauthor=T.+Laeremansauthor=E.+N.+Feinbergauthor=A.+L.+Sanbornauthor=H.+E.+Katoauthor=K.+E.+Livingstonauthor=T.+S.+Thorsenauthor=R.+C.+Klingauthor=S.+Granierauthor=P.+Gmeinerauthor=S.+M.+Husbandsauthor=J.+R.+Traynorauthor=W.+I.+Weisauthor=J.+Steyaertauthor=R.+O.+Drorauthor=B.+K.+Kobilka&title=Structural+insights+into+mu-opioid+receptor+activation&doi=10.1038%2Fnature14886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into μ-opioid receptor activation</span></div><div class="casAuthors">Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics.  To shed light on the structural basis for μOR activation, here we report a 2.1 Å X-ray crystal structure of the murine μOR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment Nb39 (nanobody 39).  The BU72-stabilized changes in the μOR binding pocket are subtle and differ from those obsd. for agonist-bound structures of the β2-adrenergic receptor (β2AR) and the M2 muscarinic receptor (M2R).  Comparison with active β2AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the μOR, and mol. dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad.  Addnl., an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFUN1wheV07Vg90H21EOLACvtfcHk0ljknOo7GwwWfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM&md5=b9af3e1351b04539379532c127c02651</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature14886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14886%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DFeinberg%26aufirst%3DE.%2BN.%26aulast%3DSanborn%26aufirst%3DA.%2BL.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DLivingston%26aufirst%3DK.%2BE.%26aulast%3DThorsen%26aufirst%3DT.%2BS.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructural%2520insights%2520into%2520mu-opioid%2520receptor%2520activation%26jtitle%3DNature%26date%3D2015%26volume%3D524%26spage%3D315%26epage%3D321%26doi%3D10.1038%2Fnature14886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koob, G. F.</span></span> <span> </span><span class="NLM_article-title">Role of different brains structures in the expression of the physical morphine withdrawal syndrome</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1578378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK38XisVygtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1992&pages=669-677&author=R.+Maldonadoauthor=L.+Stinusauthor=L.+H.+Goldauthor=G.+F.+Koob&title=Role+of+different+brains+structures+in+the+expression+of+the+physical+morphine+withdrawal+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of different brain structures in the expression of the physical morphine withdrawal syndrome</span></div><div class="casAuthors">Maldonado, R.; Stinus, L.; Gold, L. H.; Koob, G. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">669-77</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The aim of this study was to investigate the neuroanatomical regions implicated in the expression of the phys. signs of morphine withdrawal by using local intracerebral injections of methylnaloxonium in dependent rats.  Guide cannulas were implanted and aimed at the lateral ventricle, nucleus accumbens, central amygdala, anterior hypothalamus, medial thalamus, periaqueductal gray matter, locus ceruleus and nucleus raphe magnus.  After surgery, rats were made phys. dependent by s.c. implantation of two 75-mg morphine pellets.  Methylnaloxonium, a quaternary deriv. of naloxone (31-100 ng), was administered 723 h after pellet implantation.  Methylnaloxonium administered i.c.v. induced a withdrawal syndrome similar to systemic naloxone, although several signs such as diarrhea, salivation, lacrimation and rhinorrhea did not appear, suggesting possible peripheral mediation.  The most sensitive site for methylnaloxonium-pptd. withdrawal was the locus ceruleus.  Signs such as jumping, rearing and locomotor activity were particularly frequent after methylnaloxonium injections into the locus ceruleus.  Rearing and locomotor activity were also strongly increased after methylaloxonium administration into the periaqueductal gray matter.  Wet dog shakes were mainly obsd. after methylnaloxonium administration into the anterior preoptic hypothalamus and nucleus raphe magnus.  Injections of methylnaloxonium into the amygdala produced a weak withdrawal syndrome, and the nucleus accumbens and medial thalamus were the least sensitive structures.  These results suggest that the locus ceruleus, and secondarily the periaqueductal gray matter, play an important role in the pptn. of the phys. signs of opiate withdrawal, mainly in the expression of its motor component.  The expression of other signs of withdrawal appear to be multisite detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqNnoHHkAhkLVg90H21EOLACvtfcHk0liXWnbrHE86lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisVygtLs%253D&md5=96461cc5fd3e0b90e04c29ae822201ce</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DStinus%26aufirst%3DL.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26atitle%3DRole%2520of%2520different%2520brains%2520structures%2520in%2520the%2520expression%2520of%2520the%2520physical%2520morphine%2520withdrawal%2520syndrome%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1992%26volume%3D261%26spage%3D669%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>An exploratory,
randomised, double-blind,
placebo and active therapy-controlled, Phase I study, to assess the
safety, tolerability, pharmacokinetics, pharmacodynamics, and food-
effect of single and multiple ascending oral doses of EST73502 in
healthy adults and patients with chronic, moderate moderate-to to-severe
osteoarthritis pain. Study EudraCT Number 2018-000258-23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+exploratory%2C%0Arandomised%2C+double-blind%2C%0Aplacebo+and+active+therapy-controlled%2C+Phase+I+study%2C+to+assess+the%0Asafety%2C+tolerability%2C+pharmacokinetics%2C+pharmacodynamics%2C+and+food-%0Aeffect+of+single+and+multiple+ascending+oral+doses+of+EST73502+in%0Ahealthy+adults+and+patients+with+chronic%2C+moderate+moderate-to+to-severe%0Aosteoarthritis+pain.+Study+EudraCT+Number+2018-000258-23."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+screening+libraries+and+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liXWnbrHE86lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, E. A.</span></span> <span> </span><span class="NLM_article-title">Using measured pKa, logP and solubility to investigate supersaturation and predict BCS class</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.2174/138920008786485155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.2174%2F138920008786485155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=18991583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=869-878&author=K.+J.+Boxauthor=E.+A.+Comer&title=Using+measured+pKa%2C+logP+and+solubility+to+investigate+supersaturation+and+predict+BCS+class&doi=10.2174%2F138920008786485155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class</span></div><div class="casAuthors">Box, K. J.; Comer, J. E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">869-878</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ionization, lipophilicity and soly. have a profound influence on the transport properties of drug mols.  We will present an overview of why physicochem. properties are important, before discussing how the properties are related to each other.  Findings are based on research in our own labs. using our com. instruments and software to measure the pKa, lipophilicity (LogP) and intrinsic soly. (LogS0) of 84 marketed ionizable drugs.  In general, the most lipophilic mols. were the least sol. in water.  Plots of LogP vs. LogS0 show results for these drugs clustered according to other properties, including m.p., no. of H-bond donors and acceptors, ability to supersaturate, and BCS class.  Mols. with high m.p. tended to have a larger no. of H-bond donors and acceptors, and to be less sol. than predicted from their LogP.  Mols. with low m.p. tended to have little H-bond donor capacity, and tended to be more sol. than predicted from their LogP.  Mols. that could form supersatd. solns. tended to have higher m.ps., and to be less sol. than predicted from their LogP.  Mols. in BCS Classes I - III tended to cluster in different parts of the plot.  It is proposed that comparing measured LogP and LogS0 of new mols. with these plots will facilitate a quick assessment of their likely BCS Class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjSonznQUhwbVg90H21EOLACvtfcHk0liXWnbrHE86lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb4%253D&md5=d330301b360589feb67aa92fc0227ea6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F138920008786485155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485155%26sid%3Dliteratum%253Aachs%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DE.%2BA.%26atitle%3DUsing%2520measured%2520pKa%252C%2520logP%2520and%2520solubility%2520to%2520investigate%2520supersaturation%2520and%2520predict%2520BCS%2520class%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D869%26epage%3D878%26doi%3D10.2174%2F138920008786485155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>D67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lj6B1VDos_QBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobley, C. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, S. M.</span></span> <span> </span><span class="NLM_article-title">Decision making in <i>xia</i>2</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>D69</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1107/S0907444913015308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0907444913015308" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D69&publication_year=2013&pages=1260-1273&author=G.+Winterauthor=C.+M.+C.+Lobleyauthor=S.+M.+Prince&title=Decision+making+in+xia2&doi=10.1107%2FS0907444913015308"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444913015308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913015308%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DLobley%26aufirst%3DC.%2BM.%2BC.%26aulast%3DPrince%26aufirst%3DS.%2BM.%26atitle%3DDecision%2520making%2520in%2520xia2%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3DD69%26spage%3D1260%26epage%3D1273%26doi%3D10.1107%2FS0907444913015308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">A short history of <i>SHELX</i></span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>A64</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lj6B1VDos_QBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macrae, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidcock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Monge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Streek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. A.</span></span> <span> </span><span class="NLM_article-title">Mercury CSD 2.0 - new features for the visualization and investigation of crystal structures</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1107/S0021889807067908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0021889807067908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Gmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=466-470&author=C.+F.+Macraeauthor=I.+J.+Brunoauthor=J.+A.+Chisholmauthor=P.+R.+Edgingtonauthor=P.+McCabeauthor=E.+Pidcockauthor=L.+Rodriguez-Mongeauthor=R.+Taylorauthor=J.+van+de+Streekauthor=P.+A.+Wood&title=Mercury+CSD+2.0+-+new+features+for+the+visualization+and+investigation+of+crystal+structures&doi=10.1107%2FS0021889807067908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mercury CSD 2.0 - new features for the visualization and investigation of crystal structures</span></div><div class="casAuthors">Macrae, Clare F.; Bruno, Ian J.; Chisholm, James A.; Edgington, Paul R.; McCabe, Patrick; Pidcock, Elna; Rodriguez-Monge, Lucia; Taylor, Robin; van de Streek, Jacco; Wood, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The program Mercury, developed by the Cambridge Crystallog. Data Center, is designed primarily as a crystal structure visualization tool.  A new module of functionality has been produced, called the Materials Module, which allows highly customizable searching of structural databases for intermol. interaction motifs and packing patterns.  This new module also includes the ability to perform packing similarity calcns. between structures contg. the same compd.  In addn. to the Materials Module, a range of further enhancements to Mercury has been added in this latest release, including void visualization and links to ConQuest, Mogul and IsoStar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFbwrUJZMm4bVg90H21EOLACvtfcHk0lj6B1VDos_QBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Gmtb0%253D&md5=db23811e250db28395ee5258fe95da4d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889807067908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807067908%26sid%3Dliteratum%253Aachs%26aulast%3DMacrae%26aufirst%3DC.%2BF.%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DChisholm%26aufirst%3DJ.%2BA.%26aulast%3DEdgington%26aufirst%3DP.%2BR.%26aulast%3DMcCabe%26aufirst%3DP.%26aulast%3DPidcock%26aufirst%3DE.%26aulast%3DRodriguez-Monge%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3Dvan%2Bde%2BStreek%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DP.%2BA.%26atitle%3DMercury%2520CSD%25202.0%2520-%2520new%2520features%2520for%2520the%2520visualization%2520and%2520investigation%2520of%2520crystal%2520structures%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2008%26volume%3D41%26spage%3D466%26epage%3D470%26doi%3D10.1107%2FS0021889807067908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flack, H. D.</span></span> <span> </span><span class="NLM_article-title">On enantiomorph-polarity estimation</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>A39</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1107/S0108767383001762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0108767383001762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaL3sXmtVeqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A39&publication_year=1983&pages=876-881&author=H.+D.+Flack&title=On+enantiomorph-polarity+estimation&doi=10.1107%2FS0108767383001762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">On enantiomorph-polarity estimation</span></div><div class="casAuthors">Flack, H. D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A:  Foundations of Crystallography</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">A39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">876-81</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    </div><div class="casAbstract">The behavior of Roger's η parameter (1981) for enantiomorph-polarity estn. is examd. theor. and exptl. on simulated intensity data for 7 well-assorted compds.  An alternative parameter x, based on incoherent scattering from twin components related by a center of symmetry, is also considered.  Both parameters are very well adapted to implementation in a least-squares program and converge well.  The η parameter can give false and over-precise indications of chirality-polarity for structures which are nearly centrosym., whereas the x parameter does not have this fault and converges more rapidly than η.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowaeaLtSgacrVg90H21EOLACvtfcHk0livgBKL2QKSag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXmtVeqtLo%253D&md5=ceb7d60023992a868f9832763caf0341</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0108767383001762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767383001762%26sid%3Dliteratum%253Aachs%26aulast%3DFlack%26aufirst%3DH.%2BD.%26atitle%3DOn%2520enantiomorph-polarity%2520estimation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1983%26volume%3DA39%26spage%3D876%26epage%3D881%26doi%3D10.1107%2FS0108767383001762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lomize, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogozheva, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomize, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosberg, H. I.</span></span> <span> </span><span class="NLM_article-title">Positioning of proteins in membranes: A computational approach</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1318</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1110/ps.062126106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1110%2Fps.062126106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=16731967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVKqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1318-1333&author=A.+L.+Lomizeauthor=I.+D.+Pogozhevaauthor=M.+A.+Lomizeauthor=H.+I.+Mosberg&title=Positioning+of+proteins+in+membranes%3A+A+computational+approach&doi=10.1110%2Fps.062126106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Positioning of proteins in membranes: a computational approach</span></div><div class="casAuthors">Lomize, Andrei L.; Pogozheva, Irina D.; Lomize, Mikhail A.; Mosberg, Henry I.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1318-1333</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A new computational approach has been developed to det. the spatial arrangement of proteins in membranes by minimizing their transfer energies from water to the lipid bilayer.  The membrane hydrocarbon core was approximated as a planar slab of adjustable thickness with decadiene-like interior and interfacial polarity profiles derived from published EPR studies.  Applicability and accuracy of the method was verified for a set of 24 transmembrane proteins whose orientations in membranes have been studied by spin-labeling, chem. modification, fluorescence, ATR FTIR, NMR, cryo-microscopy, and neutron diffraction.  Subsequently, the optimal rotational and translational positions were calcd. for 109 transmembrane, five integral monotopic and 27 peripheral protein complexes with known 3D structures.  This method can reliably distinguish transmembrane and integral monotopic proteins from water-sol. proteins based on their transfer energies and membrane penetration depths.  The accuracies of calcd. hydrophobic thicknesses and tilt angles were ∼1 Å and 2°, resp., judging from their deviations in different crystal forms of the same proteins.  The hydrophobic thicknesses of transmembrane proteins ranged from 21.1 to 43.8 Å depending on the type of biol. membrane, while their tilt angles with respect to the bilayer normal varied from zero in sym. complexes to 26° in asym. structures.  Calcd. hydrophobic boundaries of proteins are located ∼5 Å lower than lipid phosphates and correspond to the zero membrane depth parameter of spin-labeled residues.  Coordinates of all studied proteins with their membrane boundaries can be found in the Orientations of Proteins in Membranes (OPM) database: http://opm.phar.umich.edu/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQXXJ5AlXcvrVg90H21EOLACvtfcHk0livgBKL2QKSag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVKqtbg%253D&md5=a05527682c9bc1742fab35228061774a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1110%2Fps.062126106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.062126106%26sid%3Dliteratum%253Aachs%26aulast%3DLomize%26aufirst%3DA.%2BL.%26aulast%3DPogozheva%26aufirst%3DI.%2BD.%26aulast%3DLomize%26aufirst%3DM.%2BA.%26aulast%3DMosberg%26aufirst%3DH.%2BI.%26atitle%3DPositioning%2520of%2520proteins%2520in%2520membranes%253A%2520A%2520computational%2520approach%26jtitle%3DProtein%2520Sci.%26date%3D2006%26volume%3D15%26spage%3D1318%26epage%3D1333%26doi%3D10.1110%2Fps.062126106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span> <i>Discovery Studio
16</i>; <span class="NLM_publisher-name">Dassault Systèmes
BIOVIA</span>: <span class="NLM_publisher-loc">San Diego, CA</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Discovery+Studio%0A16%3B+Dassault+Syst%C3%A8mes%0ABIOVIA%3A+San+Diego%2C+CA%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DDiscovery%2520Studio%250A16%26pub%3DDassault%2520Syst%25C3%25A8mes%250ABIOVIA%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diller, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.</span></span> <span> </span><span class="NLM_article-title">High throughput docking for library design and library prioritization</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=11276081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlels7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2001&pages=113-124&author=D.+J.+Dillerauthor=K.+M.+Merz&title=High+throughput+docking+for+library+design+and+library+prioritization&doi=10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput docking for library design and library prioritization</span></div><div class="casAuthors">Diller, David J.; Merz, Kenneth M., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The prioritization of the screening of combinatorial libraries is an extremely important task for the rapid identification of tight binding ligands and ultimately pharmaceutical compds.  When structural information for the target is available, mol. docking is an approach that can be used for prioritization.  Here, we present the initial validation of a new rapid approach to mol. docking developed for prioritizing combinatorial libraries.  The algorithm is tested on 103 individual cases from the protein data bank and in nearly 90% of these cases docks the ligand to within 2.0 Å of the obsd. binding mode.  Because the mean CPU time is <5 s/mol, this approach can process hundreds of thousands of compds. per wk.  Furthermore, if a somewhat less thorough search is performed, the search time drops to 1 s/mol, thus allowing millions of compds. to be docked per wk and tested for potential activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRE1RQbB3WD7Vg90H21EOLACvtfcHk0livgBKL2QKSag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlels7c%253D&md5=a84ff9a463495594d85db465b27e9216</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0134%252820010501%252943%253A2%253C113%253A%253AAID-PROT1023%253E3.0.CO%253B2-T%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26atitle%3DHigh%2520throughput%2520docking%2520for%2520library%2520design%2520and%2520library%2520prioritization%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2001%26volume%3D43%26spage%3D113%26epage%3D124%26doi%3D10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>S <i>chrödinger
Release 2017-4: Maestro</i>; <span class="NLM_publisher-name">Schrödinger,
LLC</span>,: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=S+chr%C3%B6dinger%0ARelease+2017-4%3A+Maestro%3B+Schr%C3%B6dinger%2C%0ALLC%2C%3A+New+York%2C%0ANY%2C+2020."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3Dchr%25C3%25B6dinger%250ARelease%25202017-4%253A%2520Maestro%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, K. J.</span>; <span class="NLM_string-name">Chow, E.</span>; <span class="NLM_string-name">Xu, H.</span>; <span class="NLM_string-name">Dror, R. O.</span>; <span class="NLM_string-name">Eastwood, M. P.</span>; <span class="NLM_string-name">Gregersen, B. A.</span>; <span class="NLM_string-name">Klepeis, J. L.</span>; <span class="NLM_string-name">Kolossvary, I.</span>; <span class="NLM_string-name">Moraes, M. A.</span>; <span class="NLM_string-name">Sacerdoti, F. D.</span>; <span class="NLM_string-name">Salmon, J. K.</span>; <span class="NLM_string-name">Shan, Y.</span>; <span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters</span>.  <i>Proceedings of the ACM/IEEE Conference on Supercomputing (SC06)</i>, Tampa, FL, November 11–17, 2006; <span class="NLM_publisher-name">ACM/IEEE</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1109%2FSC.2006.54" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+J.+Bowers&author=E.+Chow&author=H.+Xu&author=R.+O.+Dror&author=M.+P.+Eastwood&author=B.+A.+Gregersen&author=J.+L.+Klepeis&author=I.+Kolossvary&author=M.+A.+Moraes&author=F.+D.+Sacerdoti&author=J.+K.+Salmon&author=Y.+Shan&author=D.+E.+Shaw&title=Proceedings+of+the+ACM%2FIEEE+Conference+on+Supercomputing+%28SC06%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1109%2FSC.2006.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1109%252FSC.2006.54%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DK.%2BJ.%26atitle%3DScalable%2520Algorithms%2520for%2520Molecular%2520Dynamics%2520Simulations%2520on%2520Commodity%2520Clusters%26btitle%3DProceedings%2520of%2520the%2520ACM%252FIEEE%2520Conference%2520on%2520Supercomputing%2520%2528SC06%2529%26pub%3DACM%252FIEEE%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Randall, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selitto, J. J.</span></span> <span> </span><span class="NLM_article-title">A method for measurement of analgesic activity on inflamed tissue</span>. <i>Arch. Int. Pharmacodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=13471093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaG1cXis1Gnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1957&pages=409-419&author=L.+O.+Randallauthor=J.+J.+Selitto&title=A+method+for+measurement+of+analgesic+activity+on+inflamed+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A method for measurement of analgesic activity on inflamed tissue</span></div><div class="casAuthors">Randall, Lowell O.; Selitto, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">409-19</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">The inflamed feet of the rat were twice as sensitive to pressure as were normal feet.  Salicylate, phenylbutazone, and Ro 2-5383 raise the pain threshold of inflamed but not of normal feet, and aminopyrine and narcotic analgesics raise it in both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWxvjwjaEQurVg90H21EOLACvtfcHk0li4zGuTGehUxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXis1Gnug%253D%253D&md5=b4ddc4f843cb6b8963315e1e7c69edeb</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRandall%26aufirst%3DL.%2BO.%26aulast%3DSelitto%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520method%2520for%2520measurement%2520of%2520analgesic%2520activity%2520on%2520inflamed%2520tissue%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1957%26volume%3D111%26spage%3D409%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basbaum, A. I.</span></span> <span> </span><span class="NLM_article-title">Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(98)00045-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2FS0304-3959%2898%2900045-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=9696476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADyaK1czlvFKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1998&pages=215-222&author=A.+B.+Malmbergauthor=A.+I.+Basbaum&title=Partial+sciatic+nerve+injury+in+the+mouse+as+a+model+of+neuropathic+pain%3A+behavioral+and+neuroanatomical+correlates&doi=10.1016%2FS0304-3959%2898%2900045-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates</span></div><div class="casAuthors">Malmberg A B; Basbaum A I</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">215-22</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The generation of knock-out and transgenic mice offers a promising approach to the identification of novel biochemical factors that contribute to persistent pain conditions.  To take advantage of these mice, however, it is important to demonstrate that the traditional models of persistent pain, which were largely developed for studies in the rat, can be used in the mouse.  Here, we combined behavioral and anatomical methods to characterize the pathophysiology of a partial nerve injury-evoked pain condition in the 'normal' mouse.  In male C57BL6 mice we tied a tight ligature around 1/3 to 1/2 of the diameter of the sciatic nerve and evaluated the time-course and magnitude of the ensuing mechanical and thermal allodynia.  We also used immunocytochemistry to analyze nerve injury-induced changes in substance P (SP) and NK-1 (SP) receptor expression in the spinal cord.  As in the rat, partial nerve injury markedly decreased paw withdrawal thresholds to both mechanical and thermal stimuli on the injured side.  We detected threshold changes one day after the injury.  The thermal allodynia resolved by 49 days, but the mechanical allodynia persisted for the duration of the study (70 days).  We found no changes contralateral to the nerve injury.  Sympatholytic treatment with guanethidine significantly reduced both the thermal and mechanical allodynia.  We observed a reduction of SP immunoreactivity in the superficial dorsal horn on the injured side at 7 and 14, but not at 3 or 70 days after the nerve injury, and we observed an increase of NK-1 receptor expression at 3, 7, 14 and 42, but not at 70 days after the injury.  We conclude that partial injury to the sciatic nerve produces a comparable allodynia and neurochemical plasticity in the rat and mouse.  These results establish a valuable model for future studies of the biochemical basis of neuropathic pain in mice with specific gene modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9ebNsr6ajcSEJCPKhJPuqfW6udTcc2eYzqVQqZ_xWc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czlvFKltw%253D%253D&md5=b3fb6f6fc75f5738f9d3d025bc63b432</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2898%2900045-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252898%252900045-1%26sid%3Dliteratum%253Aachs%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3DPartial%2520sciatic%2520nerve%2520injury%2520in%2520the%2520mouse%2520as%2520a%2520model%2520of%2520neuropathic%2520pain%253A%2520behavioral%2520and%2520neuroanatomical%2520correlates%26jtitle%3DPain%26date%3D1998%26volume%3D76%26spage%3D215%26epage%3D222%26doi%3D10.1016%2FS0304-3959%2898%2900045-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogrel, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of tactile allodynia in the rat paw</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eYzqVQqZ_xWc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520assessment%2520of%2520tactile%2520allodynia%2520in%2520the%2520rat%2520paw%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mónica García, Virginia Llorente, Lourdes Garriga, Ute Christmann, Sergi Rodríguez-Escrich, Marina Virgili, Begoña Fernández, Magda Bordas, Eva Ayet, Javier Burgueño, Marta Pujol, Albert Dordal, Enrique Portillo-Salido, Georgia Gris, José Miguel Vela, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Almansa</span>. </span><span class="cited-content_cbyCitation_article-title">Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10139-10154. <a href="https://doi.org/10.1021/acs.jmedchem.1c00417" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPropionamide%252BDerivatives%252Bas%252BDual%252B%2525CE%2525BC-Opioid%252BReceptor%252BAgonists%252Band%252B%2525CF%2525831%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM%25C3%25B3nica%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D08072021%26volume%3D64%26issue%3D14%26spage%3D10139%26epage%3D10154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel Obeng, Takato Hiranita, Francisco León, Lance R. McMahon, <span class="NLM_string-name hlFld-ContribAuthor">Christopher R. McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6523-6548. <a href="https://doi.org/10.1021/acs.jmedchem.1c00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BApproaches%25252C%252BDrug%252BCandidates%25252C%252Band%252BTargets%252Bin%252BPain%252BDrug%252BDiscovery%26aulast%3DObeng%26aufirst%3DSamuel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6523%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zhuang</span>, <span class="hlFld-ContribAuthor ">Jiaying  Xiong</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Hao</span>, <span class="hlFld-ContribAuthor ">Wei  Du</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Bifeng  Liu</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced side effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113658. <a href="https://doi.org/10.1016/j.ejmech.2021.113658" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113658%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252B%2525CE%2525BC%252Bopioid%252Band%252B%2525CF%2525831%252Breceptor%252Bligands%252Bas%252Bnovel%252Banalgesics%252Bwith%252Breduced%252Bside%252Beffects%26aulast%3DZhuang%26aufirst%3DTao%26date%3D2021%26volume%3D223%26spage%3D113658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca Serena  Abatematteo</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Marialessandra  Contino</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Carmen  Abate</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (12)
                                     , 6359. <a href="https://doi.org/10.3390/ijms22126359" title="DOI URL">https://doi.org/10.3390/ijms22126359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22126359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22126359%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMulti-Target%252BDirected%252BLigands%252B%252528MTDLs%252529%252BBinding%252Bthe%252B%2525CF%2525831%252BReceptor%252Bas%252BPromising%252BTherapeutics%25253A%252BState%252Bof%252Bthe%252BArt%252Band%252BPerspectives%26aulast%3DAbatematteo%26aufirst%3DFrancesca%2BSerena%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D12%26spage%3D6359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of oxycodone (<b>1</b>, MOR agonist), E-52862 (<b>2</b>, σ<sub>1</sub>R antagonist), and dual MOR and σ<sub>1</sub>R ligands <b>3</b> and <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOI, <sup><i>t</i></sup>BuOK, DMSO–DME, 0–5 °C, 1 h; (b) MeOH, rt, 16 h; (c) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min, or TEA, DCM, 0 °C; (d) <sup><i>t</i></sup>BuOK, THF, rt, 16 h; (e) NaH, DMF, rt; (f) TFA, DCM, rt or reflux; (g) K<sub>2</sub>CO<sub>3</sub> or DIPEA, NaI, acetonitrile, 80 °C, 16 h; (h) EtOH–water 9:1, rt, 16 h; (i) <sup><i>t</i></sup>BuOK, THF, −78 to −30 °C, 1–4 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSOI, NaH, DMSO, rt to 50 °C, 1 h; (b) NH<sub>3,</sub> MeOH, rt, 16 h; (c) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min; (d) <sup><i>t</i></sup>BuOK, THF, rt, 16 h; (e) NaH, DMF, rt, 16 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtOH–water 6:1, rt, 4 h; (b) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min (<b>14g</b>), or TEA, DCM, 0 °C, 2 h (<b>14l</b>), or NaHCO<sub>3</sub>, DCM, rt, 16 h (<b>14m</b>); (c) <sup><i>t</i></sup>BuOK, THF, −78 °C to −30 °C, 1–4 h (up to 0 °C, 3 h for <b>14m</b>).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, EtOAc–water, 0 °C, 30 min; (b) (i) <sup><i>t</i></sup>BuOK, THF, <i>T</i> < −60 °C, 1 h, (ii) crystallization from AcO<sup><i>i</i></sup>Pr–heptane; (c) TFA, DCM, rt, 3 h; (d) <b>13</b>, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, 80 °C, 16 h.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. View of the asymmetric unit of the crystal structure of the hydrobromide salt of <b>14u (</b>CCDC 1979266), showing the <i>R</i> configuration at position 2 (C1 atom).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>14u</b> superimposed onto the MOR (left), σ<sub>1</sub>R (middle), and the merged MOR-σ<sub>1</sub>R (right) pharmacophores (the AR feature is shown unhighlighted). Pharmacophores were constructed as described in previous work.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure and in vitro profile of the clinical candidate <b>14u</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Evolution of the molecular dynamics run for compounds <b>14u</b> and <b>14x</b> docked in the MOR (5C1M). (B) Docking pose of <b>14u</b> in the active MOR (5C1M). (C) 2D diagram of the main interactions of <b>14u</b> with the active MOR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Dose–response antinociception curves in the paw pressure test of <b>14u</b> administered alone (filled points) or in the presence of the selective σ<sub>1</sub>R agonist PRE084 (empty points, A) and the MOR antagonist naloxone (empty points, B) in male CD1 mice after systemic (po) administration. Each point and vertical line represents the mean ± SEM percentage of effect (<i>n</i> = 6–12 per group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Effect of <b>14u</b> (blue bars) or oxycodone (<b>1</b>, gray) in comparison to vehicle (white) on PSNL-induced mechanical allodynia in male CD1 mice. Compound <b>14u</b> (5 mg/kg) and oxycodone (1.25 mg/kg) were systemically (ip) administered b.i.d. during 10 days. (B) Naloxone precipitated withdrawal response in PSNL mice repeatedly administered with <b>14u</b> (blue), oxycodone (gray), or vehicle (white) during 11 days. Naloxone (1 mg/kg, sc) was administered on day 11, 30 min after each treatment administration. The withdrawal response was evaluated immediately after naloxone injection using a global score as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Each bar and vertical line represent the mean ± SEM percentage of effect (<i>n</i> = 6–12 per group): *<i>p</i> < 0.05, **<i>p</i> < 0,01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/medium/jm0c01127_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>14u</b> (blue bars) or oxycodone (gray bars) on intestinal transit inhibition measured in the charcoal test vs the analgesic response in male CD1 mice after systemic (po) administration. Each bar and vertical line represent the mean ± SEM percentage of effect (<i>n</i> = 6–12 per group): ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01127/20201218/images/large/jm0c01127_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01127&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, M. L.</span></span>, Ed. <span> </span><span class="NLM_article-title">Opioids and Pain Relief: A Historical Perspective</span>.  <i>Progress in Pain Research and Management</i>; <span class="NLM_publisher-name">IASP Press</span>: <span class="NLM_publisher-loc">Seattle, WA</span>, <span class="NLM_year">2003</span>; Vol  <span class="NLM_volume">25</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+L.+Meldrum&title=Progress+in+Pain+Research+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeldrum%26aufirst%3DM.%2BL.%26atitle%3DOpioids%2520and%2520Pain%2520Relief%253A%2520A%2520Historical%2520Perspective%26btitle%3DProgress%2520in%2520Pain%2520Research%2520and%2520Management%26pub%3DIASP%2520Press%26date%3D2003%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgili, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroy, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as new dual μ-opioid receptor agonists and σ<sub>1</sub> receptor antagonists for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2434</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitF2nur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2434-2454&author=M.+Garc%C3%ADaauthor=M.+Virgiliauthor=M.+Alonsoauthor=C.+Alegretauthor=B.+Fern%C3%A1ndezauthor=A.+Portauthor=R.+Pascualauthor=X.+Monroyauthor=A.+Vidal-Torresauthor=M.+T.+Serafiniauthor=J.+M.+Velaauthor=C.+Almansa&title=4-Aryl-1-oxa-4%2C9-diazaspiro%5B5.5%5Dundecane+derivatives+as+new+dual+%CE%BC-opioid+receptor+agonists+and+%CF%831+receptor+antagonists+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.9b01256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as dual μ-opioid receptor agonists and σ1 receptor antagonists for the treatment of pain</span></div><div class="casAuthors">Garcia, Monica; Virgili, Marina; Alonso, Monica; Alegret, Carles; Fernandez, Begona; Port, Adriana; Pascual, Rosalia; Monroy, Xavier; Vidal-Torres, Alba; Serafini, Maria-Teresa; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2434-2454</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-oxa-4,9-diazaspiro[5.5]undecane derivs. as potent dual ligands for the sigma-1 receptor (σ1R) and the μ-opioid receptor (MOR) are reported.  The different positions of the central scaffold, designed using a merging strategy of both targets pharmacophores, were explored using a versatile synthetic approach.  Phenethyl derivs. in position 9, substituted pyridyl moieties in position 4 and small alkyl groups in position 2 provided the best profiles.  One of the best compds., I, showed a balanced dual profile (i.e. MOR agonism and sigma antagonism) and potent analgesic activity, comparable to the MOR agonist oxycodone in the paw pressure test in mice.  Contrary to oxycodone, as expected from the addn. of σ1R antagonism, I showed local, peripheral activity in this test, which was reversed by the σ1R agonist PRE-084.  At equianalgesic doses, I showed less constipation than oxycodone, providing evidence that dual MOR agonism and σ1R antagonism may be a useful strategy for obtaining potent and safer analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN_96WgxDmIbVg90H21EOLACvtfcHk0lhQuMYFirgwNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitF2nur3M&md5=6ff458638f9069ade1ccca8adabebb9a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01256%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM.%26aulast%3DVirgili%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DAlegret%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3D4-Aryl-1-oxa-4%252C9-diazaspiro%255B5.5%255Dundecane%2520derivatives%2520as%2520new%2520dual%2520%25CE%25BC-opioid%2520receptor%2520agonists%2520and%2520%25CF%25831%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2434%26epage%3D2454%26doi%3D10.1021%2Facs.jmedchem.9b01256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickenson, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span> <span> </span><span class="NLM_article-title">Opioids in neuropathic pain: Clues from animal studies</span>. <i>Eur. J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.ejpain.2004.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejpain.2004.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15737797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=113-116&author=A.+H.+Dickensonauthor=R.+Suzuki&title=Opioids+in+neuropathic+pain%3A+Clues+from+animal+studies&doi=10.1016%2Fj.ejpain.2004.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Opioids in neuropathic pain: clues from animal studies</span></div><div class="casAuthors">Dickenson, Anthony H.; Suzuki, Rie</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-116</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  For many years the clin. consensus was that opioids were ineffective in neuropathic pain.  However this view is changing and here we discuss the mechanisms of opioid analgesia in terms of the changes that can occur in preclin. models of nerve injury.  We argue that opioid mechanisms can be perturbed by neuropathy but in most cases these neg. influences can be overcome by dose-escalation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcGfiK-MHKLLVg90H21EOLACvtfcHk0lhQuMYFirgwNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWrsro%253D&md5=edcad0356537b8256e5cb6152a06126e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpain.2004.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpain.2004.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26aulast%3DSuzuki%26aufirst%3DR.%26atitle%3DOpioids%2520in%2520neuropathic%2520pain%253A%2520Clues%2520from%2520animal%2520studies%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2005%26volume%3D9%26spage%3D113%26epage%3D116%26doi%3D10.1016%2Fj.ejpain.2004.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrman, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritz, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10830</span>– <span class="NLM_lpage">10835</span>, <span class="refDoi"> DOI: 10.1073/pnas.1300393110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1073%2Fpnas.1300393110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23754417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10830-10835&author=N.+T.+Burfordauthor=M.+J.+Clarkauthor=T.+S.+Wehrmanauthor=S.+W.+Gerritzauthor=M.+Banksauthor=J.+O%E2%80%99Connellauthor=J.+R.+Traynorauthor=A.+Alt&title=Discovery+of+positive+allosteric+modulators+and+silent+allosteric+modulators+of+the+%CE%BC-opioid+receptor&doi=10.1073%2Fpnas.1300393110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor</span></div><div class="casAuthors">Burford, Neil T.; Clark, Mary J.; Wehrman, Tom S.; Gerritz, Samuel W.; Banks, Martyn; O'Connell, Jonathan; Traynor, John R.; Alt, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10830-10835,S10830/1-S10830/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">μ-Opioid receptors are among the most studied G protein-coupled receptors because of the therapeutic value of agonists, such as morphine, that are used to treat chronic pain.  However, these drugs have significant side effects, such as respiratory suppression, constipation, allodynia, tolerance, and dependence, as well as abuse potential.  Efforts to fine tune pain control while alleviating the side effects of drugs, both physiol. and psychol., have led to the development of a wide variety of structurally diverse agonist ligands for the μ-opioid receptor, as well as compds. that target κ- and δ-opioid receptors.  In recent years, the identification of allosteric ligands for some G protein-coupled receptors has provided breakthroughs in obtaining receptor subtype-selectivity that can reduce the overall side effect profiles of a potential drug.  However, pos. allosteric modulators (PAMs) can also have the specific advantage of only modulating the activity of the receptor when the orthosteric agonist occupies the receptor, thus maintaining spatial and temporal control of receptor signaling in vivo.  This second advantage of allosteric modulators may yield breakthroughs in opioid receptor research and could lead to drugs with improved side-effect profiles or fewer tolerance and dependence issues compared with orthosteric opioid receptor agonists.  Here, the authors describe the discovery and characterization of μ-opioid receptor PAMs and silent allosteric modulators, identified from high-throughput screening using a β-arrestin-recruitment assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdiTL5ko3pr7Vg90H21EOLACvtfcHk0lgsT1mP75_gVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7nJ&md5=5fd64e5ae56607fa2396fdd3f32caf54</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1300393110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1300393110%26sid%3Dliteratum%253Aachs%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DWehrman%26aufirst%3DT.%2BS.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DBanks%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DAlt%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520positive%2520allosteric%2520modulators%2520and%2520silent%2520allosteric%2520modulators%2520of%2520the%2520%25CE%25BC-opioid%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10830%26epage%3D10835%26doi%3D10.1073%2Fpnas.1300393110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanath, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simopoulos, T. T.</span></span> <span> </span><span class="NLM_article-title">A brief history of the opioid epidemic and strategies for pain medicine</span>. <i>Pain Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1007/s40122-018-0097-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1007%2Fs40122-018-0097-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=29691801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjmtlekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=13-21&author=M.+R.+Jonesauthor=O.+Viswanathauthor=J.+Peckauthor=A.+D.+Kayeauthor=J.+S.+Gillauthor=T.+T.+Simopoulos&title=A+brief+history+of+the+opioid+epidemic+and+strategies+for+pain+medicine&doi=10.1007%2Fs40122-018-0097-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Brief History of the Opioid Epidemic and Strategies for Pain Medicine</span></div><div class="casAuthors">Jones Mark R; Viswanath Omar; Gill Jatinder S; Simopoulos Thomas T; Peck Jacquelin; Kaye Alan D</div><div class="citationInfo"><span class="NLM_cas:title">Pain and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>
        ISSN:<span class="NLM_cas:issn">2193-8237</span>.
    </div><div class="casAbstract">The opioid epidemic has resulted from myriad causes and will not be solved by any simple solution.  Consequent to a staggering increase in opioid-related deaths in the USA, various governmental inputs and stakeholder strategies have been proposed and implemented with varying success.  This article summarizes the history of opioid use and explores the causes for the present day epidemic.  Recent trends in opioid-related data demonstrate an almost fourfold increase in overdose deaths from 1999 to 2008.  Tragically, opioids claimed over 64,000 lives just last year.  Some solutions have undergone legislation, including the limitation of numbers of opioids postsurgery, as well as growing national prevalence of enhanced recovery after surgery protocols which focus on reduced postoperative opioid consumption and shortened hospital stays.  Stricter prescribing practices and prescription monitoring programs have been instituted in the recent past.  Improvement in abuse deterrent strategies which is a major focus of the Food and Drug Administration (FDA) for all opioid preparations will likely play an important role by increasing the safety of these medications.  Future potential strategies such as additional legislative policies, public awareness, and physician education are also detailed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUyZ-LWOyWCEbxh97K6Vt6fW6udTcc2eY_Kgw-0gKdeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjmtlekuw%253D%253D&md5=386633388006687ea4c304927a1625bb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs40122-018-0097-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40122-018-0097-6%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%2BR.%26aulast%3DViswanath%26aufirst%3DO.%26aulast%3DPeck%26aufirst%3DJ.%26aulast%3DKaye%26aufirst%3DA.%2BD.%26aulast%3DGill%26aufirst%3DJ.%2BS.%26aulast%3DSimopoulos%26aufirst%3DT.%2BT.%26atitle%3DA%2520brief%2520history%2520of%2520the%2520opioid%2520epidemic%2520and%2520strategies%2520for%2520pain%2520medicine%26jtitle%3DPain%2520Ther.%26date%3D2018%26volume%3D7%26spage%3D13%26epage%3D21%26doi%3D10.1007%2Fs40122-018-0097-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Sigma antagonists potentiate opioid analgesia in rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/0304-3940(95)11504-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0304-3940%2895%2911504-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=7644123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1995&pages=137-139&author=C.+C.+Chienauthor=G.+W.+Pasternak&title=Sigma+antagonists+potentiate+opioid+analgesia+in+rats&doi=10.1016%2F0304-3940%2895%2911504-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma antagonists potentiate opioid analgesia in rats</span></div><div class="casAuthors">Chien, Chih-Cheng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-9</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In mice, activation of sigma1 receptors antagonizes opioid analgesia.  Sigma antagonists potentiate opioid analgesia, implying that the anti-opioid sigma system is tonically active.  Co-administration of haloperidol with the mu opioid morphine, the kappa1 analgesic U 50488H or the kappa3 agonist naloxone benzoylhydrazone enhances the analgesic activity of all agents.  The effect results from sigma receptor blockade since (-)sulpiride, a selective D2 antagonist which does not block sigma receptors, is inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT7Y-iEDEl3bVg90H21EOLACvtfcHk0liYbDFqdBt6lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls12nsr8%253D&md5=66ace8f372aca6d388626a9d9ba09728</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2895%2911504-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252895%252911504-P%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DC.%2BC.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DSigma%2520antagonists%2520potentiate%2520opioid%2520analgesia%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D190%26spage%3D137%26epage%3D139%26doi%3D10.1016%2F0304-3940%2895%2911504-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cendán, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujalte, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoliu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span> <span> </span><span class="NLM_article-title">Formalin-induced pain is reduced in sigma(1) receptor knockout mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>511</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2005.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejphar.2005.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15777781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2005&pages=73-74&author=C.+M.+Cend%C3%A1nauthor=J.+M.+Pujalteauthor=E.+Portillo-Salidoauthor=L.+Montoliuauthor=J.+M.+Baeyens&title=Formalin-induced+pain+is+reduced+in+sigma%281%29+receptor+knockout+mice&doi=10.1016%2Fj.ejphar.2005.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Formalin-induced pain is reduced in σ1 receptor knockout mice</span></div><div class="casAuthors">Cendan, Cruz Miguel; Pujalte, Jose Miguel; Portillo-Salido, Enrique; Montoliu, Lluis; Baeyens, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-74</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of σ1 receptors in non-acute pain has not been explored.  In this study we show that both phases of formalin-induced pain were reduced by approx. 55% in σ1 receptor knockout mice in comparison to wild-type animals.  These results suggest that the tonic pain induced by formalin is altered in mice lacking σ1 receptors, and highlight the potential usefulness of further studies of the role of σ1 receptors in models of non-acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfs5SOcqYY7Vg90H21EOLACvtfcHk0liYbDFqdBt6lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCjsLs%253D&md5=71d93bc7957c3f85824ab4a63d174a6b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DCend%25C3%25A1n%26aufirst%3DC.%2BM.%26aulast%3DPujalte%26aufirst%3DJ.%2BM.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DMontoliu%26aufirst%3DL.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26atitle%3DFormalin-induced%2520pain%2520is%2520reduced%2520in%2520sigma%25281%2529%2520receptor%2520knockout%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D511%26spage%3D73%26epage%3D74%26doi%3D10.1016%2Fj.ejphar.2005.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuberes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrocal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contijoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laggner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the 1-arylpyrazole class of σ<sub>1</sub> receptor antagonists: Identification of 4-{2-[5-methyl-1-(naphtalen-2-yl)-1<i>H</i>-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8211</span>– <span class="NLM_lpage">8224</span>, <span class="refDoi"> DOI: 10.1021/jm3007323</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007323" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8211-8224&author=J.+L.+D%C3%ADazauthor=R.+Cuberesauthor=J.+Berrocalauthor=M.+Contijochauthor=U.+Christmannauthor=A.+Fern%C3%A1ndezauthor=A.+Portauthor=J.+Holenzauthor=H.+Buschmannauthor=C.+Laggnerauthor=M.+T.+Serafiniauthor=J.+Burgue%C3%B1oauthor=D.+Zamanilloauthor=M.+Merlosauthor=J.+M.+Velaauthor=C.+Almansa&title=Synthesis+and+biological+evaluation+of+the+1-arylpyrazole+class+of+%CF%831+receptor+antagonists%3A+Identification+of+4-%7B2-%5B5-methyl-1-%28naphtalen-2-yl%29-1H-pyrazol-3-yloxy%5Dethyl%7Dmorpholine+%28S1RA%2C+E-52862%29&doi=10.1021%2Fjm3007323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of the 1-Arylpyrazole Class of σ1 Receptor Antagonists: Identification of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)</span></div><div class="casAuthors">Diaz, Jose Luis; Cuberes, Rosa; Berrocal, Joana; Contijoch, Montserrat; Christmann, Ute; Fernandez, Ariadna; Port, Adriana; Holenz, Jorg; Buschmann, Helmut; Laggner, Christian; Serafini, Maria Teresa; Burgueno, Javier; Zamanillo, Daniel; Merlos, Manuel; Vela, Jose Miguel; Almansa, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8211-8224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of a new series of 1-arylpyrazoles as potent σ1 receptor (σ1R) antagonists are reported.  The new compds. were evaluated in vitro in human σ1R and guinea pig σ2 receptor (σ2R) binding assays.  The nature of the pyrazole substituents was crucial for activity, and a basic amine was shown to be necessary, in accordance with known receptor pharmacophores.  A wide variety of amines and spacer lengths between the amino and pyrazole groups was tolerated, but only the ethylenoxy spacer and small cyclic amines provided compds. with sufficient selectivity for σ1R vs σ2R.  The most selective compds. were further profiled, and 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862, I), which showed high activity in the mouse capsaicin model of neurogenic pain, emerged as the most interesting candidate.  In addn., compd. I exerted dose-dependent antinociceptive effects in several neuropathic pain models.  This, together with its good physicochem., safety, and ADME properties, led compd. I to be selected as clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQxd7-vnvc7Vg90H21EOLACvtfcHk0liYbDFqdBt6lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7bI&md5=0d6a5c8008d27635117c3901ec1db3c4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm3007323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007323%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCuberes%26aufirst%3DR.%26aulast%3DBerrocal%26aufirst%3DJ.%26aulast%3DContijoch%26aufirst%3DM.%26aulast%3DChristmann%26aufirst%3DU.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DPort%26aufirst%3DA.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DM.%2BT.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%25201-arylpyrazole%2520class%2520of%2520%25CF%25831%2520receptor%2520antagonists%253A%2520Identification%2520of%25204-%257B2-%255B5-methyl-1-%2528naphtalen-2-yl%2529-1H-pyrazol-3-yloxy%255Dethyl%257Dmorpholine%2520%2528S1RA%252C%2520E-52862%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8211%26epage%3D8224%26doi%3D10.1021%2Fjm3007323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Puente, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocasalbas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touriño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bura, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Pastor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>711</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejphar.2013.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23632394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=711&publication_year=2013&pages=63-72&author=A.+Vidal-Torresauthor=B.+de+la+Puenteauthor=M.+Rocasalbasauthor=C.+Touri%C3%B1oauthor=S.+A.+Buraauthor=B.+Fern%C3%A1ndez-Pastorauthor=L.+Romeroauthor=X.+Codonyauthor=D.+Zamanilloauthor=H.+Buschmannauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=R.+Maldonadoauthor=J.+M.+Vela&title=Sigma-1+receptor+antagonism+as+opioid+adjuvant+strategy%3A+Enhancement+of+opioid+antinociception+without+increasing+adverse+effects&doi=10.1016%2Fj.ejphar.2013.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects</span></div><div class="casAuthors">Vidal-Torres, Alba; de la Puente, Beatriz; Rocasalbas, Maria; Tourino, Clara; Andreea Bura, Simona; Fernandez-Pastor, Begona; Romero, Luz; Codony, Xavier; Zamanillo, Daniel; Buschmann, Helmut; Merlos, Manuel; Manuel Baeyens, Jose; Maldonado, Rafael; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">711</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While opioids are potent analgesics widely used in the management of pain, a no. of well-known adverse effects limit their use.  The sigma-1 receptor is a ligand-regulated mol. chaperone involved in pain processing, including modulation of opioid antinociception.  However, data supporting the potential use of sigma-1 receptor ligands as suitable opioid adjuvants are based on studies that use non selective ligands.  Also, safety issues derived from combination therapy are poorly addressed.  In this study we used the new selective sigma-1 receptor antagonist S1RA (E-52862) to characterize the effect of selective sigma-1 receptor blockade on opioid-induced efficacy- and safety-related outcomes in mice.  S1RA (40 mg/kg) had no effect in the tail-flick test but did enhance the antinociceptive potency of several opioids by a factor between 2 and 3.3.  The potentiating effect of S1RA on morphine antinociception did not occur in sigma-1 receptor knockout mice, which supports the selective involvement of the sigma-1 receptor.  Interestingly, S1RA co-administration restored morphine antinociception in tolerant mice and reverted the reward effects of morphine in the conditioned place preference paradigm.  In addn., enhancement of antinociception was not accompanied by potentiation of other opioid-induced effects, such as the development of morphine analgesic tolerance, phys. dependence, inhibition of gastrointestinal transit, or mydriasis.  The use of sigma-1 receptor antagonists as opioid adjuvants could represent a promising pharmacol. strategy to enhance opioid potency and, most importantly, to increase the safety margin of opioids.  S1RA is currently in phase II clin. trials for the treatment of several pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTGE08MufobVg90H21EOLACvtfcHk0lj-3ZVh9e4WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVyksLc%253D&md5=c2cd0eb6fe5a9232bff11fe1539f74d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVidal-Torres%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DB.%26aulast%3DRocasalbas%26aufirst%3DM.%26aulast%3DTouri%25C3%25B1o%26aufirst%3DC.%26aulast%3DBura%26aufirst%3DS.%2BA.%26aulast%3DFern%25C3%25A1ndez-Pastor%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma-1%2520receptor%2520antagonism%2520as%2520opioid%2520adjuvant%2520strategy%253A%2520Enhancement%2520of%2520opioid%2520antinociception%2520without%2520increasing%2520adverse%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D711%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.ejphar.2013.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Sigma 1 receptor: A new therapeutic target for pain</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>716</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.01.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.ejphar.2013.01.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23500210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=78-93&author=D.+Zamanilloauthor=L.+Romeroauthor=M.+Merlosauthor=J.+M.+Vela&title=Sigma+1+receptor%3A+A+new+therapeutic+target+for+pain&doi=10.1016%2Fj.ejphar.2013.01.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma 1 receptor: A new therapeutic target for pain</span></div><div class="casAuthors">Zamanillo, Daniel; Romero, Luz; Merlos, Manuel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">78-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sigma 1 receptor (σ1 receptor) is a unique ligand-regulated mol. chaperone located mainly in the endoplasmic reticulum and the plasma membrane. σ1 receptor is activated under stress or pathol. conditions and interacts with several neurotransmitter receptors and ion channels to modulate their function.  The effects reported preclinically with σ1 receptor ligands are consistent with a role for σ1 receptor in central sensitization and pain hypersensitivity and suggest a potential therapeutic use of σ1 receptor antagonists for the management of neuropathic pain as monotherapy.  Moreover, data support their use in opioid adjuvant therapy: combination of σ1 receptor antagonists and opioids results in potentiation of opioid analgesia, without significant increases in opioid-related unwanted effects.  Results from clin. trials using selective σ1 receptor antagonists in several pain conditions are eagerly awaited to ascertain the potential of σ1 receptor modulation in pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZl3UX9-U94rVg90H21EOLACvtfcHk0lj-3ZVh9e4WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju70%253D&md5=7eba2c57ef558fbc50fb90d7067ab2e8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.01.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.01.068%26sid%3Dliteratum%253Aachs%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSigma%25201%2520receptor%253A%2520A%2520new%2520therapeutic%2520target%2520for%2520pain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D78%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2013.01.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span>E.U.
Clinical Trials Register. An exploratory, randomized, double blind,
placebo controlled, parallel groups Phase II clinical trial to evaluate
the efficacy and safety of E-52862 (400 mg) by oral route, as part
of an analgesic therapy balanced with morphine, followed by an open
label extension, in the treatment of post-operative pain due to abdominal
hysterectomy Available from <a href="http://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003302-24/results" class="extLink">www.clinicaltrialsregister.eu/ctr-search/trial/2011-003302-24/results</a> (accessed Jun 3, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=E.U.%0AClinical+Trials+Register.+An+exploratory%2C+randomized%2C+double+blind%2C%0Aplacebo+controlled%2C+parallel+groups+Phase+II+clinical+trial+to+evaluate%0Athe+efficacy+and+safety+of+E-52862+%28400+mg%29+by+oral+route%2C+as+part%0Aof+an+analgesic+therapy+balanced+with+morphine%2C+followed+by+an+open%0Alabel+extension%2C+in+the+treatment+of+post-operative+pain+due+to+abdominal%0Ahysterectomy+Available+from+www.clinicaltrialsregister.eu%2Fctr-search%2Ftrial%2F2011-003302-24%2Fresults+%28accessed+Jun+3%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backonja, M.</span></span> <span> </span><span class="NLM_article-title">Combination drug therapy for chronic pain: a call for more clinical studies</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2010.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.jpain.2010.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=20851058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslOns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=157-166&author=J.+Maoauthor=M.+S.+Goldauthor=M.+Backonja&title=Combination+drug+therapy+for+chronic+pain%3A+a+call+for+more+clinical+studies&doi=10.1016%2Fj.jpain.2010.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Combination Drug Therapy for Chronic Pain: A Call for More Clinical Studies</span></div><div class="casAuthors">Mao, Jianren; Gold, Michael S.; Backonja, Miroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-166</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Chronic pain is a debilitating clin. condition assocd. with a variety of disease entities including diabetic neuropathy, postherpetic neuralgia, low back pathol., fibromyalgia, and neurol. disorders.  For many general practitioners and specialists, managing chronic pain has become a daunting challenge.  As a modality of multidisciplinary chronic pain management, medications are often prescribed in combinations, an approach referred to as combination drug therapy (CDT).  However, many medications for pain therapy, including antidepressants and opioid analgesics, have significant side effects that can compd. when used in combination and impact the effectiveness of CDT.  To date, clin. practice of CDT for chronic pain has been based largely on clin. experiences.  In this article, we will focus on (1) the scientific basis and rationales for CDT, (2) current clin. data on CDT, and (3) the need for more clin. studies to establish a framework for the use of CDT.  Perspective: More preclin., clin., and translational studies are needed to improve the efficacy of combination drug therapy that is an integral part of a comprehensive approach to the management of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjDPNs-xJvEbVg90H21EOLACvtfcHk0ljP3amgsbmGEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslOns7Y%253D&md5=955711ac2946dd44adc0e8b96b6ee423</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2010.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2010.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DGold%26aufirst%3DM.%2BS.%26aulast%3DBackonja%26aufirst%3DM.%26atitle%3DCombination%2520drug%2520therapy%2520for%2520chronic%2520pain%253A%2520a%2520call%2520for%2520more%2520clinical%2520studies%26jtitle%3DJ.%2520Pain%26date%3D2011%26volume%3D12%26spage%3D157%26epage%3D166%26doi%3D10.1016%2Fj.jpain.2010.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6523</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1021/jm058225d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-43&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm&doi=10.1021%2Fjm058225d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0ljP3amgsbmGEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D43%26doi%3D10.1021%2Fjm058225d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of multitarget-directed ligands: Strategies and emerging paradigms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8881</span>– <span class="NLM_lpage">8914</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8881-8914&author=J.+Zhouauthor=X.+Jiangauthor=S.+Heauthor=H.+Jiangauthor=F.+Fengauthor=W.+Liuauthor=W.+Quauthor=H.+Sun&title=Rational+design+of+multitarget-directed+ligands%3A+Strategies+and+emerging+paradigms&doi=10.1021%2Facs.jmedchem.9b00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms</span></div><div class="casAuthors">Zhou, Junting; Jiang, Xueyang; He, Siyu; Jiang, Hongli; Feng, Feng; Liu, Wenyuan; Qu, Wei; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8881-8914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit satisfactory efficacy.  Recently, increasing evidence indicates that simultaneous modulation of multiple targets may improve both therapeutic safety and efficacy, compared with single-target drugs.  However, few multitarget drugs are on market or in clin. trials, despite the best efforts of medicinal chemists.  This article discusses the systematic establishment of target combination, lead generation, and optimization of multitarget-directed ligands (MTDLs).  Moreover, we analyze some MTDLs research cases for several complex diseases in recent years and the physicochem. properties of 117 clin. multitarget drugs, with the aim to reveal the trends and insights of the potential use of MTDLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLqk7hMZnoLVg90H21EOLACvtfcHk0ljP3amgsbmGEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D&md5=37adb9bc31802e62fd7f8d0d6e7697e3</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520multitarget-directed%2520ligands%253A%2520Strategies%2520and%2520emerging%2520paradigms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8881%26epage%3D8914%26doi%3D10.1021%2Facs.jmedchem.9b00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Selective sigma-1 receptor antagonists for the treatment of pain</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.4155/fmc.14.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.4155%2Ffmc.14.54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=25078137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1179-1199&author=C.+Almansaauthor=J.+M.+Vela&title=Selective+sigma-1+receptor+antagonists+for+the+treatment+of+pain&doi=10.4155%2Ffmc.14.54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selective sigma-1 receptor antagonists for the treatment of pain</span></div><div class="casAuthors">Almansa, Carmen; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1179-1199</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The sigma-1 receptor (σ1R) is located in areas of the CNS key for pain control and belongs to a unique target class with chaperoning functions over different mol. targets involved in transmission and amplification of nociceptive messages.  Preclin. evidence supports a role for σ1R antagonists in the treatment of pain states where hypersensitivity develops as hyperalgesia and allodynia, two common symptoms encountered in neuropathic and other chronic pain conditions.  Addnl., σ1R antagonists increase opioid analgesia without increasing opioid-related unwanted effects, which point to their potential use as opioid adjuvant therapy.  This review summarizes the structure and function of the σ1R as well as the medicinal chem. and pharmacol. studies directed to the identification of σ1R antagonists for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0qGYS21i37Vg90H21EOLACvtfcHk0lhcx_djUpvAWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjK&md5=3ced452012e44f478a377f0fa52995d4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.54%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DC.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520sigma-1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1179%26epage%3D1199%26doi%3D10.4155%2Ffmc.14.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitza, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gintant, G. A.</span></span> <span> </span><span class="NLM_article-title">The [<sup>3</sup>H]-dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K<sup>+</sup>]<sub>o</sub></span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5D-dofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+Comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do&doi=10.1016%2Fj.vascn.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lhcx_djUpvAWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255D-dofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520Comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Fernández, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Cano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artacho-Cordón, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montilla-García, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entrena, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span> <span> </span><span class="NLM_article-title">Potentiation of morphine-induced mechanical antinociception by σ<sub>1</sub> receptor inhibition: role of peripheral σ<sub>1</sub> receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2Fj.neuropharm.2013.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=23524304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=348-358&author=C.+S%C3%A1nchez-Fern%C3%A1ndezauthor=F.+R.+Nietoauthor=R.+Gonz%C3%A1lez-Canoauthor=A.+Artacho-Cord%C3%B3nauthor=L.+Romeroauthor=A.+Montilla-Garc%C3%ADaauthor=D.+Zamanilloauthor=J.+M.+Baeyensauthor=J.+M.+Entrenaauthor=E.+J.+Cobos&title=Potentiation+of+morphine-induced+mechanical+antinociception+by+%CF%831+receptor+inhibition%3A+role+of+peripheral+%CF%831+receptors&doi=10.1016%2Fj.neuropharm.2013.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors</span></div><div class="casAuthors">Sanchez-Fernandez, Cristina; Nieto, Francisco Rafael; Gonzalez-Cano, Rafael; Artacho-Cordon, Antonia; Romero, Lucia; Montilla-Garcia, Angeles; Zamanillo, Daniel; Baeyens, Jose Manuel; Entrena, Jose Manuel; Cobos, Enrique Jose</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">348-358</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We studied the modulation of morphine-induced mech. antinociception and side effects by σ1 receptor inhibition.  Both wild-type (WT) and σ1 receptor knockout (σ1-KO) mice showed similar responses to paw pressure (100-600 g).  The systemic (s.c.) or local (intraplantar) administration of σ1 antagonists (BD-1063, BD-1047, NE-100 and S1RA) was devoid of antinociceptive effects in WT mice.  However, σ1-KO mice exhibited an enhanced mech. antinociception in response to systemic morphine (1-16 mg/kg).  Similarly, systemic treatment of WT mice with σ1 antagonists markedly potentiated morphine-induced antinociception, and its effects were reversed by the selective σ1 agonist PRE-084.  Although the local administration of morphine (50-200 μg) was devoid of antinociceptive effects in WT mice, it induced dose-dependent antinociception in σ1-KO mice.  This effect was limited to the injected paw.  Enhancement of peripheral morphine antinociception was replicated in WT mice locally co-administered with σ1 antagonists and the opioid.  None of the σ1 antagonists tested enhanced morphine-antinociception in σ1-KO mice, confirming a σ1-mediated action.  Morphine-induced side-effects (hyperlocomotion and inhibition of gastrointestinal transit) were unaltered in σ1-KO mice.  These results cannot be explained by a direct interaction of σ1 ligands with μ-opioid receptors or adaptive changes of μ-receptors in σ1-KO mice, given that [3H]DAMGO binding in forebrain, spinal cord, and hind-paw skin membranes was unaltered in mutant mice, and none of the σ1 drugs tested bound to μ-opioid receptors.  These results show that σ1 receptor inhibition potentiates morphine-induced mech. analgesia but not its acute side effects, and that this enhanced analgesia can be induced at peripheral level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc2KFSqih3HbVg90H21EOLACvtfcHk0lg4Rv1NHf_t6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVSqt7s%253D&md5=d21562671453852a7e07c15232726ade</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Fern%25C3%25A1ndez%26aufirst%3DC.%26aulast%3DNieto%26aufirst%3DF.%2BR.%26aulast%3DGonz%25C3%25A1lez-Cano%26aufirst%3DR.%26aulast%3DArtacho-Cord%25C3%25B3n%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DMontilla-Garc%25C3%25ADa%26aufirst%3DA.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DEntrena%26aufirst%3DJ.%2BM.%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26atitle%3DPotentiation%2520of%2520morphine-induced%2520mechanical%2520antinociception%2520by%2520%25CF%25831%2520receptor%2520inhibition%253A%2520role%2520of%2520peripheral%2520%25CF%25831%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D348%26epage%3D358%26doi%3D10.1016%2Fj.neuropharm.2013.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Virgili, M.</span>; <span class="NLM_string-name">Alonso, M.</span>; <span class="NLM_string-name">Alegret, C.</span>; <span class="NLM_string-name">Almansa, C.</span>; <span class="NLM_string-name">García, M.</span></span> <span> </span><span class="NLM_article-title">Alkyl Derivatives of 1-Oxa-4,9-diazaspiroundecane Compounds Having Multimodal Activity Against Pain</span>. PCT Int. Appl. <span class="NLM_patent">WO2015185209A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Virgili&author=M.+Alonso&author=C.+Alegret&author=C.+Almansa&author=M.+Garc%C3%ADa&title=Alkyl+Derivatives+of+1-Oxa-4%2C9-diazaspiroundecane+Compounds+Having+Multimodal+Activity+Against+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVirgili%26aufirst%3DM.%26atitle%3DAlkyl%2520Derivatives%2520of%25201-Oxa-4%252C9-diazaspiroundecane%2520Compounds%2520Having%2520Multimodal%2520Activity%2520Against%2520Pain%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, B.</span>; <span class="NLM_string-name">Ennis, D.</span>; <span class="NLM_string-name">Eriksson, T.</span>; <span class="NLM_string-name">Gibson, S.</span>; <span class="NLM_string-name">Gu, E.</span>; <span class="NLM_string-name">Hassall, I.</span>; <span class="NLM_string-name">Hemmerling, M.</span>; <span class="NLM_string-name">Josefsson, B.</span>; <span class="NLM_string-name">Ivanova, S.</span>; <span class="NLM_string-name">Kavitake, S.</span>; <span class="NLM_string-name">Kumar, S. S.</span>; <span class="NLM_string-name">Kumar, V.</span>; <span class="NLM_string-name">Lingesha, S.</span>; <span class="NLM_string-name">Mensonides-Harsema, M.</span>; <span class="NLM_string-name">Merifield, E.</span>; <span class="NLM_string-name">Mo, J.</span>; <span class="NLM_string-name">Pavey, J.</span>; <span class="NLM_string-name">Pimm, A.</span>; <span class="NLM_string-name">Reuberson, J.</span>; <span class="NLM_string-name">Rogers, M.</span>; <span class="NLM_string-name">Schulz, H.</span>; <span class="NLM_string-name">Strandberg, P.</span>; <span class="NLM_string-name">Zhengyu, W.</span>; <span class="NLM_string-name">Cooper, M.</span></span> <span> </span><span class="NLM_article-title">Novel Tricyclic Spiropiperidine Compounds, their Synthesis and their Uses as Modulators of Chemokine Receptor Activity</span>. PCT Int. Appl. <span class="NLM_patent">WO2008010765A1</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Elkins&author=D.+Ennis&author=T.+Eriksson&author=S.+Gibson&author=E.+Gu&author=I.+Hassall&author=M.+Hemmerling&author=B.+Josefsson&author=S.+Ivanova&author=S.+Kavitake&author=S.+S.+Kumar&author=V.+Kumar&author=S.+Lingesha&author=M.+Mensonides-Harsema&author=E.+Merifield&author=J.+Mo&author=J.+Pavey&author=A.+Pimm&author=J.+Reuberson&author=M.+Rogers&author=H.+Schulz&author=P.+Strandberg&author=W.+Zhengyu&author=M.+Cooper&title=Novel+Tricyclic+Spiropiperidine+Compounds%2C+their+Synthesis+and+their+Uses+as+Modulators+of+Chemokine+Receptor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DElkins%26aufirst%3DB.%26atitle%3DNovel%2520Tricyclic%2520Spiropiperidine%2520Compounds%252C%2520their%2520Synthesis%2520and%2520their%2520Uses%2520as%2520Modulators%2520of%2520Chemokine%2520Receptor%2520Activity%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaykovsky, M.</span></span> <span> </span><span class="NLM_article-title">Dimethyloxosulfonium methylide ((CH<sub>3</sub>)<sub>2</sub>SOCH<sub>2</sub>) and dimethylsulfonium methylide ((CH<sub>3</sub>)<sub>2</sub>SCH<sub>2</sub>). Formation and application to organic synthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1353</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1021/ja01084a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01084a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaF2MXntlGrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1965&pages=1353-1364&author=E.+J.+Coreyauthor=M.+Chaykovsky&title=Dimethyloxosulfonium+methylide+%28%28CH3%292SOCH2%29+and+dimethylsulfonium+methylide+%28%28CH3%292SCH2%29.+Formation+and+application+to+organic+synthesis&doi=10.1021%2Fja01084a034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dimethyloxosulfonium methylide and dimethylsulfonium methylide. Formation and application to organic synthesis</span></div><div class="casAuthors">Corey, E. J.; Chaykovsky, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1353-64</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The generation of dimethyloxosulfonium methylide (Me2SOCH2) and dimethylsulfonium methylide (Me2SCH2) as reactive intermediates is described.  Both ylides are nucleophiles and both function to transfer methylene to certain electrophilic unsatd. linkages, including C:O, C:N, C:S, and in certain cases, C:C.  The less reactive oxosulfonium ylide interacts with the carbonyl function of aromatic and nonconjugated aldehydes and ketones to form oxiranes and with α,β-unsatd. ketones which are Michael receptors to form cyclopropyl ketones.  The sulfonium ylide reacts with the same substrates to give oxiranes exclusively even with the α,β-unsatd. carbonyl systems.  These reactions are quite general and, therefore, of considerable practical value.  The stereochemistry of carbonyl addn. to cyclohexanones varies depending on the ylide; the oxosulfonium ylide reacts by equatorial addn. (i.e., of methylene) and the sulfonium ylide shows a preference for axial addn.  A no. of other reactions of these ylides are described including "over-all methylene insertion," and a differential comparison of their chem. properties is made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0xfN-tNfFLVg90H21EOLACvtfcHk0lg4Rv1NHf_t6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXntlGrtw%253D%253D&md5=ae22573e36db50409c7832e5950df7f1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja01084a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01084a034%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DChaykovsky%26aufirst%3DM.%26atitle%3DDimethyloxosulfonium%2520methylide%2520%2528%2528CH3%25292SOCH2%2529%2520and%2520dimethylsulfonium%2520methylide%2520%2528%2528CH3%25292SCH2%2529.%2520Formation%2520and%2520application%2520to%2520organic%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1965%26volume%3D87%26spage%3D1353%26epage%3D1364%26doi%3D10.1021%2Fja01084a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abrecht, S.</span></span> <span> </span><span class="NLM_article-title">Method for the Preparation of Alpha-bromo-lactam Derivatives</span>. U.S. Patent <span class="NLM_patent">US6,114,541</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=S.+Abrecht&title=Method+for+the+Preparation+of+Alpha-bromo-lactam+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbrecht%26aufirst%3DS.%26atitle%3DMethod%2520for%2520the%2520Preparation%2520of%2520Alpha-bromo-lactam%2520Derivatives%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleissner, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Rice, F. Y.</span></span> <span> </span><span class="NLM_article-title">Characterization of the binding of [<sup>3</sup>H](+)pentazocine to recognition sites in guinea pig brain</span>. <i>Eur. J. Pharmacol., Mol. Pharmacol. Sect.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1016/0922-4106(92)90153-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0922-4106%2892%2990153-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1359973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1992&pages=371-378&author=D.+L.+DeHaven-Hudkinsauthor=L.+C.+Fleissnerauthor=F.+Y.+Ford-Rice&title=Characterization+of+the+binding+of+%5B3H%5D%28%2B%29pentazocine+to+recognition+sites+in+guinea+pig+brain&doi=10.1016%2F0922-4106%2892%2990153-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain</span></div><div class="casAuthors">DeHaven-Hudkins, Diane L.; Fleissner, Lorraine C.; Ford-Rice, Felicia Y.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-8</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    </div><div class="casAbstract">The selective σ-opioid compd. (+)-pentazocine was radiolabeled and its binding characteristics in guinea pig brain membranes were investigated.  [3H](+)-Pentazocine bound to a single high-affinity site with a KD = 2.9 nM and a Bmax = 1998 fmol/mg protein.  Satn. was achieved at a ligand concn. of 15 nM.  The maximal specific binding was obsd. at 37° and was >90% of total binding.  The equil. was reached by 120 min and dissocn. was complete by 420 min, with a t1/2 of 121 min.  Li+, Ca2+, and Mg2+ inhibited the binding at high concns., and the binding was insensitive to adenyl and guanyl nucleotides.  Stereoselectivity was obsd. for the inhibition of binding by benzomorphans, 3-(3-hydroxyphenyl)-N-propylpiperidine and butaclamol.  The (+)-enantiomers and α-diastereomers of pentazocine and cyclazocine were more potent than their corresponding (-)-enantiomers and β-diastereomers.  The rank order of potency for the σ ref. agents to displace [3H](+)-pentazocine binding was similar to that reported using the 3H-labeled σ-ligands dextromethorphan, 1,3-di(2-tolyl)guanidine, and (+)-3-(3-hydroxyphenyl)-N-propylpiperidine.  Haloperidol, (+)-pentazocine, (+)-3-(3-hydroxyphenyl)-N-propylpiperidine and rimcazole were competitive inhibitors of binding to the [3H](+)-pentazocine-defined σ recognition site, suggesting that these different structural classes of compds. all bind to a single mol. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptZ7zLKpE3bVg90H21EOLACvtfcHk0lg7uvC1ixzJfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtl2lsbs%253D&md5=323649e2b05dedbaa1dd6e9e77255d75</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2892%2990153-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252892%252990153-M%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DFleissner%26aufirst%3DL.%2BC.%26aulast%3DFord-Rice%26aufirst%3DF.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520of%2520%255B3H%255D%2528%252B%2529pentazocine%2520to%2520recognition%2520sites%2520in%2520guinea%2520pig%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1992%26volume%3D227%26spage%3D371%26epage%3D378%26doi%3D10.1016%2F0922-4106%2892%2990153-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroy, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, J.</span></span> <span> </span><span class="NLM_article-title">A complementary scale of biased agonism for agonists with differing maximal responses</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">15389</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-15258-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1038%2Fs41598-017-15258-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=29133887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADC%252BC1M3gvVegsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=15389&author=J.+Burgue%C3%B1oauthor=M.+Pujolauthor=X.+Monroyauthor=D.+Rocheauthor=M.+J.+Varelaauthor=M.+Merlosauthor=J.+Giraldo&title=A+complementary+scale+of+biased+agonism+for+agonists+with+differing+maximal+responses&doi=10.1038%2Fs41598-017-15258-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses</span></div><div class="casAuthors">Burgueno Javier; Pujol Marta; Monroy Xavier; Merlos Manuel; Roche David; Giraldo Jesus; Roche David; Giraldo Jesus; Roche David; Varela Maria Jose</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15389</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compelling data in the literature from the recent years leave no doubt about the pluridimensional nature of G protein-coupled receptor function and the fact that some ligands can couple with different efficacies to the multiple pathways that a receptor can signal through, a phenomenon most commonly known as functional selectivity or biased agonism.  Nowadays, transduction coefficients (log(τ/KA)), based on the Black and Leff operational model of agonism, are widely used to calculate bias.  Nevertheless, combining both affinity and efficacy in a single parameter can result in compounds showing a defined calculated bias of one pathway over other though displaying varying experimental bias preferences.  In this paper, we present a novel scale (log(τ)), that attempts to give extra substance to different compound profiles in order to better classify compounds and quantify their bias.  The efficacy-driven log(τ) scale is not proposed as an alternative to the affinity&efficacy-driven log(τ/KA) scale but as a complement in those situations where partial agonism is present.  Both theoretical and practical approaches using μ-opioid receptor agonists are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8ACsymX9-Ay-bLEOO4dYpfW6udTcc2eZ-8XdYn0ncqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3gvVegsg%253D%253D&md5=8c43e0cc2e5e1fe47fa40c2c3d50b7f6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-15258-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-15258-z%26sid%3Dliteratum%253Aachs%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DPujol%26aufirst%3DM.%26aulast%3DMonroy%26aufirst%3DX.%26aulast%3DRoche%26aufirst%3DD.%26aulast%3DVarela%26aufirst%3DM.%2BJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DGiraldo%26aufirst%3DJ.%26atitle%3DA%2520complementary%2520scale%2520of%2520biased%2520agonism%2520for%2520agonists%2520with%2520differing%2520maximal%2520responses%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D15389%26doi%3D10.1038%2Fs41598-017-15258-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, E.</span></span> <span> </span><span class="NLM_article-title">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1002/syn.20103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1002%2Fsyn.20103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=15635593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=192-195&author=E.+J.+Cobosauthor=J.+M.+Baeyensauthor=E.+Del+Pozo&title=Phenytoin+differentially+modulates+the+affinity+of+agonist+and+antagonist+ligands+for+sigma+1+receptors+of+guinea+pig+brain&doi=10.1002%2Fsyn.20103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phenytoin differentially modulates the affinity of agonist and antagonist ligands for σ1 receptors of guinea pig brain</span></div><div class="casAuthors">Cobos, Enrique J.; Baeyens, Jose M.; Del Pozo, Esperanza</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">192-195</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors evaluated the effects of phenytoin (DPH) on the affinity for sigma-1 (σ1) receptors of agonist or antagonist σ1 ligands in guinea pig brain.  Heterologous competition expts. showed that DPH (250 μM and 1 mM) concn.-dependently increased the affinity of the σ1 agonists dextromethorphan, (+)-SKF-10,047, (+)-3-PPP, and PRE-084.  However, neither DPH 250 μM nor 1 mM increased (in fact, they slightly decreased) the affinity of the σ1 receptor antagonists haloperidol, BD 1063, NE-100, progesterone, and BD 1047.  These findings suggest that allosteric modulation by DPH of the affinity of σ1 receptor ligands depends on the agonist or antagonist characteristics of the ligand.  Therefore, detg. in vitro the differential modulation by DPH of σ1 ligand affinity appears to constitute a procedure that can predict the pharmacol. profile of different σ1 ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoossDgzqW_ibVg90H21EOLACvtfcHk0lg7uvC1ixzJfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cgtb4%253D&md5=2243891ce029ec03b1910ce6bd4e49c8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20103%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DDel%2BPozo%26aufirst%3DE.%26atitle%3DPhenytoin%2520differentially%2520modulates%2520the%2520affinity%2520of%2520agonist%2520and%2520antagonist%2520ligands%2520for%2520sigma%25201%2520receptors%2520of%2520guinea%2520pig%2520brain%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D192%26epage%3D195%26doi%3D10.1002%2Fsyn.20103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Stresser, D. M.</span></span> <span> </span><span class="NLM_article-title">High-throughput Screening of Human Cytochrome P450 inhibitors Using Fluorometric Substrates. Methodology for 25 Enzyme/Substrate Pairs</span>. In  <i>Optimization in Drug Discovery. In Vitro Methods</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span>, <span class="NLM_string-name">Caldwell, G. W.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">230</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1385%2F1-59259-800-5%3A215" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=215-230&author=D.+M.+Stresserauthor=Z.+Yan&author=G.+W.+Caldwell&title=Optimization+in+Drug+Discovery.+In+Vitro+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1385%2F1-59259-800-5%3A215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F1-59259-800-5%253A215%26sid%3Dliteratum%253Aachs%26aulast%3DStresser%26aufirst%3DD.%2BM.%26atitle%3DHigh-throughput%2520Screening%2520of%2520Human%2520Cytochrome%2520P450%2520inhibitors%2520Using%2520Fluorometric%2520Substrates.%2520Methodology%2520for%252025%2520Enzyme%252FSubstrate%2520Pairs%26btitle%3DOptimization%2520in%2520Drug%2520Discovery.%2520In%2520Vitro%2520Methods%26aulast%3DYan%26aufirst%3DZ.%26pub%3DHumana%2520Press%26date%3D2004%26spage%3D215%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span>; <span class="NLM_string-name">Caldwell, G. W.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Cytochrome P450 inhibition in Human Liver Microsomes</span>. In  <i>Optimization in Drug Discovery. In Vitro Methods</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span>, <span class="NLM_string-name">Caldwell, G. W.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2004</span>; pp  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">244</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1385%2F1-59259-800-5%3A231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=231-244&author=Z.+Yan&author=G.+W.+Caldwellauthor=Z.+Yan&author=G.+W.+Caldwell&title=Optimization+in+Drug+Discovery.+In+Vitro+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1385%2F1-59259-800-5%3A231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F1-59259-800-5%253A231%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DEvaluation%2520of%2520Cytochrome%2520P450%2520inhibition%2520in%2520Human%2520Liver%2520Microsomes%26btitle%3DOptimization%2520in%2520Drug%2520Discovery.%2520In%2520Vitro%2520Methods%26aulast%3DYan%26aufirst%3DZ.%26pub%3DHumana%2520Press%26date%3D2004%26spage%3D231%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span> <i>Drug Interaction Studies—Study Design, Data Analysis, Implications
for Dosing and Labeling</i>; <span class="NLM_publisher-name">Center for Drug
Evaluation and Research (CDER), Food and Drug Administration</span>, September 2006 and February 2012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Drug+Interaction+Studies%E2%80%94Study+Design%2C+Data+Analysis%2C+Implications%0Afor+Dosing+and+Labeling%3B+Center+for+Drug%0AEvaluation+and+Research+%28CDER%29%2C+Food+and+Drug+Administration%2C+September+2006+and+February+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDrug%2520Interaction%2520Studies%25E2%2580%2594Study%2520Design%252C%2520Data%2520Analysis%252C%2520Implications%250Afor%2520Dosing%2520and%2520Labeling%26pub%3DCenter%2520for%2520Drug%250AEvaluation%2520and%2520Research%2520%2528CDER%2529%252C%2520Food%2520and%2520Drug%2520Administration" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastall, P.</span></span> <span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhca75qunaQ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lhca75qunaQ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Putnam, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bombick, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doolittle, D.J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/S0887-2333(02)00050-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2FS0887-2333%2802%2900050-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=12206827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Khsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=599-607&author=K.+P.+Putnamauthor=D.+W.+Bombickauthor=D.J.+Doolittle&title=Evaluation+of+eight+in+vitro+assays+for+assessing+the+cytotoxicity+of+cigarette+smoke+condensate&doi=10.1016%2FS0887-2333%2802%2900050-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate</span></div><div class="casAuthors">Putnam, K. P.; Bombick, D. W.; Doolittle, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology in Vitro</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">599-607</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The accurate assessment of cytotoxicity is important for evaluating the potential of a test agent to induce pathologies that result from cell killing and to det. appropriate doses for other endpoints, such as genetic toxicol. studies.  The objective of this work was to det. the most sensitive assays for assessing cytotoxicity in Chinese hamster ovary (CHO) cells following short-term (1 h) and long-term (24 h) exposure to cigarette smoke condensate (CSC).  Eight in vitro cytotoxicity assays with different endpoints were used to evaluate the cytotoxicity of Kentucky ref. 1R4F (K1R4F) CSC in CHO cells.  The assays used for this study were neutral red uptake, LDH release, kenacid blue binding, MTT formation, XTT formation, acid phosphatase activity, sulforhodamine B binding and resazurin binding.  Four of the more widely used cytotoxicity assays (neutral red, MTT, kenacid blue and LDH) were also evaluated at 3-, 6-, 12- and 18-h time points.  At the 1-h exposure time, LDH was the most sensitive with toxicity obsd. beginning at 100 μg/mL.  None of the other assays demonstrated a concn.-dependent increase in toxicity after 1-h exposures even at the max. concn. of 150 μg/mL of CSC.  Following 24 h of exposure, neutral red and kenacid blue were the most sensitive.  The results of the study indicate the assay that measured membrane integrity was the most sensitive for short exposure times, whereas the neutral red and kenacid blue assays that measured total cell no. were more sensitive for longer exposure times.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraDGdWNI78VLVg90H21EOLACvtfcHk0lhca75qunaQ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Khsrc%253D&md5=c9f7eededcbdc95816f16111d76e2178</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0887-2333%2802%2900050-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0887-2333%252802%252900050-4%26sid%3Dliteratum%253Aachs%26aulast%3DPutnam%26aufirst%3DK.%2BP.%26aulast%3DBombick%26aufirst%3DD.%2BW.%26aulast%3DDoolittle%26aufirst%3DD.J.%26atitle%3DEvaluation%2520of%2520eight%2520in%2520vitro%2520assays%2520for%2520assessing%2520the%2520cytotoxicity%2520of%2520cigarette%2520smoke%2520condensate%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2002%26volume%3D16%26spage%3D599%26epage%3D607%26doi%3D10.1016%2FS0887-2333%2802%2900050-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0livpH_82ckNiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reifferscheid, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heil, J.</span></span> <span> </span><span class="NLM_article-title">Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data</span>. <i>Mutat. Res., Genet. Toxicol. Test.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/S0165-1218(96)90021-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2FS0165-1218%2896%2990021-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=8792833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK28XltVOqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=1996&pages=129-145&author=G.+Reifferscheidauthor=J.+Heil&title=Validation+of+the+SOS%2Fumu+test+using+test+results+of+486+chemicals+and+comparison+with+the+Ames+test+and+carcinogenicity+data&doi=10.1016%2FS0165-1218%2896%2990021-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data</span></div><div class="casAuthors">Reifferscheid, Georg; Heil, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">3,4</span>),
    <span class="NLM_cas:pages">129-145</span>CODEN:
                <span class="NLM_cas:coden">MGTOEB</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study gives a comprehensive update of all umu genotoxicity assay results published so far.  The available data of 486 chems. investigated with the umu test are compared with the Ames test (274 compds.) as well as rodent carcinogenicity data (179 compds.).  On the whole, there is good agreement between the umu test and the Ames test results, with a concordance of about 90%.  The umu test was able to detect 86% of the Ames mutagens, while the Ames test (using at least 5 strains) detected 97% of the umu pos. compds.  The elimination of TA102 from the set of Ames tester strains reduced the percentage of detectable umu genotoxins from 97 to 86%.  The agreement between carcinogenesis and umu response was 65%, which is comparable to earlier studies concerning rodent carcinogenesis and Salmonella mutagenesis.  The present compilation of umu results provides a database that can be used for the comparison of the SOS-inducing activity of chems. and their mutagenicity, resp., carcinogenicity.  The results presented here clearly demonstrate that a chem. which induces the expression of the umu operon can be regarded a rodent carcinogen with a high degree of certainty (93%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSq51aXTvfbbVg90H21EOLACvtfcHk0livpH_82ckNiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVOqsr8%253D&md5=f867f98abb745d6cfab49ffa39fad10d</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2FS0165-1218%2896%2990021-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-1218%252896%252990021-X%26sid%3Dliteratum%253Aachs%26aulast%3DReifferscheid%26aufirst%3DG.%26aulast%3DHeil%26aufirst%3DJ.%26atitle%3DValidation%2520of%2520the%2520SOS%252Fumu%2520test%2520using%2520test%2520results%2520of%2520486%2520chemicals%2520and%2520comparison%2520with%2520the%2520Ames%2520test%2520and%2520carcinogenicity%2520data%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Test.%26date%3D1996%26volume%3D369%26spage%3D129%26epage%3D145%26doi%3D10.1016%2FS0165-1218%2896%2990021-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amidon, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernäs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crison, J. R.</span></span> <span> </span><span class="NLM_article-title">A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1023/A:1016212804288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1023%2FA%3A1016212804288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=7617530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK2MXksVGqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1995&pages=413-420&author=G.+L.+Amidonauthor=H.+Lennern%C3%A4sauthor=V.+P.+Shahauthor=J.+R.+Crison&title=A+theoretical+basis+for+a+biopharmaceutic+drug+classification%3A+the+correlation+of+in+vitro+drug+product+dissolution+and+in+vivo+bioavailability&doi=10.1023%2FA%3A1016212804288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability</span></div><div class="casAuthors">Amidon, Gordon L.; Lennernaes, Hans; Shah, Vinod P.; Crison, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-20</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Plenum</span>)
        </div><div class="casAbstract">A biopharmaceutics drug classification scheme for correlating in vitro drug product dissoln. and in vivo bioavailability is proposed based on recognizing that drug dissoln. and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption.  This anal. uses a transport model and human permeability results for estg. in vivo drug absorption to illustrate the primary importance of soly. and permeability on drug absorption.  The fundamental parameters which define oral drug absorption in humans resulting from this anal. are discussed and used as a basis for this classification scheme.  These biopharmaceutic drug classes are defined as: High soly.-high permeability drugs; Low soly.-high permeability drugs; High soly.-low permeability drugs; and Low soly.-low permeability drugs.  Based on this classification scheme, suggestions are made for setting stds. for in vitro drug dissoln. testing methodol. which will correlate with the in vivo process.  This methodol. must be based on the physiol. and phys. chem. properties controlling drug absorption.  This anal.points out conditions under which no in vitro-in vivo correlation may be expected, e.g., rapidly dissolving low permeability drugs.  For very rapidly dissolving high soly. drugs, e.g., 85% dissoln. in <15 min, a simple one point dissoln. test, is all that may be needed to insure bioavailability.  For slowly dissolving drugs a dissoln. profile is required with multiple time points in systems which would include low pH, physiol. pH, and surfactants and the in vitro conditions should mimic the in vivo processes.  This classification scheme provides a basis for establishing in vitro-in vivo correlations and for estg. the absorption of drugs based on the fundamental dissoln. and permeability properties of physiol. importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJdUzHIRA0ZrVg90H21EOLACvtfcHk0livpH_82ckNiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVGqur8%253D&md5=3f472093c5341be6b36e87ddfeb7223f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1023%2FA%3A1016212804288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1016212804288%26sid%3Dliteratum%253Aachs%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26aulast%3DShah%26aufirst%3DV.%2BP.%26aulast%3DCrison%26aufirst%3DJ.%2BR.%26atitle%3DA%2520theoretical%2520basis%2520for%2520a%2520biopharmaceutic%2520drug%2520classification%253A%2520the%2520correlation%2520of%2520in%2520vitro%2520drug%2520product%2520dissolution%2520and%2520in%2520vivo%2520bioavailability%26jtitle%3DPharm.%2520Res.%26date%3D1995%26volume%3D12%26spage%3D413%26epage%3D420%26doi%3D10.1023%2FA%3A1016212804288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond Rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljYiYrzyhO9tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lê, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulos, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappell, H.</span></span> <span> </span><span class="NLM_article-title">Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1007/BF02244172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1007%2FBF02244172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1652143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK3MXksVWqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1991&pages=164-166&author=M.+J.+K.+Walkerauthor=A.+D.+L%C3%AAauthor=C.+X.+Poulosauthor=H.+Cappell&title=Role+of+central+versus+peripheral+opioid+receptors+in+analgesia+induced+by+repeated+administration+of+opioid+antagonists&doi=10.1007%2FBF02244172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists</span></div><div class="casAuthors">Walker, M. J. Katharine; Le, A. D.; Poulos, Constantine X.; Cappell, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-6</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Although analgesia induced by blockade of opioid receptors has been well established, it is still unknown whether its development is mediated by the blockade of centrally located opioid receptors.  Therefore, rats were treated with either systemically or intracerebroventricularly (ICV) applied naloxone or quaternary naltrexone (QN), an opioid antagonist that does not easily penetrate the blood-brain barrier.  Following antagonist administration, each animal was tested for paw lick latency on a 51° hot plate.  Hot plate testing and drug injections were carried out for 4 consecutive days.  Rats treated with ICV microinjections of QN or naloxone displayed paw lick latencies that were longer than those obsd. in control animals.  In contrast, rats treated with s.c. injections of QN did not show any increase in paw lick latency, whereas rats treated with s.c. injections of naloxone displayed paw lick latencies that were longer than those of control rats.  These results are consistent with the hypothesis that the blockade of central opioid receptors underlies the development of an analgesic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9PYJ90eTTUrVg90H21EOLACvtfcHk0ljYiYrzyhO9tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVWqs74%253D&md5=0a709922b479e4c4f7b699f9c97429a1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02244172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02244172%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DM.%2BJ.%2BK.%26aulast%3DL%25C3%25AA%26aufirst%3DA.%2BD.%26aulast%3DPoulos%26aufirst%3DC.%2BX.%26aulast%3DCappell%26aufirst%3DH.%26atitle%3DRole%2520of%2520central%2520versus%2520peripheral%2520opioid%2520receptors%2520in%2520analgesia%2520induced%2520by%2520repeated%2520administration%2520of%2520opioid%2520antagonists%26jtitle%3DPsychopharmacology%26date%3D1991%26volume%3D104%26spage%3D164%26epage%3D166%26doi%3D10.1007%2FBF02244172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span> <span> </span><span class="NLM_article-title">Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">1278</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.121137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1124%2Fjpet.107.121137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=17545312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslKrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=1278-1285&author=J.+Meiauthor=G.+W.+Pasternak&title=Modulation+of+brainstem+opiate+analgesia+in+the+rat+by+sigma+1+receptors%3A+a+microinjection+study&doi=10.1124%2Fjpet.107.121137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of brainstem opiate analgesia in the rat by σ1 receptors: a microinjection study</span></div><div class="casAuthors">Mei, Jianfeng; Pasternak, Gavril W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1278-1285</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">σ1 Receptors have been implicated in the modulation of opioid analgesia.  In the current study, we examd. the role of σ1 systems in the periaqueductal gray (PAG), the rostroventral medulla (RVM), and the locus coeruleus (LC) of the rat, regions previously shown to be sensitive to morphine.  Morphine was a potent analgesic in all three regions.  Coadministration of the σ1 agonist (+)-pentazocine diminished the analgesic actions of morphine in all three regions, although the PAG was far less sensitive than the other two regions.  Blockade of the σ1 receptors with haloperidol in the RVM markedly enhanced the analgesic actions of coadministered morphine, implying a tonic activity of the σ1 system in this region.  This effect was mimicked by down-regulation of RVM σ1 receptors using an antisense approach.  However, no tonic σ1 activity was obsd. in either the LC or the PAG.  The RVM also was important in modulating analgesia elicited from morphine microinjected into the PAG.  The analgesic actions of morphine given into the PAG could be attenuated by (+)-pentazocine placed into the RVM, whereas haloperidol in the RVM enhanced PAG morphine analgesia.  These studies illustrate the pharmacol. importance of σ1 receptors in the brainstem modulation of opioid analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb56qFzGuBK7Vg90H21EOLACvtfcHk0ljYiYrzyhO9tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslKrtLw%253D&md5=8e082fd6a528e53d21527454c61d3c47</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121137%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DModulation%2520of%2520brainstem%2520opiate%2520analgesia%2520in%2520the%2520rat%2520by%2520sigma%25201%2520receptors%253A%2520a%2520microinjection%2520study%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D1278%26epage%3D1285%26doi%3D10.1124%2Fjpet.107.121137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamanillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadal, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arroyos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Arconada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segalés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laloya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portillo-Salido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escriche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgueño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraldo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-García, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plata-Salamán, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">2289</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01942.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1111%2Fj.1476-5381.2012.01942.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=22404321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=2289-306&author=L.+Romeroauthor=D.+Zamanilloauthor=X.+Nadalauthor=R.+S%C3%A1nchez-Arroyosauthor=I.+Rivera-Arconadaauthor=A.+Dordalauthor=A.+Monteroauthor=A.+Muroauthor=A.+Buraauthor=C.+Segal%C3%A9sauthor=M.+Laloyaauthor=E.+Hern%C3%A1ndezauthor=E.+Portillo-Salidoauthor=M.+Escricheauthor=X.+Codonyauthor=G.+Encinaauthor=J.+Burgue%C3%B1oauthor=M.+Merlosauthor=J.+M.+Baeyensauthor=J.+Giraldoauthor=J.+A.+L%C3%B3pez-Garc%C3%ADaauthor=R.+Maldonadoauthor=C.+R.+Plata-Salam%C3%A1nauthor=J.+M.+Vela&title=Pharmacological+properties+of+S1RA%2C+a+new+sigma-1+receptor+antagonist+that+inhibits+neuropathic+pain+and+activity-induced+spinal+sensitization&doi=10.1111%2Fj.1476-5381.2012.01942.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization</span></div><div class="casAuthors">Romero, L.; Zamanillo, D.; Nadal, X.; Sanchez-Arroyos, R.; Rivera-Arconada, I.; Dordal, A.; Montero, A.; Muro, A.; Bura, A.; Segales, C.; Laloya, M.; Hernandez, E.; Portillo-Salido, E.; Escriche, M.; Codony, X.; Encina, G.; Burgueno, J.; Merlos, M.; Baeyens, J. M.; Giraldo, J.; Lopez-Garcia, J. A.; Maldonado, R.; Plata-Salaman, C. R.; Vela, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2289-2306</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The sigma-1 (σ1) receptor is a ligand-regulated mol. chaperone that has been involved in pain, but there is limited understanding of the actions assocd. with its pharmacol. modulation.  Indeed, the selectivity and pharmacol. properties of σ1 receptor ligands used as pharmacol. tools are unclear and the demonstration that σ1 receptor antagonists have efficacy in reversing central sensitization-related pain sensitivity is still missing.  Exptl. Approach The pharmacol. properties of a novel σ1 receptor antagonist (S1RA) were first characterized.  S1RA was then used to investigate the effect of pharmacol. antagonism of σ1 receptors on in vivo nociception in sensitizing conditions and on in vitro spinal cord sensitization in mice.  Drug levels and autoradiog., ex vivo binding for σ1 receptor occupancy were measured to substantiate behavioral data.  Key Results Formalin-induced nociception (both phases), capsaicin-induced mech. hypersensitivity and sciatic nerve injury-induced mech. and thermal hypersensitivity were dose-dependently inhibited by systemic administration of S1RA.  Occupancy of σ1 receptors in the CNS was significantly correlated with the antinociceptive effects.  No pharmacodynamic tolerance to the antiallodynic and antihyperalgesic effect developed following repeated administration of S1RA to nerve-injured mice.  As a mechanistic correlate, electrophysiol. recordings demonstrated that pharmacol. antagonism of σ1 receptors attenuated the wind-up responses in spinal cords sensitized by repetitive nociceptive stimulation.  Conclusions and Implications These findings contribute to evidence identifying the σ1 receptor as a modulator of activity-induced spinal sensitization and pain hypersensitivity, and suggest σ1 receptor antagonists as potential novel treatments for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK7puaGCXwhrVg90H21EOLACvtfcHk0li3zXAMrJRFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1artL3L&md5=f84eec105e338b08175e476b63f6208f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01942.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01942.x%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DNadal%26aufirst%3DX.%26aulast%3DS%25C3%25A1nchez-Arroyos%26aufirst%3DR.%26aulast%3DRivera-Arconada%26aufirst%3DI.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DMuro%26aufirst%3DA.%26aulast%3DBura%26aufirst%3DA.%26aulast%3DSegal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLaloya%26aufirst%3DM.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DPortillo-Salido%26aufirst%3DE.%26aulast%3DEscriche%26aufirst%3DM.%26aulast%3DCodony%26aufirst%3DX.%26aulast%3DEncina%26aufirst%3DG.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DMerlos%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DGiraldo%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DPlata-Salam%25C3%25A1n%26aufirst%3DC.%2BR.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3DPharmacological%2520properties%2520of%2520S1RA%252C%2520a%2520new%2520sigma-1%2520receptor%2520antagonist%2520that%2520inhibits%2520neuropathic%2520pain%2520and%2520activity-induced%2520spinal%2520sensitization%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D2289%26epage%3D306%26doi%3D10.1111%2Fj.1476-5381.2012.01942.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinberg, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into mu-opioid receptor activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nature14886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1038%2Fnature14886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=26245379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=315-321&author=W.+Huangauthor=A.+Manglikauthor=A.+J.+Venkatakrishnanauthor=T.+Laeremansauthor=E.+N.+Feinbergauthor=A.+L.+Sanbornauthor=H.+E.+Katoauthor=K.+E.+Livingstonauthor=T.+S.+Thorsenauthor=R.+C.+Klingauthor=S.+Granierauthor=P.+Gmeinerauthor=S.+M.+Husbandsauthor=J.+R.+Traynorauthor=W.+I.+Weisauthor=J.+Steyaertauthor=R.+O.+Drorauthor=B.+K.+Kobilka&title=Structural+insights+into+mu-opioid+receptor+activation&doi=10.1038%2Fnature14886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into μ-opioid receptor activation</span></div><div class="casAuthors">Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics.  To shed light on the structural basis for μOR activation, here we report a 2.1 Å X-ray crystal structure of the murine μOR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment Nb39 (nanobody 39).  The BU72-stabilized changes in the μOR binding pocket are subtle and differ from those obsd. for agonist-bound structures of the β2-adrenergic receptor (β2AR) and the M2 muscarinic receptor (M2R).  Comparison with active β2AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the μOR, and mol. dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad.  Addnl., an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFUN1wheV07Vg90H21EOLACvtfcHk0li3zXAMrJRFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM&md5=b9af3e1351b04539379532c127c02651</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature14886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14886%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DFeinberg%26aufirst%3DE.%2BN.%26aulast%3DSanborn%26aufirst%3DA.%2BL.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DLivingston%26aufirst%3DK.%2BE.%26aulast%3DThorsen%26aufirst%3DT.%2BS.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructural%2520insights%2520into%2520mu-opioid%2520receptor%2520activation%26jtitle%3DNature%26date%3D2015%26volume%3D524%26spage%3D315%26epage%3D321%26doi%3D10.1038%2Fnature14886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koob, G. F.</span></span> <span> </span><span class="NLM_article-title">Role of different brains structures in the expression of the physical morphine withdrawal syndrome</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1578378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaK38XisVygtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1992&pages=669-677&author=R.+Maldonadoauthor=L.+Stinusauthor=L.+H.+Goldauthor=G.+F.+Koob&title=Role+of+different+brains+structures+in+the+expression+of+the+physical+morphine+withdrawal+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of different brain structures in the expression of the physical morphine withdrawal syndrome</span></div><div class="casAuthors">Maldonado, R.; Stinus, L.; Gold, L. H.; Koob, G. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">669-77</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The aim of this study was to investigate the neuroanatomical regions implicated in the expression of the phys. signs of morphine withdrawal by using local intracerebral injections of methylnaloxonium in dependent rats.  Guide cannulas were implanted and aimed at the lateral ventricle, nucleus accumbens, central amygdala, anterior hypothalamus, medial thalamus, periaqueductal gray matter, locus ceruleus and nucleus raphe magnus.  After surgery, rats were made phys. dependent by s.c. implantation of two 75-mg morphine pellets.  Methylnaloxonium, a quaternary deriv. of naloxone (31-100 ng), was administered 723 h after pellet implantation.  Methylnaloxonium administered i.c.v. induced a withdrawal syndrome similar to systemic naloxone, although several signs such as diarrhea, salivation, lacrimation and rhinorrhea did not appear, suggesting possible peripheral mediation.  The most sensitive site for methylnaloxonium-pptd. withdrawal was the locus ceruleus.  Signs such as jumping, rearing and locomotor activity were particularly frequent after methylnaloxonium injections into the locus ceruleus.  Rearing and locomotor activity were also strongly increased after methylaloxonium administration into the periaqueductal gray matter.  Wet dog shakes were mainly obsd. after methylnaloxonium administration into the anterior preoptic hypothalamus and nucleus raphe magnus.  Injections of methylnaloxonium into the amygdala produced a weak withdrawal syndrome, and the nucleus accumbens and medial thalamus were the least sensitive structures.  These results suggest that the locus ceruleus, and secondarily the periaqueductal gray matter, play an important role in the pptn. of the phys. signs of opiate withdrawal, mainly in the expression of its motor component.  The expression of other signs of withdrawal appear to be multisite detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqNnoHHkAhkLVg90H21EOLACvtfcHk0li3zXAMrJRFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisVygtLs%253D&md5=96461cc5fd3e0b90e04c29ae822201ce</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DStinus%26aufirst%3DL.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26atitle%3DRole%2520of%2520different%2520brains%2520structures%2520in%2520the%2520expression%2520of%2520the%2520physical%2520morphine%2520withdrawal%2520syndrome%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1992%26volume%3D261%26spage%3D669%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>An exploratory,
randomised, double-blind,
placebo and active therapy-controlled, Phase I study, to assess the
safety, tolerability, pharmacokinetics, pharmacodynamics, and food-
effect of single and multiple ascending oral doses of EST73502 in
healthy adults and patients with chronic, moderate moderate-to to-severe
osteoarthritis pain. Study EudraCT Number 2018-000258-23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+exploratory%2C%0Arandomised%2C+double-blind%2C%0Aplacebo+and+active+therapy-controlled%2C+Phase+I+study%2C+to+assess+the%0Asafety%2C+tolerability%2C+pharmacokinetics%2C+pharmacodynamics%2C+and+food-%0Aeffect+of+single+and+multiple+ascending+oral+doses+of+EST73502+in%0Ahealthy+adults+and+patients+with+chronic%2C+moderate+moderate-to+to-severe%0Aosteoarthritis+pain.+Study+EudraCT+Number+2018-000258-23."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of Pan Assay Interference Compounds (PAINS) from screening libraries and their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+screening+libraries+and+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgNQXNTsHqXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, E. A.</span></span> <span> </span><span class="NLM_article-title">Using measured pKa, logP and solubility to investigate supersaturation and predict BCS class</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.2174/138920008786485155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.2174%2F138920008786485155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=18991583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=869-878&author=K.+J.+Boxauthor=E.+A.+Comer&title=Using+measured+pKa%2C+logP+and+solubility+to+investigate+supersaturation+and+predict+BCS+class&doi=10.2174%2F138920008786485155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class</span></div><div class="casAuthors">Box, K. J.; Comer, J. E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">869-878</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ionization, lipophilicity and soly. have a profound influence on the transport properties of drug mols.  We will present an overview of why physicochem. properties are important, before discussing how the properties are related to each other.  Findings are based on research in our own labs. using our com. instruments and software to measure the pKa, lipophilicity (LogP) and intrinsic soly. (LogS0) of 84 marketed ionizable drugs.  In general, the most lipophilic mols. were the least sol. in water.  Plots of LogP vs. LogS0 show results for these drugs clustered according to other properties, including m.p., no. of H-bond donors and acceptors, ability to supersaturate, and BCS class.  Mols. with high m.p. tended to have a larger no. of H-bond donors and acceptors, and to be less sol. than predicted from their LogP.  Mols. with low m.p. tended to have little H-bond donor capacity, and tended to be more sol. than predicted from their LogP.  Mols. that could form supersatd. solns. tended to have higher m.ps., and to be less sol. than predicted from their LogP.  Mols. in BCS Classes I - III tended to cluster in different parts of the plot.  It is proposed that comparing measured LogP and LogS0 of new mols. with these plots will facilitate a quick assessment of their likely BCS Class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjSonznQUhwbVg90H21EOLACvtfcHk0lgNQXNTsHqXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb4%253D&md5=d330301b360589feb67aa92fc0227ea6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F138920008786485155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485155%26sid%3Dliteratum%253Aachs%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DComer%26aufirst%3DE.%2BA.%26atitle%3DUsing%2520measured%2520pKa%252C%2520logP%2520and%2520solubility%2520to%2520investigate%2520supersaturation%2520and%2520predict%2520BCS%2520class%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D869%26epage%3D878%26doi%3D10.2174%2F138920008786485155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vonrhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flensburg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smart, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paciorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span> <span> </span><span class="NLM_article-title">Data processing and analysis with the autoPROC toolbox</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>D67</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lgNQXNTsHqXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobley, C. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, S. M.</span></span> <span> </span><span class="NLM_article-title">Decision making in <i>xia</i>2</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>D69</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1107/S0907444913015308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0907444913015308" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D69&publication_year=2013&pages=1260-1273&author=G.+Winterauthor=C.+M.+C.+Lobleyauthor=S.+M.+Prince&title=Decision+making+in+xia2&doi=10.1107%2FS0907444913015308"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444913015308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913015308%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DLobley%26aufirst%3DC.%2BM.%2BC.%26aulast%3DPrince%26aufirst%3DS.%2BM.%26atitle%3DDecision%2520making%2520in%2520xia2%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3DD69%26spage%3D1260%26epage%3D1273%26doi%3D10.1107%2FS0907444913015308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">A short history of <i>SHELX</i></span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>A64</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lj9F5SJrzl7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macrae, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgington, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidcock, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Monge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Streek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. A.</span></span> <span> </span><span class="NLM_article-title">Mercury CSD 2.0 - new features for the visualization and investigation of crystal structures</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1107/S0021889807067908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0021889807067908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Gmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=466-470&author=C.+F.+Macraeauthor=I.+J.+Brunoauthor=J.+A.+Chisholmauthor=P.+R.+Edgingtonauthor=P.+McCabeauthor=E.+Pidcockauthor=L.+Rodriguez-Mongeauthor=R.+Taylorauthor=J.+van+de+Streekauthor=P.+A.+Wood&title=Mercury+CSD+2.0+-+new+features+for+the+visualization+and+investigation+of+crystal+structures&doi=10.1107%2FS0021889807067908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mercury CSD 2.0 - new features for the visualization and investigation of crystal structures</span></div><div class="casAuthors">Macrae, Clare F.; Bruno, Ian J.; Chisholm, James A.; Edgington, Paul R.; McCabe, Patrick; Pidcock, Elna; Rodriguez-Monge, Lucia; Taylor, Robin; van de Streek, Jacco; Wood, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The program Mercury, developed by the Cambridge Crystallog. Data Center, is designed primarily as a crystal structure visualization tool.  A new module of functionality has been produced, called the Materials Module, which allows highly customizable searching of structural databases for intermol. interaction motifs and packing patterns.  This new module also includes the ability to perform packing similarity calcns. between structures contg. the same compd.  In addn. to the Materials Module, a range of further enhancements to Mercury has been added in this latest release, including void visualization and links to ConQuest, Mogul and IsoStar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFbwrUJZMm4bVg90H21EOLACvtfcHk0lj9F5SJrzl7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Gmtb0%253D&md5=db23811e250db28395ee5258fe95da4d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889807067908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807067908%26sid%3Dliteratum%253Aachs%26aulast%3DMacrae%26aufirst%3DC.%2BF.%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DChisholm%26aufirst%3DJ.%2BA.%26aulast%3DEdgington%26aufirst%3DP.%2BR.%26aulast%3DMcCabe%26aufirst%3DP.%26aulast%3DPidcock%26aufirst%3DE.%26aulast%3DRodriguez-Monge%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3Dvan%2Bde%2BStreek%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DP.%2BA.%26atitle%3DMercury%2520CSD%25202.0%2520-%2520new%2520features%2520for%2520the%2520visualization%2520and%2520investigation%2520of%2520crystal%2520structures%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2008%26volume%3D41%26spage%3D466%26epage%3D470%26doi%3D10.1107%2FS0021889807067908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flack, H. D.</span></span> <span> </span><span class="NLM_article-title">On enantiomorph-polarity estimation</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>A39</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1107/S0108767383001762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1107%2FS0108767383001762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaL3sXmtVeqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A39&publication_year=1983&pages=876-881&author=H.+D.+Flack&title=On+enantiomorph-polarity+estimation&doi=10.1107%2FS0108767383001762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">On enantiomorph-polarity estimation</span></div><div class="casAuthors">Flack, H. D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A:  Foundations of Crystallography</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">A39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">876-81</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    </div><div class="casAbstract">The behavior of Roger's η parameter (1981) for enantiomorph-polarity estn. is examd. theor. and exptl. on simulated intensity data for 7 well-assorted compds.  An alternative parameter x, based on incoherent scattering from twin components related by a center of symmetry, is also considered.  Both parameters are very well adapted to implementation in a least-squares program and converge well.  The η parameter can give false and over-precise indications of chirality-polarity for structures which are nearly centrosym., whereas the x parameter does not have this fault and converges more rapidly than η.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowaeaLtSgacrVg90H21EOLACvtfcHk0lhmYc64dldGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXmtVeqtLo%253D&md5=ceb7d60023992a868f9832763caf0341</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0108767383001762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767383001762%26sid%3Dliteratum%253Aachs%26aulast%3DFlack%26aufirst%3DH.%2BD.%26atitle%3DOn%2520enantiomorph-polarity%2520estimation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1983%26volume%3DA39%26spage%3D876%26epage%3D881%26doi%3D10.1107%2FS0108767383001762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lomize, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogozheva, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomize, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosberg, H. I.</span></span> <span> </span><span class="NLM_article-title">Positioning of proteins in membranes: A computational approach</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1318</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1110/ps.062126106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1110%2Fps.062126106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=16731967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVKqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1318-1333&author=A.+L.+Lomizeauthor=I.+D.+Pogozhevaauthor=M.+A.+Lomizeauthor=H.+I.+Mosberg&title=Positioning+of+proteins+in+membranes%3A+A+computational+approach&doi=10.1110%2Fps.062126106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Positioning of proteins in membranes: a computational approach</span></div><div class="casAuthors">Lomize, Andrei L.; Pogozheva, Irina D.; Lomize, Mikhail A.; Mosberg, Henry I.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1318-1333</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A new computational approach has been developed to det. the spatial arrangement of proteins in membranes by minimizing their transfer energies from water to the lipid bilayer.  The membrane hydrocarbon core was approximated as a planar slab of adjustable thickness with decadiene-like interior and interfacial polarity profiles derived from published EPR studies.  Applicability and accuracy of the method was verified for a set of 24 transmembrane proteins whose orientations in membranes have been studied by spin-labeling, chem. modification, fluorescence, ATR FTIR, NMR, cryo-microscopy, and neutron diffraction.  Subsequently, the optimal rotational and translational positions were calcd. for 109 transmembrane, five integral monotopic and 27 peripheral protein complexes with known 3D structures.  This method can reliably distinguish transmembrane and integral monotopic proteins from water-sol. proteins based on their transfer energies and membrane penetration depths.  The accuracies of calcd. hydrophobic thicknesses and tilt angles were ∼1 Å and 2°, resp., judging from their deviations in different crystal forms of the same proteins.  The hydrophobic thicknesses of transmembrane proteins ranged from 21.1 to 43.8 Å depending on the type of biol. membrane, while their tilt angles with respect to the bilayer normal varied from zero in sym. complexes to 26° in asym. structures.  Calcd. hydrophobic boundaries of proteins are located ∼5 Å lower than lipid phosphates and correspond to the zero membrane depth parameter of spin-labeled residues.  Coordinates of all studied proteins with their membrane boundaries can be found in the Orientations of Proteins in Membranes (OPM) database: http://opm.phar.umich.edu/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQXXJ5AlXcvrVg90H21EOLACvtfcHk0lhmYc64dldGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVKqtbg%253D&md5=a05527682c9bc1742fab35228061774a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1110%2Fps.062126106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.062126106%26sid%3Dliteratum%253Aachs%26aulast%3DLomize%26aufirst%3DA.%2BL.%26aulast%3DPogozheva%26aufirst%3DI.%2BD.%26aulast%3DLomize%26aufirst%3DM.%2BA.%26aulast%3DMosberg%26aufirst%3DH.%2BI.%26atitle%3DPositioning%2520of%2520proteins%2520in%2520membranes%253A%2520A%2520computational%2520approach%26jtitle%3DProtein%2520Sci.%26date%3D2006%26volume%3D15%26spage%3D1318%26epage%3D1333%26doi%3D10.1110%2Fps.062126106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span> <i>Discovery Studio
16</i>; <span class="NLM_publisher-name">Dassault Systèmes
BIOVIA</span>: <span class="NLM_publisher-loc">San Diego, CA</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Discovery+Studio%0A16%3B+Dassault+Syst%C3%A8mes%0ABIOVIA%3A+San+Diego%2C+CA%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DDiscovery%2520Studio%250A16%26pub%3DDassault%2520Syst%25C3%25A8mes%250ABIOVIA%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diller, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.</span></span> <span> </span><span class="NLM_article-title">High throughput docking for library design and library prioritization</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=11276081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlels7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2001&pages=113-124&author=D.+J.+Dillerauthor=K.+M.+Merz&title=High+throughput+docking+for+library+design+and+library+prioritization&doi=10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput docking for library design and library prioritization</span></div><div class="casAuthors">Diller, David J.; Merz, Kenneth M., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The prioritization of the screening of combinatorial libraries is an extremely important task for the rapid identification of tight binding ligands and ultimately pharmaceutical compds.  When structural information for the target is available, mol. docking is an approach that can be used for prioritization.  Here, we present the initial validation of a new rapid approach to mol. docking developed for prioritizing combinatorial libraries.  The algorithm is tested on 103 individual cases from the protein data bank and in nearly 90% of these cases docks the ligand to within 2.0 Å of the obsd. binding mode.  Because the mean CPU time is <5 s/mol, this approach can process hundreds of thousands of compds. per wk.  Furthermore, if a somewhat less thorough search is performed, the search time drops to 1 s/mol, thus allowing millions of compds. to be docked per wk and tested for potential activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRE1RQbB3WD7Vg90H21EOLACvtfcHk0lhmYc64dldGqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlels7c%253D&md5=a84ff9a463495594d85db465b27e9216</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0134%252820010501%252943%253A2%253C113%253A%253AAID-PROT1023%253E3.0.CO%253B2-T%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DD.%2BJ.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26atitle%3DHigh%2520throughput%2520docking%2520for%2520library%2520design%2520and%2520library%2520prioritization%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2001%26volume%3D43%26spage%3D113%26epage%3D124%26doi%3D10.1002%2F1097-0134%2820010501%2943%3A2%3C113%3A%3AAID-PROT1023%3E3.0.CO%3B2-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>S <i>chrödinger
Release 2017-4: Maestro</i>; <span class="NLM_publisher-name">Schrödinger,
LLC</span>,: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=S+chr%C3%B6dinger%0ARelease+2017-4%3A+Maestro%3B+Schr%C3%B6dinger%2C%0ALLC%2C%3A+New+York%2C%0ANY%2C+2020."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3Dchr%25C3%25B6dinger%250ARelease%25202017-4%253A%2520Maestro%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, K. J.</span>; <span class="NLM_string-name">Chow, E.</span>; <span class="NLM_string-name">Xu, H.</span>; <span class="NLM_string-name">Dror, R. O.</span>; <span class="NLM_string-name">Eastwood, M. P.</span>; <span class="NLM_string-name">Gregersen, B. A.</span>; <span class="NLM_string-name">Klepeis, J. L.</span>; <span class="NLM_string-name">Kolossvary, I.</span>; <span class="NLM_string-name">Moraes, M. A.</span>; <span class="NLM_string-name">Sacerdoti, F. D.</span>; <span class="NLM_string-name">Salmon, J. K.</span>; <span class="NLM_string-name">Shan, Y.</span>; <span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters</span>.  <i>Proceedings of the ACM/IEEE Conference on Supercomputing (SC06)</i>, Tampa, FL, November 11–17, 2006; <span class="NLM_publisher-name">ACM/IEEE</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1109%2FSC.2006.54" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+J.+Bowers&author=E.+Chow&author=H.+Xu&author=R.+O.+Dror&author=M.+P.+Eastwood&author=B.+A.+Gregersen&author=J.+L.+Klepeis&author=I.+Kolossvary&author=M.+A.+Moraes&author=F.+D.+Sacerdoti&author=J.+K.+Salmon&author=Y.+Shan&author=D.+E.+Shaw&title=Proceedings+of+the+ACM%2FIEEE+Conference+on+Supercomputing+%28SC06%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1109%2FSC.2006.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1109%252FSC.2006.54%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DK.%2BJ.%26atitle%3DScalable%2520Algorithms%2520for%2520Molecular%2520Dynamics%2520Simulations%2520on%2520Commodity%2520Clusters%26btitle%3DProceedings%2520of%2520the%2520ACM%252FIEEE%2520Conference%2520on%2520Supercomputing%2520%2528SC06%2529%26pub%3DACM%252FIEEE%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Randall, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selitto, J. J.</span></span> <span> </span><span class="NLM_article-title">A method for measurement of analgesic activity on inflamed tissue</span>. <i>Arch. Int. Pharmacodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=13471093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A528%3ADyaG1cXis1Gnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1957&pages=409-419&author=L.+O.+Randallauthor=J.+J.+Selitto&title=A+method+for+measurement+of+analgesic+activity+on+inflamed+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A method for measurement of analgesic activity on inflamed tissue</span></div><div class="casAuthors">Randall, Lowell O.; Selitto, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">409-19</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">The inflamed feet of the rat were twice as sensitive to pressure as were normal feet.  Salicylate, phenylbutazone, and Ro 2-5383 raise the pain threshold of inflamed but not of normal feet, and aminopyrine and narcotic analgesics raise it in both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWxvjwjaEQurVg90H21EOLACvtfcHk0lh27fwrQbAZrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXis1Gnug%253D%253D&md5=b4ddc4f843cb6b8963315e1e7c69edeb</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRandall%26aufirst%3DL.%2BO.%26aulast%3DSelitto%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520method%2520for%2520measurement%2520of%2520analgesic%2520activity%2520on%2520inflamed%2520tissue%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1957%26volume%3D111%26spage%3D409%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basbaum, A. I.</span></span> <span> </span><span class="NLM_article-title">Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(98)00045-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2FS0304-3959%2898%2900045-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=9696476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADyaK1czlvFKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1998&pages=215-222&author=A.+B.+Malmbergauthor=A.+I.+Basbaum&title=Partial+sciatic+nerve+injury+in+the+mouse+as+a+model+of+neuropathic+pain%3A+behavioral+and+neuroanatomical+correlates&doi=10.1016%2FS0304-3959%2898%2900045-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates</span></div><div class="casAuthors">Malmberg A B; Basbaum A I</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">215-22</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The generation of knock-out and transgenic mice offers a promising approach to the identification of novel biochemical factors that contribute to persistent pain conditions.  To take advantage of these mice, however, it is important to demonstrate that the traditional models of persistent pain, which were largely developed for studies in the rat, can be used in the mouse.  Here, we combined behavioral and anatomical methods to characterize the pathophysiology of a partial nerve injury-evoked pain condition in the 'normal' mouse.  In male C57BL6 mice we tied a tight ligature around 1/3 to 1/2 of the diameter of the sciatic nerve and evaluated the time-course and magnitude of the ensuing mechanical and thermal allodynia.  We also used immunocytochemistry to analyze nerve injury-induced changes in substance P (SP) and NK-1 (SP) receptor expression in the spinal cord.  As in the rat, partial nerve injury markedly decreased paw withdrawal thresholds to both mechanical and thermal stimuli on the injured side.  We detected threshold changes one day after the injury.  The thermal allodynia resolved by 49 days, but the mechanical allodynia persisted for the duration of the study (70 days).  We found no changes contralateral to the nerve injury.  Sympatholytic treatment with guanethidine significantly reduced both the thermal and mechanical allodynia.  We observed a reduction of SP immunoreactivity in the superficial dorsal horn on the injured side at 7 and 14, but not at 3 or 70 days after the nerve injury, and we observed an increase of NK-1 receptor expression at 3, 7, 14 and 42, but not at 70 days after the injury.  We conclude that partial injury to the sciatic nerve produces a comparable allodynia and neurochemical plasticity in the rat and mouse.  These results establish a valuable model for future studies of the biochemical basis of neuropathic pain in mice with specific gene modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9ebNsr6ajcSEJCPKhJPuqfW6udTcc2ebuIlaXzw-Qb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czlvFKltw%253D%253D&md5=b3fb6f6fc75f5738f9d3d025bc63b432</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2898%2900045-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252898%252900045-1%26sid%3Dliteratum%253Aachs%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3DPartial%2520sciatic%2520nerve%2520injury%2520in%2520the%2520mouse%2520as%2520a%2520model%2520of%2520neuropathic%2520pain%253A%2520behavioral%2520and%2520neuroanatomical%2520correlates%26jtitle%3DPain%26date%3D1998%26volume%3D76%26spage%3D215%26epage%3D222%26doi%3D10.1016%2FS0304-3959%2898%2900045-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogrel, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of tactile allodynia in the rat paw</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2ebuIlaXzw-Qb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520assessment%2520of%2520tactile%2520allodynia%2520in%2520the%2520rat%2520paw%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e5227-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01127">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33776"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01127?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01127</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Analytical data for all the final compounds and intermediates, optical purity of enantiopure compounds, and experimental methods for affinity measurement in selectivity panel targets(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_001.pdf">jm0c01127_si_001.pdf (1.78 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01127/suppl_file/jm0c01127_si_002.csv">jm0c01127_si_002.csv (3.52 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01127&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01127" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01127" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a3de1ba2d238c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
